Pharmacological Targets
A knowledge base of drug targets, used for the treatment of tuberculosis, and those considered as promising in the development of new pharmaceuticals. All pharmacological targets are differentiated into three categories: the targets of approved drugs (Launched); drugs targets studied in clinical trials (Clinical); targets of pharmacological substances investigated in preclinical studies (Preclinical). Relevant information indirectly characterizing the degree of reliability of the association of a particular target with the disease in question was included in our database.
One may browse the records in the database or search for a particular drug target using target name as a query.
Pharmacological targets are associated with links on the appropriate information in UniProt, KEGG and PDB.
Loading .. Please wait
| Target's name | UniProt | PDB | Kegg | Pharmacotheraputic application | ||
|---|---|---|---|---|---|---|
| Launched | Clinical | Preclinical | ||||
| Target's name | UniProt | PDB | Kegg | Pharmacotheraputic application | ||
| Launched | Clinical | Preclinical | ||||
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | Q07973 | Cancer | ||||
| 1-Acyl-sn-glycerol-3-phosphate acyltransferase beta precursor (isoform a) | O15120 | Cancer | ||||
| 1-Acylglycerol-3-phosphate O-acyltransferase ABHD5 | Q8WTS1 | Cancer Diabetes | ||||
| 1-Phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (isoform 1) | P19174 |  | Cancer | |||
| 1-Phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (isoform 2) | P19174 | Cancer | ||||
| 1-Phosphatidylinositol-3-phosphate 5-kinase (isoform 2) | Q9Y2I7 | Diabetes | ||||
| 11beta-Hydroxysteroid Dehydrogenase (nonspecified subtype) | Diabetes | Cancer | ||||
| 14-3-3 Protein epsilon | P62258 | Cancer | ||||
| 14-3-3 Protein sigma | P31947 | Cancer | ||||
| 15-hydroxyprostaglandin dehydrogenase (NAD+) (isoform 1) | P15428 | Cancer | ||||
| 15-Lipoxygenase (nonspecified subtype) | Cancer Diabetes | Malaria | ||||
| 17-beta-Hydroxysteroid dehydrogenase (nonspecified subtype) | Cancer | Diabetes | ||||
| 2'-Deoxynucleoside 5'-phosphate N-hydrolase 1 (isoform 1) | O43598 | Cancer | ||||
| 2-5A-Dependent Ribonuclease | Q05823 | Cancer | ||||
| 2-Amino-3-carboxymuconate-6-semialdehyde | Q8TDX5 | Cancer Diabetes | ||||
| 26S Proteasome non-ATPase regulatory subunit 14 | O00487 | Cancer Diabetes | ||||
| 3 beta-Hydroxysteroid dehydrogenase/Delta 5-->4-isomerase (nonspecified subtype) | Cancer | |||||
| 3 beta-Hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 | P14060 | Cancer | ||||
| 3-Hydroxyacyl-CoA dehydrogenase type-2 | Q99714 | | Cancer | |||
| 3-Keto-steroid reductase | P56937 | Cancer | ||||
| 3-oxo-5-alpha-Steroid 4-dehydrogenase 1 | P18405 | Cancer | ||||
| 3-oxo-5-alpha-Steroid 4-dehydrogenase 2 | P31213 | Cancer | ||||
| 3-Oxoacyl-(acyl-carrier protein) reductase | Q8I2S7 | Cancer Leishmaniasis Malaria | ||||
| 3-Phosphoinositide-dependent protein kinase 1 (isoform 1) | O15530 | | Cancer | Diabetes | ||
| 4-Aminobutyrate transaminase isoform 1 (GABA aminotransferase; GABA-AT) | P80404 | Epilepsy | Cancer | |||
| 406892MIR100 | Cancer | |||||
| 40S Ribosomal protein S5 | P46782 | Cancer | ||||
| 40S Ribosomal protein SA (isoform 1) | P08865 | Cancer | ||||
| 4F2 Cell-surface antigen heavy chain | P08195 | | Cancer | |||
| 5'-Nucleotidase | P21589 | Cancer | ||||
| 5-Hydroxytryptamine Receptor (5-HT; Serotonin Receptor) (nonspecified subtype) | Epilepsy | Cancer | ||||
| 5-Hydroxytryptamine receptor 1A | P08908 | Epilepsy | Cancer Diabetes | |||
| 5-Hydroxytryptamine receptor 1B | P28222 | Cancer | Diabetes | |||
| 5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified subtype) | Epilepsy | |||||
| 5-Hydroxytryptamine receptor 2A (isoform 1) | P28223 | Epilepsy | Cancer Diabetes | |||
| 5-Hydroxytryptamine Receptor 2B | P41595 | Epilepsy | Cancer Diabetes | |||
| 5-Hydroxytryptamine Receptor 2C (5-HT2C) | P28335 | Malaria | Cancer Diabetes Epilepsy | |||
| 5-Hydroxytryptamine Receptor 3 (5-HT3 receptor) (nonspecified subtype) | Cancer Epilepsy | |||||
| 5-Hydroxytryptamine receptor 4 (isoform a) | Q13639 | Diabetes | ||||
| 5-Hydroxytryptamine receptor 4 (isoform b) | Q13639 | Diabetes | ||||
| 5-Hydroxytryptamine receptor 4 (isoform d) | Q13639 | Diabetes | ||||
| 5-Hydroxytryptamine receptor 4 (isoform g) | Q13639 | Diabetes | ||||
| 5-Hydroxytryptamine receptor 4 (isoform i) | Q13639 | Diabetes | ||||
| 5-Hydroxytryptamine receptor 6 | P50406 | Epilepsy | Cancer Diabetes | |||
| 5-Hydroxytryptamine receptor 7 | P34969 | Epilepsy | Diabetes | |||
| 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | Q16877 | Cancer | ||||
| 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (isoform 1) | Q16875 | Cancer | ||||
| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (isoform 3) | Q16875 | Cancer | ||||
| 60 kDa Heat shock protein, mitochondrial | P10809 | Cancer | ||||
| 7,8-Dihydro-8-oxoguanine triphosphatase (isoform p18) | P36639 | | Cancer | |||
| 7,8-Dihydro-8-oxoguanine triphosphatase (isoform p22) | P36639 | | Cancer | |||
| 7-Methylguanosine phosphate-specific 5'-nucleotidase | Q969T7 | Cancer | ||||
| 72 kDa Type IV collagenase (isoform 1) | P08253 | | Cancer Epilepsy | Diabetes | ||
| 72 kDa Type IV collagenase (isoform 2) | P08253 | | Cancer Epilepsy | Diabetes | ||
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (isoform 1) | Q15118 | Cancer Diabetes | ||||
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (isoform 2) | Q15118 | | Cancer Diabetes | |||
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | Q15119 | Cancer Diabetes | ||||
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | Q16654 | Diabetes | Cancer | |||
| ABCA1 | Cancer Diabetes | |||||
| ABCB1 variant 1 | Cancer | |||||
| ABCB1 variant 3 | Cancer | |||||
| ABCC1 variant 1 | Cancer | |||||
| ABCC3 variant 1 | Cancer | |||||
| ABCC3 variant 2 | Cancer | |||||
| ABCG2 variant 1 | Cancer | |||||
| ABCG2 variant 2 | Cancer | |||||
| Abelson tyrosine-protein kinase 2 | P42684 | Cancer | ||||
| Abhydrolase domain containing 6 | Q9BV23 | Cancer Diabetes | ||||
| Acetyl-CoA carboxylase 1 (isoform 1) | Q13085 | Cancer Diabetes | ||||
| Acetyl-CoA carboxylase 1 (isoform 4) | Q13085 | Cancer Diabetes | ||||
| Acetyl-CoA carboxylase 2 | O00763 | | Diabetes | Cancer | ||
| Acetyl-CoA Carboxylases (ACC) (nonspecified subtype) | Diabetes | Cancer Malaria Tuberculosis | ||||
| Acetyl-coenzyme A synthetase, cytoplasmic | Q9NR19 | Cancer | ||||
| Acetylcholine receptor subunit alpha (isoform 1) | P02708 | Cancer Epilepsy | ||||
| Acetylcholine receptor subunit alpha (isoform 2) | P02708 | Cancer Epilepsy | ||||
| Acetylcholine Receptors (Nicotinic) (nAChR) (nonspecified subtype) | Cancer | Malaria | Diabetes Epilepsy | |||
| Acetylcholinesterase | P22303 | |  | Cancer Epilepsy | Leishmaniasis | Diabetes Tuberculosis |
| Acid ceramidase (isoform a) | Q13510 | Cancer | ||||
| Acid ceramidase (isoform b) | Q13510 | Cancer | ||||
| Acid-Sensing Ion Channel (ASIC) (nonspecified subtype) | Cancer | |||||
| Acid-sensing ion channel 1 (isoform b) | P78348 | Cancer Epilepsy | ||||
| Acidic mammalian chitinase (AMCase) | Q9BZP6 | Cancer Diabetes Leishmaniasis | ||||
| Acidic mammalian chitinase (isoform c) | Q9BZP6 | Leishmaniasis | Cancer Diabetes | |||
| Actin (nonspecified subtype) | Cancer | |||||
| Actin related protein 2/3 complex | Cancer Diabetes | |||||
| Activated CDC42 kinase 1 (isoform 1) | Q07912 | | Cancer | |||
| Activated CDC42 kinase 1 (isoform 3) | Q07912 | Cancer | ||||
| Activin Receptor Type-1 | Q04771 | Cancer | ||||
| Activin receptor type-1B (isoform 1) | P36896 | Cancer | ||||
| Activin receptor type-1B (isoform 2) | P36896 | Cancer | ||||
| Activin receptor type-2B | Q13705 | | Diabetes | |||
| ACVRL1 variant 1 | Cancer | |||||
| ACVRL1 variant 2 | Cancer | |||||
| Acyl-CoA desaturase | O00767 | Cancer Diabetes | Malaria | |||
| Acyl-CoA Synthetase Short-Chain (nonspecified subtype) | Cancer | |||||
| Acyl-protein thioesterase 1 | O75608 | Cancer | ||||
| Acyl-protein thioesterase 2 | O95372 | Cancer | ||||
| Acylamino-acid-releasing enzyme | P13798 | Cancer Epilepsy | ||||
| Acylglycerol kinase, mitochondrial | Q53H12 | Cancer | ||||
| Adapter molecule crk (isoform a) | P46108 | | Cancer | |||
| Adapter molecule crk (isoform b) | P46108 | Cancer | ||||
| Adenomatous polyposis coli protein (isoform 1) | P25054 | | Cancer | |||
| Adenomatous polyposis coli protein (isoform 2) | P25054 | | Cancer | |||
| Adenomatous polyposis coli protein (isoform 3) | P25054 | Cancer | ||||
| Adenomatous polyposis coli protein (isoform 4) | P25054 | Cancer | ||||
| Adenosine A2A receptor | P29274 | Cancer | Epilepsy | Diabetes | ||
| Adenosine A2B receptor | P29275 | Cancer | Epilepsy | Diabetes | ||
| Adenosine A3 receptor | P0DMS8 | | Cancer | Diabetes Epilepsy | ||
| Adenosine deaminase | P00813 | Cancer | ||||
| Adenosine deaminase (nonspecified subtype) | Cancer | |||||
| Adenosine kinase (isoform 1) | P55263 | | Epilepsy | Cancer | ||
| Adenosine kinase (isoform 2) | P55263 | | Epilepsy | Cancer | ||
| Adenosine receptor (nonspecified subtype) | Cancer | Diabetes | ||||
| Adenosine receptor A1 | P30542 | Cancer Diabetes Epilepsy | Malaria | |||
| Adenosylhomocysteinase | P23526 | | Cancer | Malaria | ||
| Adenosylhomocysteinase (isoform X1) | P23526 | | Cancer | Malaria | ||
| Adenylate Cyclase (nonspecified subtype) | Cancer | Malaria | ||||
| Adenylosuccinate synthetase isozyme 2 | P30520 | Cancer | ||||
| Adhesion G-protein coupled receptor G1 (isoform a) | Q9Y653 | Cancer | ||||
| Adhesion G-protein coupled receptor G1 (isoform c) | Q9Y653 | Cancer | ||||
| Adhesion G-protein coupled receptor G5 | Q8IZF4 | Cancer | ||||
| Adiponectin receptor protein 1 | Q96A54 | Cancer Diabetes | ||||
| Adiponectin receptor protein 2 | Q86V24 | Cancer Diabetes | ||||
| ADM | P35318 | Cancer Diabetes | ||||
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38) | P28907 | Cancer | ||||
| ADP-ribosylation factor 1 | P84077 | Cancer | ||||
| ADP-ribosylation factor 6 | P62330 | | Cancer | |||
| ADP-ribosylation factor GTPase-activating protein 1 (isoform a) | Q8N6T3 | | Cancer | |||
| ADP/ATP Translocase (nonspecified subtype) | Cancer | Diabetes | ||||
| Advanced glycosylation end product-specific receptor (isoform 3) | Q15109 | | Diabetes | Cancer | ||
| Advanced glycosylation end product-specific receptor (isoform 4) | Q15109 | | Diabetes | Cancer | ||
| Advanced glycosylation end product-specific receptor (isoform 7) | Q15109 | | Diabetes | Cancer | ||
| Advanced glycosylation end product-specific receptor precursor (isoform 1) | Q15109 | | Diabetes | Cancer | ||
| Advanced glycosylation end product-specific receptor precursor (isoform 2) | Q15109 | | Diabetes | Cancer | ||
| Aggrecanase (nonspecified subtype) | Cancer | |||||
| AGS-16 | Cancer | |||||
| AIMP2 | Cancer | |||||
| AKT1 variant 1 | Cancer | Diabetes | ||||
| AKT1 variant 2 | Cancer | Diabetes | ||||
| AKT1 variant 3 | Cancer | Diabetes | ||||
| AKT2 variant 1 | Cancer | |||||
| AKT2 variant 2 | Cancer | |||||
| AKT3 variant 1 | Cancer | |||||
| AKT3 variant 2 | Cancer | |||||
| Alcohol Dehydrogenase (nonspecified subtype) | Cancer | |||||
| Alcohol dehydrogenase class-3 | P11766 | | Cancer Diabetes | |||
| Aldehyde dehydrogenase family 1 member A3 | P47895 | Cancer | ||||
| Aldehyde dehydrogenase, dimeric NADP-preferring | P30838 | Cancer | ||||
| Aldehyde dehydrogenase, mitochondrial (isoform 1) | P05091 | | Cancer | |||
| Aldehyde dehydrogenase, mitochondrial (isoform 2) | P05091 | | Cancer | |||
| ALDH1A1 | Cancer | |||||
| Aldo-keto reductase family 1 member B10 | O60218 | Cancer | Diabetes Epilepsy | |||
| Aldo-keto reductase family 1 member C1 | Q04828 | | Cancer | |||
| Aldo-keto reductase family 1 member C2 | P52895 | | Cancer | Diabetes | ||
| Aldo-keto reductase family 1 member C3 (isoform 1) | P42330 | | Cancer | Diabetes | ||
| Aldo-keto reductase family 1 member C3 (isoform 2) | P42330 | | Cancer | Diabetes | ||
| Aldose Reductase (Aldehyde reductase) | P15121 | Cancer Diabetes | Leishmaniasis | |||
| ALK | Cancer Malaria | |||||
| ALK tyrosine kinase receptor | Q9UM73 | Cancer | ||||
| Alkaline phosphatase, placental type | P05187 | | Cancer | |||
| Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | Cancer Diabetes | ||||
| alpha-1A adrenergic receptor (isoform X1) | P35348 | Cancer | ||||
| alpha-1A Adrenoceptor receptor (isoform 3) | P35348 | Cancer | ||||
| alpha-1D Adrenoceptor | P25100 | Cancer Epilepsy | ||||
| Alpha-2,8-sialyltransferase 8B | Q92186 | Cancer | ||||
| alpha-Adrenoceptor (nonspecified subtype) | Cancer | |||||
| alpha-Amylase (nonspecified subtype) | Diabetes | Cancer | ||||
| Alpha-crystallin | Cancer | |||||
| Alpha-crystallin A chain | P02489 | Cancer | ||||
| Alpha-enolase (isoform 1) | P06733 | Cancer | ||||
| Alpha-fetoprotein | P02771 | Cancer | ||||
| Alpha-globin transcription factor CP2 (isoform 1) | Q12800 | Cancer | ||||
| Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 | Q96Q83 | Cancer | ||||
| Alpha-ketoglutarate-dependent dioxygenase FTO | Q9C0B1 | Epilepsy | ||||
| alpha-Mannosidase (nonspecified subtype) | | Cancer Tuberculosis | Diabetes | |||
| Alpha-mannosidase 2 | Q16706 | Cancer | ||||
| alpha-Methylacyl-CoA racemase (isoform 1) | Q9UHK6 | Cancer | ||||
| Alpha-N-Acetylgalactosaminidase | P17050 | | Cancer Diabetes | |||
| alpha-Secretase (nonspecified subtype) | Cancer | |||||
| Alpha-synuclein (isoform 1) | P37840 | | Cancer | |||
| Alpha-synuclein (isoform 4) | P37840 | Cancer | ||||
| alpha1-Adrenoceptor (nonspecified subtype) | Cancer Epilepsy | |||||
| alpha1A-Adrenoceptor (isoform 2) | P35348 | Cancer | ||||
| Alpha1B-adrenoceptor | P35368 | Cancer | Diabetes | |||
| alpha2-Adrenoceptor (nonspecified subtype) | Epilepsy | Diabetes Malaria | ||||
| alpha2A-Adrenoceptor | P08913 | | Cancer | Diabetes Epilepsy | ||
| AMIGO2 variant 2 | Cancer | |||||
| Amiloride-sensitive cation channel 2, neuronal (isoform a) | P78348 | Tuberculosis | Cancer Epilepsy | |||
| Amine oxidase [flavin-containing] A | P21397 | | | Tuberculosis | Cancer Diabetes Leishmaniasis Epilepsy | Malaria |
| Amine oxidase [flavin-containing] B | P27338 | | | Diabetes | Cancer Epilepsy | Malaria Tuberculosis |
| Aminopeptidase N | P15144 | Cancer | Malaria | |||
| AMP-activated protein kinase (AMPK) | Cancer Diabetes Epilepsy | Leishmaniasis Malaria | ||||
| AMP-activated protein kinase alpha1beta1gamma1 | Diabetes | Cancer | ||||
| AMP-activated protein kinase alpha2beta1gamma1 | Cancer Diabetes | |||||
| AMP-activated protein kinase alpha2beta1gamma2 | Diabetes | Cancer | ||||
| Amphiphysin (isoform 1) | P49418 | Cancer | ||||
| Amphiphysin (isoform 2) | P49418 | | Cancer | |||
| Amyloid beta A4 protein (isoform a) | P05067 | | Epilepsy | Cancer | ||
| Amyloid beta A4 protein (isoform b) | P05067 | | Epilepsy | Cancer | ||
| Amyloid beta A4 protein (isoform c) | P05067 | | Epilepsy | |||
| Amyloid beta A4 protein (isoform e) | P05067 | | Epilepsy | |||
| Amyloid beta A4 protein (isoform f) | P05067 | | Epilepsy | |||
| Amyloid beta A4 protein (isoform g) | P05067 | | Epilepsy | |||
| Amyloid beta A4 protein (isoform h) | P05067 | | Epilepsy | |||
| Amyloid beta A4 protein (isoform i) | P05067 | | Epilepsy | |||
| Amyloid beta A4 protein (isoform j) | P05067 | | Epilepsy | |||
| Anandamide membrane transporter (AMT) | Cancer | |||||
| Anaphase promoting complex/cyclosome (APC/C) | Cancer | |||||
| Androgen receptor (isoform 1) | P10275 | Cancer | Diabetes Leishmaniasis | |||
| Androgen receptor (isoform 2) | P10275 | | Cancer | Diabetes Leishmaniasis | ||
| Angiopoietin 1 (isoform a) | Q15389 | Cancer | ||||
| Angiopoietin-1 receptor (Tie-2) | Q02763 | | Cancer | Diabetes | ||
| Angiopoietin-2 (isoform a) | O15123 | | Cancer | |||
| Angiopoietin-2 (isoform b) | O15123 | | Cancer | |||
| Angiopoietin-related protein 4 (isoform a) | Q9BY76 | Cancer | ||||
| Angiopoietin-related protein 4 (isoform b) | Q9BY76 | Cancer | ||||
| Angiotensin receptor (AT) (nonspecified subtype) | Diabetes | |||||
| Angiotensin-converting enzyme (isoform 1) | P12821 | | Cancer Diabetes | |||
| Angiotensin-converting enzyme (isoform 2) | P12821 | | Cancer Diabetes | |||
| Angiotensin-converting enzyme (isoform 3) | P12821 | | Cancer Diabetes | |||
| ANGPT2 variant 1 | Cancer | |||||
| ANGPT2 variant 2 | Cancer | |||||
| Annexin A2 (isoform 1) | P07355 | | Cancer | |||
| Annexin A2 (isoform 2) | P07355 | Cancer | ||||
| ANO5 variant 1 | Cancer | |||||
| Anoctamin-1 | Q5XXA6 | Cancer | ||||
| Anterior gradient protein 2 homolog | O95994 | Cancer | ||||
| Anthrax toxin receptor 1 (isoform 1) | Q9H6X2 | Cancer | ||||
| Anthrax toxin receptor 1 (isoform 2) | Q9H6X2 | Cancer | ||||
| Anti-Muellerian hormone type-2 receptor (isoform 1) | Q16671 | Cancer | ||||
| Anti-Muellerian hormone type-2 receptor (isoform 2) | Q16671 | Cancer | ||||
| Anti-Muellerian hormone type-2 receptor (isoform 3) | Q16671 | Cancer | ||||
| Antileukoproteinase | P03973 | Cancer | ||||
| Apelin | Q9ULZ1 | Cancer | ||||
| Apelin receptor | P35414 | Cancer | Diabetes | |||
| APEX1 variant 1 | Cancer | |||||
| APEX1 variant 4 | Cancer | |||||
| APOA1 | Cancer | Diabetes | ||||
| APOB | Cancer Diabetes | |||||
| APOBEC3G | Cancer | |||||
| APOH | Cancer | |||||
| Apolipoprotein B-100 | P04114 | Cancer Diabetes | ||||
| Apolipoprotein E (isoform 2) | P02649 | | Cancer | |||
| Apolipoprotein E (isoform 1) | P02649 | Cancer | ||||
| Apoptosis regulator BAX (isoform 1) | Q07812 | Cancer | Diabetes | |||
| Apoptosis regulator BAX (isoform Beta) | Q07812 | | Cancer | Diabetes | ||
| Apoptosis regulator Bcl-2 (isoform alpha) | P10415 | | Cancer | Diabetes | ||
| Apoptosis regulator Bcl-2 (isoform beta) | P10415 | | Cancer | Diabetes | ||
| Apoptosis regulator Bcl-2 (isoform X1) | P10415 | | Cancer | Diabetes | ||
| APTX variant 1 | Cancer | |||||
| APTX variant 10 | Cancer | |||||
| APTX variant 11 | Cancer | |||||
| APTX variant 6 | Cancer | |||||
| APTX variant 7 | Cancer | |||||
| APTX variant 8 | Cancer | |||||
| AQP3 | Cancer | |||||
| Aquaporin-1 (isoform 1) | P29972 | | Cancer | |||
| Aquaporin-1 (isoform 2) | P29972 | | Cancer | |||
| Aquaporin-3 | Q92482 | Cancer | ||||
| AR variant 1 | Cancer | Diabetes | ||||
| AR variant 2 | Cancer | Diabetes | ||||
| Arachidonate 12-lipoxygenase, 12S-type | P18054 | Cancer Diabetes | Malaria | |||
| Arachidonate 15-lipoxygenase | P16050 | Cancer Diabetes | Malaria | |||
| Arachidonate 5-lipoxygenase (5-LOX) | P09917 | Cancer Diabetes | ||||
| Arachidonate 5-lipoxygenase-activating protein (isoform 1) | P20292 | | Cancer | |||
| Arachidonate 5-lipoxygenase-activating protein (isoform 2) | P20292 | | Cancer | |||
| Arginase (nonspecified subtype) | Cancer | |||||
| ARL8B | Cancer | |||||
| Armadillo repeat protein deleted in velo-cardio-facial syndrome | O00192 | Cancer | ||||
| Armadillo repeat protein deleted in velo-cardio-facial syndrome (isoform X2 ) | O00192 | Cancer | ||||
| Aromatase | P11511 | Cancer | Diabetes | Malaria | ||
| Artemin (isoform 3) | Q5T4W7 | Cancer | ||||
| Aryl hydrocarbon receptor (AhR) | P35869 | Cancer | Diabetes | |||
| Arylamine N-acetyltransferase 1 | P18440 | Cancer | ||||
| Asparagine synthetase [glutamine-hydrolyzing] (isoform a) | P08243 | Cancer | ||||
| Aspartate aminotransferase, cytoplasmic | P17174 | Cancer | ||||
| ATP citrate synthase (isoform 1) | P53396 | Cancer | Diabetes | |||
| ATP Synthase, H+ Transporting, Mitochondrial F0 complex | Malaria | Cancer Tuberculosis | ||||
| ATP synthase, H+ transporting, mitochondrial F1 complex | Malaria | Cancer Tuberculosis | ||||
| ATP-Binding Cassette (ABC) Transporter (nonspecified subtype) | | Cancer Leishmaniasis Tuberculosis | ||||
| ATP-binding cassette sub-family G member 2 (isoform 1) | Q9UNQ0 | Cancer Diabetes | ||||
| ATP-binding cassette sub-family G member 2 (isoform 2) | Q9UNQ0 | Cancer Diabetes | ||||
| ATP-dependent RNA helicase DDX3X (isoform 1) | O00571 | Cancer | ||||
| ATP-dependent RNA helicase DDX3X (isoform 2) | O00571 | Cancer | ||||
| ATP-dependent RNA helicase DDX3X (isoform 3) | O00571 | Cancer | ||||
| ATPase (nonspecified subtype) | Cancer Tuberculosis | |||||
| ATPase family AAA domain-containing protein 2 | Q6PL18 | Cancer | ||||
| ATPase inhibitor, mitochondrial (isoform 1) | Q9UII2 | Cancer Diabetes | ||||
| ATPase, H+ transporting, lysosomal V0 subunit A2 | Q9Y487 | Cancer | ||||
| Atypical chemokine receptor 3 | P25106 | Cancer | ||||
| AURKA variant 1 | Cancer | |||||
| AURKA variant 2 | Cancer | |||||
| AURKB | Cancer | |||||
| Aurora Kinase (nonspecified subtype) | Cancer | Diabetes | ||||
| Aurora kinase A | O14965 | | Cancer | Diabetes | ||
| Aurora kinase B | Q96GD4 | Cancer | Diabetes | |||
| Aurora kinase C (isoform 1) | Q9UQB9 | Cancer | ||||
| Aurora kinase C (isoform 2) | Q9UQB9 | Cancer | ||||
| AXL variant 1 | Cancer | |||||
| AXL variant 2 | Cancer | |||||
| B- and T-lymphocyte attenuator (isoform 1) | Q7Z6A9 | Cancer | ||||
| B-cell CLL/lymphoma 9 protein | O00512 | | Cancer | Diabetes | ||
| B-cell lymphoma 3 protein | P20749 | | Cancer | |||
| B-cell lymphoma 3 protein (isoform X1) | P20749 | | Cancer | |||
| B-cell lymphoma 6 protein (isoform 1) | P41182 | Cancer | ||||
| B-cell lymphoma 6 protein (isoform 2) | P41182 | | Cancer | |||
| B-cell lymphoma 6 protein (isoform 3) | P41182 | Cancer | ||||
| B-cell receptor CD22 | P20273 | Cancer | ||||
| B-lymphocyte antigen CD19 (isoform 1) | P15391 | Cancer | Diabetes | |||
| B-lymphocyte antigen CD19 (isoform 2) | P15391 | Cancer | Diabetes | |||
| B-lymphocyte antigen CD20 | P11836 | Cancer | Diabetes | |||
| Baculoviral IAP repeat-containing protein 2 (isoform 1) | Q13490 | | Cancer | |||
| Baculoviral IAP repeat-containing protein 2 (isoform 3) | Q13490 | Cancer | ||||
| Baculoviral IAP repeat-containing protein 3 | Q13489 | Cancer | ||||
| Baculoviral IAP repeat-containing protein 5 (isoform 1) | O15392 | | Cancer | |||
| Baculoviral IAP repeat-containing protein 5 (isoform 2) | O15392 | | Cancer | |||
| Baculoviral IAP repeat-containing protein 5 (isoform 3) | O15392 | | Cancer | |||
| BAG family molecular chaperone regulator 1 | Q99933 | Cancer | ||||
| BAG family molecular chaperone regulator 3 | O95817 | Cancer | ||||
| BARF1 protein | P03228 | Cancer | ||||
| Basigin (isoform 1) | P35613 | | Cancer | Malaria | ||
| Basigin (isoform 2) | P35613 | | Cancer | Malaria | ||
| Basigin (isoform 4) | P35613 | Cancer | Malaria | |||
| Bcl-2-like protein 1 (isoform 1) | Q07817 | | Cancer | Diabetes | ||
| Bcl-2-like protein 1 (isoform 2) | Q07817 | | Cancer | Diabetes | ||
| Bcl-2-like protein 2 | Q92843 | | Cancer | |||
| BCL2 variant alpha | Cancer | |||||
| BCL2 variant beta | Cancer | |||||
| BCL2 variant X2 | Cancer | |||||
| Bcl2-associated agonist of cell death | Q92934 | Cancer | ||||
| BCL2-associated X protein (delta isoform) | Q07812 | Cancer | Diabetes | |||
| BCL2-related protein A1 (isoform 1) | Q16548 | Cancer | ||||
| BCL2L1 variant 1 | Cancer | |||||
| BCL2L1 variant 2 | Cancer | |||||
| BDNF/NT-3 growth factors receptor (isoform a) | Q16620 | Cancer | Diabetes | |||
| BDNF/NT-3 growth factors receptor (isoform b) | Q16620 | Cancer | Diabetes | |||
| BDNF/NT-3 growth factors receptor (isoform c) | Q16620 | | Cancer | Diabetes | ||
| Beclin-1 | Q14457 | Cancer | ||||
| beta-Adrenergic-receptor kinase 1 | P25098 | Cancer | ||||
| beta-Adrenoceptor (nonspecified subtype) | Cancer | |||||
| beta-Galactosidase (isoform a) | P16278 | | Diabetes | Cancer | ||
| Beta-galactoside alpha-2,6-sialyltransferase | P15907 | Cancer | ||||
| beta-Glucuronidase | P08236 | | Cancer | Diabetes Epilepsy | ||
| Beta-nerve growth factor | P01138 | | Cancer | |||
| beta-Secretase (nonspecified subtype) | Cancer | Diabetes Epilepsy | ||||
| beta1-Adrenoceptor | P08588 | Diabetes | Cancer | |||
| beta2-Adrenoceptor | P07550 | | Diabetes | Epilepsy | Cancer | |
| beta3-Adrenoceptor | P13945 | Cancer Diabetes | ||||
| Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (isoform 1) | Q6NYC1 | Cancer | ||||
| Bifunctional glutamate/proline--tRNA ligase | P07814 | Cancer | ||||
| Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial | P13995 | Cancer | ||||
| Bifunctional polynucleotide phosphatase/kinase | Q96T60 | Cancer | ||||
| Bifunctional purine biosynthesis protein PURH | P31939 | | Cancer | |||
| Bile acid receptor (isoform 1) | Q96RI1 | | Cancer Diabetes | |||
| Bile acid receptor (isoform 2) | Q96RI1 | | Cancer Diabetes | Leishmaniasis | ||
| Bile salt-activated lipase | P19835 | Cancer | ||||
| BIRC5 variant 1 | Cancer | |||||
| BIRC5 variant 2 | Cancer | |||||
| BIRC5 variant 3 | Cancer | |||||
| Bloom syndrome protein (isoform 1) | P54132 | Cancer | ||||
| Bloom syndrome protein (isoform 2) | P54132 | Cancer | ||||
| Bloom syndrome protein (isoform 3) | P54132 | Cancer | ||||
| BMI1 | Cancer | |||||
| BMP2 | Cancer | |||||
| BMP2 variant X1 | Cancer | |||||
| Bombesin receptor (nonspecified subtype) | Cancer | |||||
| Bombesin receptor subtype-3 | P32247 | Cancer Diabetes | ||||
| Bone marrow stromal antigen 2 | Q10589 | | Cancer | |||
| Bone morphogenetic protein 10 | O95393 | Cancer | ||||
| Bone morphogenetic protein 4 | P12644 | Cancer Diabetes | ||||
| Bone Morphogenetic Protein Receptor (nonspecified subtype) | Cancer | |||||
| Bone Morphogenetic Protein Receptor Type I (nonspecified subtype) | Cancer | |||||
| Bone morphogenetic protein receptor type-1B | O00238 | Cancer | ||||
| Bone morphogenetic protein receptor type-IA | P36894 | Cancer | ||||
| BPI fold-containing family A member 1 | Q9NP55 | Cancer | ||||
| BPTF variant 1 | Cancer | |||||
| BPTF variant 2 | Cancer | |||||
| Bradykinin B1 receptor | P46663 | Cancer | Diabetes | |||
| Bradykinin B2 receptor (B2R) | P30411 | Cancer | ||||
| Bradykinin receptor (nonspecified subtype) | Cancer | |||||
| BRAF variant 1 | Cancer | |||||
| BRAF variant 2 | Cancer | |||||
| Branched-chain-amino-acid aminotransferase, cytosolic (isoform 1) | P54687 | | Cancer | |||
| BRCA2 | Cancer | |||||
| Breakpoint cluster region protein (BCR) (isoform 1) | P11274 | Cancer | Diabetes | |||
| Breakpoint cluster region protein (BCR) (isoform 2) | P11274 | | Cancer | Diabetes | ||
| Breast cancer type 1 susceptibility protein (isoform 1) | P38398 | | Cancer | |||
| Breast cancer type 1 susceptibility protein (isoform 2) | P38398 | Cancer | ||||
| Breast cancer type 1 susceptibility protein (isoform 3) | P38398 | | Cancer | |||
| Breast cancer type 1 susceptibility protein (isoform 4) | P38398 | | Cancer | |||
| Breast cancer type 1 susceptibility protein (isoform 5) | P38398 | Cancer | ||||
| Brefeldin A-inhibited guanine nucleotide-exchange protein 1 | Q9Y6D6 | Cancer | ||||
| Brefeldin A-inhibited guanine nucleotide-exchange protein 2 | Q9Y6D5 | Cancer | ||||
| Bromodomain adjacent to zinc finger domain protein 2A (isoform 1) | Q9UIF9 | | Cancer | |||
| Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | | Cancer | |||
| Bromodomain testis-specific protein | Q58F21 | Cancer | ||||
| Bromodomain-containing protein 1 | O95696 | Cancer | ||||
| Bromodomain-containing protein 2 (isoform 1) | P25440 | Cancer | Diabetes | |||
| Bromodomain-containing protein 2 (isoform 2) | P25440 | | Cancer | Diabetes | ||
| Bromodomain-containing protein 2 (isoform 3) | P25440 | | Cancer | Diabetes | ||
| Bromodomain-containing protein 3 (Brd3) | Q15059 | | Cancer | Diabetes | ||
| Bromodomain-containing protein 4 (isoform long) | O60885 | | Cancer | Diabetes | ||
| Bromodomain-containing protein 4 (isoform short) | O60885 | | Cancer | Diabetes | ||
| Bromodomain-containing protein 7 (isoform 1) | Q9NPI1 | Cancer | ||||
| Bromodomain-containing protein 9 | Q9H8M2 | Cancer | ||||
| BRSK2 variant 2 | Cancer | |||||
| BUB1 budding uninhibited by benzimidazoles 1 homolog (BUB1) | O43683 | Cancer | ||||
| Butyrophilin subfamily 3 member A1 (isoform 1) | O00481 | Cancer | ||||
| Butyrophilin subfamily 3 member A3 (isoform 1) | O00478 | Cancer | ||||
| Butyrophilin subfamily 3 member A3 (isoform 2) | O00478 | Cancer | ||||
| C-1-Tetrahydrofolate synthase, cytoplasmic | P11586 | | Cancer | |||
| C-C chemokine receptor type 1 (CCR1) | P32246 | Cancer | Diabetes | |||
| C-C chemokine receptor type 10 | P46092 | Cancer | ||||
| C-C chemokine receptor type 2 (isoform A) | P41597 | Cancer | Diabetes | |||
| C-C chemokine receptor type 2 (isoform B) | P41597 | Cancer | Diabetes | |||
| C-C chemokine receptor type 3 (isoform 1) | P51677 | Cancer | ||||
| C-C chemokine receptor type 3 (isoform X1) | P51677 | Cancer | ||||
| C-C chemokine receptor type 4 | P51679 | Cancer | ||||
| C-C chemokine receptor type 5 | P51681 | Cancer | Diabetes | |||
| C-C chemokine receptor type 6 | P51684 | Cancer | ||||
| C-C chemokine receptor type 7 | P32248 | Cancer | ||||
| C-C chemokine receptor type 8 (CCR-8) | P51685 | Cancer | ||||
| C-C chemokine receptor type 9 | P51686 | Cancer | ||||
| C-C motif chemokine 2 | P13500 | | Cancer | |||
| C-C Motif Chemokine 20 | P78556 | Cancer | ||||
| c-Mer proto-oncogene tyrosine kinase | Q12866 | Cancer | ||||
| C-terminal binding protein 1 | Q13363 | Cancer | ||||
| C-type lectin domain family 1 member B | Q9P126 | Cancer | ||||
| C-type lectin domain family 10 member A (isoform 1) | Q8IUN9 | Cancer | ||||
| C-type lectin domain family 14 member A precursor | Q86T13 | Cancer | Diabetes | |||
| C-type lectin domain family 4 member G (isoform 1) | Q6UXB4 | Cancer | ||||
| C-type lectin-like receptor-1 | Q8NC01 | Cancer | ||||
| C-X-C Chemokine Receptor CXCR1/CXCR2 (IL-8 Receptor) (nonspecified subtype) | Cancer Diabetes | |||||
| C-X-C chemokine receptor type 1 | P25024 | | Cancer Diabetes | |||
| C-X-C chemokine receptor type 2 | P25025 | Cancer Diabetes | ||||
| C-X-C chemokine receptor type 3 (isoform A) | P49682 | Cancer Diabetes | ||||
| C-X-C chemokine receptor type 4 (isoform a) | P61073 | | | Cancer | Diabetes | Tuberculosis |
| C-X-C chemokine receptor type 4 (isoform b) | P61073 | | Cancer | Diabetes | Tuberculosis | |
| C-X-C chemokine receptor type 4 (isoform c) | P61073 | Cancer | Diabetes | Tuberculosis | ||
| C-X-C chemokine receptor type 5 (isoform 1) | P32302 | Cancer | ||||
| C-X-C chemokine receptor type 5 (isoform 2) | P32302 | Cancer | ||||
| C2orf68 | Cancer | |||||
| C5a anaphylatoxin chemotactic receptor 1 | P21730 | Cancer | ||||
| CA7 variant 1 | Cancer | |||||
| CAAX prenyl protease 2 (isoform 1) | Q9Y256 | Cancer | ||||
| CAD protein | P27708 | Cancer | ||||
| Cadherin-17 | Q12864 | Cancer | ||||
| Cadherin-2 | P19022 | Cancer | ||||
| Cadherin-3 | P22223 | Cancer | ||||
| Cadherin-5 | P33151 | Cancer | ||||
| Calcineurin subunit B type 1 | P63098 | Diabetes | Cancer | |||
| Calcineurin subunit B type 2 | Q96LZ3 | Diabetes | Cancer | |||
| Calcitonin | P01258 | Cancer | ||||
| Calcitonin Gene-Related Peptide 1 | P06881 | Diabetes | ||||
| Calcitonin gene-related peptide type 1 receptor | Q16602 | | Diabetes | |||
| Calcitonin receptor (isoform 1) | P30988 | Diabetes | ||||
| Calcitonin receptor (isoform 2) | P30988 | Diabetes | ||||
| Calcium channel (nonspecified subtype) | Cancer | Diabetes Leishmaniasis Epilepsy | ||||
| Calcium release-activated channel (CRAC) | Cancer Diabetes | |||||
| Calcium-activated chloride channel regulators (nonspecified subtype) | Cancer | |||||
| Calcium-Activated K(Ca) Potassium Channel (nonspecified subtype) | Cancer | |||||
| Calcium-activated potassium channel subunit alpha-1 (isoform a) | Q12791 | Cancer | ||||
| Calcium-activated potassium channel subunit alpha-1 (isoform b) | Q12791 | Cancer | ||||
| Calcium-activated potassium channel subunit alpha-1 (isoform c) | Q12791 | | Cancer | |||
| Calcium-activated potassium channel subunit alpha-1 (isoform e) | Q12791 | | Cancer | |||
| Calcium-dependent protein kinase CDPK1 (Toxoplasma gondii) | S7UHK8 | Cancer | Malaria | |||
| Calcium/calmodulin-dependent protein kinase (nonspecified subtype) | Cancer | |||||
| Calcium/calmodulin-dependent protein kinase II delta | Q13557 | | Cancer | |||
| Calcium/calmodulin-dependent protein kinase kinase 1 (isoform a) | Q8N5S9 | Cancer | ||||
| Calcium/calmodulin-dependent protein kinase kinase 2 (isoform 1) | Q96RR4 | Cancer | ||||
| Calcium/calmodulin-dependent protein kinase kinase 2 (isoform 2) | Q96RR4 | Cancer | ||||
| Calcium/calmodulin-dependent protein kinase type 1 | Q14012 | Cancer | ||||
| Calcium/calmodulin-dependent protein kinase type II (CaMK-II) | Cancer Diabetes | |||||
| Calcium/calmodulin-dependent protein kinase type II subunit gamma (isoform 1) | Q13555 | Cancer | ||||
| Calmodulin-1 | P0DP23 | | Cancer | |||
| Calpain (nonspecified subtype) | Epilepsy | Cancer Diabetes | ||||
| Calpain-1 catalytic subunit | P07384 | | Cancer Epilepsy | |||
| Calpain-2 catalytic subunit | P17655 | | Cancer Malaria | |||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Q9Y233 | Cancer Diabetes | Epilepsy | |||
| cAMP Phosphodiesterase (nonspecified subtype) | Cancer Diabetes | |||||
| cAMP Responsive Element Binding Protein (CREB) (nonspecified subtype) | Cancer | |||||
| cAMP responsive element binding protein 5 (isoform alpha) | Q02930 | Cancer | Diabetes | |||
| cAMP-Dependent protein kinase (PKA) | Cancer | Diabetes | Malaria Epilepsy | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B (isoform 1) | Q07343 | | Cancer Diabetes | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B (isoform 2) | Q07343 | | Cancer Diabetes | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B (isoform 3) | Q07343 | | Cancer Diabetes | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D (isoform 1) | Q08499 | | Cancer | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D (isoform 2) | Q08499 | | Cancer | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D (isoform 3) | Q08499 | | Cancer | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D (isoform 5) | Q08499 | | Cancer | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D (isoform 7) | Q08499 | | Cancer | |||
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D (isoform 9) | Q08499 | | Cancer | |||
| CAMPATH-1 antigen precursor | P31358 | Cancer | ||||
| Canalicular multispecific organic anion transporter 1 | Q92887 | Cancer | ||||
| Cancer/testis antigen (nonspecified subtype) | Cancer | |||||
| Cancer/testis antigen 1 | P78358 | Cancer | ||||
| Cannabinoid receptor (nonspecified subtype) | Cancer Epilepsy | Diabetes | ||||
| Cannabinoid receptor 1 (isoform 1) | P21554 | | Cancer Diabetes | Malaria Epilepsy | ||
| Cannabinoid receptor 2 | P34972 | Cancer | Diabetes | Malaria Epilepsy | ||
| Caprin-1 (isoform 1) | Q14444 | Cancer | ||||
| Carbonic Anhydrase (nonspecified subtype) | Cancer Diabetes Epilepsy Tuberculosis | Malaria | ||||
| Carbonic anhydrase 1 | P00915 | | Cancer Diabetes Epilepsy Tuberculosis | |||
| Carbonic anhydrase 12 | O43570 | | Cancer | Epilepsy Tuberculosis | ||
| Carbonic anhydrase 13 | Q8N1Q1 | Epilepsy | Cancer | |||
| Carbonic anhydrase 14 | Q9ULX7 | Epilepsy | Cancer | |||
| Carbonic anhydrase 2 | P00918 | | | Cancer Diabetes Epilepsy | Tuberculosis | |
| Carbonic anhydrase 3 | P07451 | | Cancer | Epilepsy Tuberculosis | ||
| Carbonic anhydrase 4 | P22748 | | Cancer | Epilepsy | ||
| Carbonic anhydrase 5A, mitochondrial precursor | P35218 | Cancer Epilepsy | ||||
| Carbonic anhydrase 5B, mitochondrial | Q9Y2D0 | Cancer | Epilepsy Tuberculosis | |||
| Carbonic anhydrase 6 | P23280 | Epilepsy | Cancer | |||
| Carbonic anhydrase 7 (isoform 1) | P43166 | | Diabetes Epilepsy | Cancer | Tuberculosis | |
| Carbonic anhydrase 9 | Q16790 | Cancer | Epilepsy | Diabetes | ||
| Carbonic Anhydrase V (nonspecified subtype) | Cancer Epilepsy | |||||
| Carbonyl reductase [NADPH] 1 (isoform 1) | P16152 | Cancer | ||||
| Carboxylesterase 2 | O00748 | Cancer | ||||
| Carboxypeptidase A (nonspecified subtype) | Cancer | |||||
| Carboxypeptidase M | P14384 | Cancer | ||||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule (CEA) (nonspecified subtype) | Cancer | |||||
| Carcinoembryonic antigen-related cell adhesion molecule 1 (isoform 1) | P13688 | Cancer | ||||
| Carcinoembryonic antigen-related cell adhesion molecule 1 (isoform 2) | P13688 | Cancer | ||||
| Carcinoembryonic antigen-related cell adhesion molecule 1 (isoform 6) | P13688 | Cancer | ||||
| Carcinoembryonic antigen-related cell adhesion molecule 5 | P06731 | | Cancer | |||
| Carcinoembryonic antigen-related cell adhesion molecule 6 | P40199 | Cancer | ||||
| Carnitine O-Palmitoyltransferase 1 (CPT-1) (nonspecified subtype) | Diabetes | Cancer | ||||
| Casein kinase I (nonspecified subtype) | Cancer Diabetes | |||||
| Casein kinase I isoform alpha (isoform 1) | P48729 | Malaria | Cancer | |||
| Casein kinase I isoform alpha (isoform 2) | P48729 | Malaria | Cancer | |||
| Casein kinase I isoform delta (isoform 1) | P48730 | | Cancer | |||
| Casein kinase I isoform delta (isoform 2) | P48730 | | Cancer | |||
| Casein kinase I isoform epsilon | P49674 | | Cancer | Diabetes | ||
| Casein kinase I isoform gamma-1 | Q9HCP0 | Cancer | ||||
| Casein kinase II (CKII) (nonspecified subtype) | Cancer | Diabetes | ||||
| Casein kinase II subunit alpha | P68400 | | Cancer | |||
| Casein kinase II subunit alpha' | P19784 | Cancer | ||||
| Casein kinase II subunit beta | P67870 | | Cancer | Diabetes | ||
| CASP8 and FADD-like apoptosis regulator (isoform 1) | O15519 | Cancer | ||||
| CASP8 and FADD-like apoptosis regulator (isoform 2) | O15519 | Cancer | ||||
| CASP8 and FADD-like apoptosis regulator (isoform 3) | O15519 | Cancer | ||||
| Caspase (nonspecified subtype) | Cancer | Diabetes | ||||
| Caspase-1 (isoform alpha) | P29466 | | Diabetes Epilepsy | Cancer | ||
| Caspase-1 (isoform beta) | P29466 | Diabetes Epilepsy | Cancer | |||
| Caspase-14 | P31944 | Cancer | ||||
| Caspase-2 (isoform 1) | P42575 | | Cancer | |||
| Caspase-2 (isoform 3) | P42575 | | Cancer | |||
| Caspase-3 (isoform alpha) | P42574 | | Cancer | Malaria | Diabetes Epilepsy | |
| Caspase-7 (isoform alpha) | P55210 | | Cancer | |||
| Caspase-7 (isoform beta) | P55210 | | Cancer | |||
| Caspase-8 (isoform A) | Q14790 | | Cancer | Epilepsy | ||
| Caspase-8 (isoform B) | Q14790 | | Cancer | Epilepsy | ||
| Caspase-8 (isoform C) | Q14790 | | Cancer | Epilepsy | ||
| Caspase-8 (isoform G) | Q14790 | | Cancer | Epilepsy | ||
| Caspase-9 (isoform 3) | P55211 | Cancer | ||||
| Caspase-9 (isoform alpha) | P55211 | | Cancer | |||
| Cat eye syndrome critical region protein 2 | Q9BXF3 | Cancer | ||||
| Catechol O-methyltransferase (isoform 1) | P21964 | Cancer | Diabetes | |||
| Catechol O-methyltransferase (isoform 2) | P21964 | Cancer | Diabetes | |||
| Catechol O-methyltransferase (isoform 3) | P21964 | Cancer | Diabetes | |||
| Catechol O-methyltransferase (isoform 4) | P21964 | Cancer | Diabetes | |||
| Catenin beta-1 | P35222 | | Cancer | Diabetes | ||
| Cathepsin B | P07858 | | Cancer | Diabetes Leishmaniasis Epilepsy | ||
| Cathepsin D | P07339 | | Cancer | Diabetes Malaria | ||
| Cathepsin E | P14091 | Cancer | ||||
| Cathepsin F precursor | Q9UBX1 | Cancer | ||||
| Cathepsin K | P43235 | | Cancer | Diabetes Leishmaniasis Malaria | ||
| Cathepsin L | P07711 | | Cancer | Diabetes Epilepsy | ||
| Cathepsin S (isoform 1) | P25774 | | Cancer | Diabetes | ||
| Cathepsin S (isoform 2) | P25774 | | Cancer | Diabetes Malaria | ||
| Caveolin-1 (isoform 1) | Q03135 | Cancer | ||||
| Caveolin-1 (isoform 2) | Q03135 | Cancer | ||||
| CBL | Cancer | |||||
| CBLB | Cancer | |||||
| CCDC88A variant 2 | Cancer | |||||
| CCK receptor (nonspecified subtype) | Cancer Epilepsy | |||||
| CCK1 | P32238 | | Cancer | Diabetes | Epilepsy | |
| CCL2 | Cancer Diabetes | |||||
| CCND1 | Cancer | Diabetes Malaria | ||||
| CCNE1 | Cancer | |||||
| CCR5 variant A | Cancer | Diabetes | ||||
| CCR5 variant B | Cancer | Diabetes | ||||
| CCR9 variant A | Cancer | |||||
| CD14 variant 1 | Cancer | |||||
| CD14 variant 3 | Cancer | |||||
| CD160 antigen | O95971 | Cancer | ||||
| CD166 antigen (isoform 1) | Q13740 | Cancer | ||||
| CD166 antigen (isoform 2) | Q13740 | Cancer | ||||
| CD200 antigen (isoform a) | P41217 | Cancer | ||||
| CD226 antigen (isoform X1) | Q15762 | Cancer | ||||
| CD226 antigen (isoform a) | Q15762 | Cancer | ||||
| CD27 | P26842 | Cancer | ||||
| CD274 variant 1 | Cancer | |||||
| CD276 antigen (isoform 1) | Q5ZPR3 | Cancer | ||||
| CD276 antigen (isoform 2) | Q5ZPR3 | Cancer | ||||
| CD276 variant 1 | Cancer | |||||
| CD276 variant 2 | Cancer | |||||
| CD3 Complex (T Cell Receptor Complex) | Cancer Diabetes | |||||
| CD40 ligand (CD40L; CD154) | P29965 | | Cancer Diabetes | |||
| CD44 antigen (isoform 1) | P16070 | | | Cancer | Tuberculosis | |
| CD44 antigen (isoform 3) | P16070 | | | Cancer | Tuberculosis | |
| CD44 antigen (isoform 4) | P16070 | | | Cancer | Tuberculosis | |
| CD44 antigen (isoform 5) | P16070 | | | Cancer | Tuberculosis | |
| CD44 antigen (isoform 6) | P16070 | | | Cancer | Tuberculosis | |
| CD44 variant 1 | Cancer | |||||
| CD44 variant 3 | Cancer | |||||
| CD44 variant 4 | Cancer | |||||
| CD44 variant 5 | Cancer | |||||
| CD44 variant 6 | Cancer | |||||
| CD47 variant 1 | Cancer | |||||
| CD59 glycoprotein | P13987 | | Cancer | |||
| CD59 glycoprotein preproprotein | P13987 | | Cancer | |||
| CD63 antigen | P08962 | Cancer | ||||
| CD70 antigen | P32970 | Cancer | ||||
| CD9 antigen | P21926 | Cancer | ||||
| CDC20 | Cancer | |||||
| CDCP1 variant 1 | Cancer | |||||
| CDH1 | Cancer | |||||
| CDK1 variant 1 | Cancer | |||||
| CDK1 variant 2 | Cancer | |||||
| CDK1 variant 4 | Cancer | |||||
| CDK1/Cyclin B | Cancer | Diabetes Leishmaniasis Epilepsy | ||||
| CDK12/Cyclin K | Cancer | |||||
| CDK2/Cyclin A | Cancer | Diabetes | ||||
| CDK2/Cyclin E | Cancer | Diabetes | ||||
| CDK3/Cyclin E | Cancer | |||||
| CDK4 | Cancer | |||||
| CDK4/Cyclin D | Cancer | |||||
| CDK4/Cyclin D1 | Cancer | |||||
| CDK4/Cyclin D3 | Cancer | |||||
| CDK5/p25 | Cancer | Diabetes Epilepsy | ||||
| CDK6/Cyclin D1 | Cancer | |||||
| CDK6/Cyclin D2 | Cancer | |||||
| CDK6/Cyclin D3 | Cancer | |||||
| CDK7/Cyclin H | Cancer Diabetes | |||||
| CDK8/Cyclin C | Cancer Diabetes | |||||
| CDK9 | Cancer | |||||
| CDK9/Cyclin T1 | Cancer | Diabetes | ||||
| CDKL3 variant 1 | Cancer | |||||
| CDKN1A | Cancer | |||||
| CDKN1A variant 2 | Cancer | |||||
| CDKN1A variant 3 | Cancer | |||||
| CDKN2AIP variant 1 | Cancer | |||||
| CEBPA | Cancer | Diabetes | ||||
| CEBPB | Cancer Diabetes | |||||
| CECR2-containing remodeling factor complex | Cancer | |||||
| Cell division control protein 42 homolog (isoform 1) | P60953 | | Cancer | Diabetes | ||
| Cell division control protein 42 homolog (isoform 2) | P60953 | | Cancer | Diabetes | ||
| Cell division control protein 42 homolog (isoform 3) | P60953 | | Cancer | Diabetes | ||
| Cell division cycle 7-related protein kinase (isoform 1) | O00311 | Cancer | ||||
| Cell division cycle 7-related protein kinase (isoform 2) | O00311 | Cancer | ||||
| Cell Surface Glycoprotein MUC18 (CD146) | P43121 | Cancer | ||||
| Cellular retinoic acid-binding protein 2 | P29373 | | Cancer | |||
| Cellular tumor antigen p53 (isoform a) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform b) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform c) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform d) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform e) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform f) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform g) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform h) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform i) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform j) | P04637 | | Cancer | |||
| Cellular tumor antigen p53 (isoform k) | P04637 | Cancer | ||||
| Cellular tumor antigen p53 (isoform l) | P04637 | Cancer | ||||
| Centromere-associated protein E | Q02224 | Cancer | ||||
| Centrosomal protein of 290 kDa (Cep290) | O15078 | Cancer | ||||
| Centrosome-associated protein CEP250 | Q9BV73 | Cancer | ||||
| Centrosome-associated protein CEP250 (isoform X3) | Q9BV73 | Cancer | ||||
| Ceramidase (nonspecified subtype) | Cancer | |||||
| Ceramide glucosyltransferase | Q16739 | Cancer Diabetes | ||||
| Ceramide kinase | Q8TCT0 | Cancer | ||||
| CFLAR variant 1 | Cancer | |||||
| CFLAR variant 2 | Cancer | |||||
| CFLAR variant 3 | Cancer | |||||
| CFTR inhibitory factor | Q9HZR3 | Cancer | ||||
| cGMP Phosphdiesterase (PDE) (nonspecified subtype) | Cancer Diabetes | |||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (isoform PDE2A1) | O00408 | | Cancer | Diabetes Malaria Epilepsy | ||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (isoform PDE2A2) | O00408 | | Cancer | Diabetes Malaria Epilepsy | ||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (isoform PDE2A3) | O00408 | | Cancer | Diabetes Malaria Epilepsy | ||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (isoform PDE2A4) | O00408 | | Cancer | Diabetes Malaria Epilepsy | ||
| cGMP-Dependent Protein Kinase (Protein Kinase G; PKG) (nonspecified subtype) | Cancer | Tuberculosis | ||||
| cGMP-dependent protein kinase 1 (isoform 1) | Q13976 | Cancer | Tuberculosis | |||
| cGMP-dependent protein kinase 1 (isoform 2) | Q13976 | | Cancer | Tuberculosis | ||
| cGMP-inhibited 3',5'-cyclic phosphodiesterase 3 (PDE3) (nonspecified subtype) | Cancer Diabetes | |||||
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A (isoform 1) | Q14432 | Cancer | ||||
| cGMP-specific 3',5'-cyclic phosphodiesterase (PDE5) (isoform 1) | O76074 | Cancer Diabetes | Malaria | |||
| cGMP-specific 3',5'-cyclic phosphodiesterase (PDE5) (isoform 2) | O76074 | | Cancer Diabetes | Malaria | ||
| Chaperone (nonspecified subtype) | Malaria | Cancer Diabetes Schistosomiasis | ||||
| CHEK1 variant 1 | Cancer | |||||
| CHEK1 variant 2 | Cancer | |||||
| CHEK1 variant 3 | Cancer | |||||
| CHEK2 variant 1 | Cancer | |||||
| CHEK2 variant 3 | Cancer | |||||
| CHEK2 variant 5 | Cancer | |||||
| Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) | O43927 | Cancer | ||||
| Chemokine (C-X-C motif) ligand 9 | Q07325 | Cancer | ||||
| Chemokine (C-X-C motif) receptor 3 (isoform B) | P49682 | Cancer Diabetes | ||||
| Chemokine CXC receptor (nonspecified subtype) | Cancer | |||||
| Chemokine receptor (nonspecified subtype) | Cancer | Diabetes | ||||
| Chitinase 3-like 1 | P36222 | | Cancer | |||
| Chitotriosidase-1 | Q13231 | | Cancer | |||
| Chloride channel (nonspecified subtype) | Cancer | |||||
| Cholesterol side-chain cleavage enzyme, mitochondrial | P05108 | Cancer | ||||
| Cholesteryl ester transfer protein | P11597 | Cancer Diabetes | ||||
| Choline kinase alpha | P35790 | | Cancer | Leishmaniasis Malaria | ||
| Choline/ethanolamine kinase beta | Q9Y259 | | Cancer | Leishmaniasis Malaria | ||
| Cholinesterase | P06276 | | Cancer Epilepsy | Malaria | ||
| Chondroitin sulfate proteoglycan 4 | Q6UVK1 | Cancer | ||||
| Chondrolectin | Q9H9P2 | Cancer | ||||
| Chondrolectin (isoform 2) | Q9H9P2 | Cancer | ||||
| Chondrolectin (isoform 3) | Q9H9P2 | Cancer | ||||
| CHRNA9 | Cancer | |||||
| Chromobox protein homolog 7 | O95931 | Cancer | ||||
| Chromobox protein homolog 8 | Q9HC52 | Cancer | ||||
| Chromodomain Y-like protein (isoform a) | Q9Y232 | | Cancer | |||
| Chromodomain Y-like protein 2 | Q8N8U2 | Cancer | ||||
| Chymase | P23946 | | Cancer Diabetes | |||
| Chymotrypsin (nonspecified subtype) | Cancer | Epilepsy | ||||
| Class III phosphatidylinositol 3-kinase (PI3-kinase) sub-complex | Cancer | Diabetes | ||||
| Clathrin heavy chain 1 (isoform 1) | Q00610 | Cancer | ||||
| Clathrin heavy chain 1 (isoform 2) | Q00610 | | Cancer | |||
| Claudin-1 | O95832 | Cancer | ||||
| Claudin-18 (isoform 1) | P56856 | Cancer | ||||
| Claudin-18 (isoform 2) | P56856 | Cancer | ||||
| Claudin-2 (isoform 1) | P57739 | Cancer | ||||
| Claudin-2 (isoform 2) | P57739 | Cancer | ||||
| Claudin-3 | O15551 | Cancer | ||||
| Claudin-4 | O14493 | Cancer | ||||
| Claudin-6 | P56747 | Cancer | ||||
| CLDN3 | Cancer | |||||
| Cleft lip and palate transmembrane protein 1 (isoform 2) | O96005 | Cancer | ||||
| Cleft lip and palate transmembrane protein 1 (isoform 3) | O96005 | Cancer | ||||
| CLU variant 1 | Cancer | |||||
| CLU variant 3 | Cancer | |||||
| Clusterin preproprotein (isoform 1) | P10909 | Cancer | ||||
| CMKLR1 variant 1 | Cancer | |||||
| CMKLR1 variant 2 | Cancer | |||||
| CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (isoform a) | Q11203 | Cancer | ||||
| CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (isoform k) | Q11203 | Cancer | ||||
| CMPK1 variant 1 | Cancer | |||||
| CMPK1 variant 2 | Cancer | |||||
| Coagulation factor IX | P00740 | Cancer | ||||
| Coagulation factor VII (FVIIa) | P08709 | | Cancer | |||
| Coagulation factor VIII | P00451 | Cancer | ||||
| Coagulation factor X | P00742 | | Cancer | |||
| Collagen alpha-3(VI) chain (isoform 1) | P12111 | Cancer | ||||
| Collagen alpha-3(VI) chain (isoform 4) | P12111 | Cancer | ||||
| Collagen alpha-3(VI) chain (isoform 5) | P12111 | Cancer | ||||
| Collagen type IV alpha-3-binding protein (isoform 1) | Q9Y5P4 | | Diabetes | Cancer | ||
| Collagen type IV alpha-3-binding protein (isoform 2) | Q9Y5P4 | | Diabetes | Cancer | ||
| Collagen type IV alpha-3-binding protein (isoform 3) | Q9Y5P4 | | Cancer Diabetes | |||
| Collagenase (nonspecified subtype) | Cancer | |||||
| Collagenase 3 (MMP-13) | P45452 | | Cancer | Diabetes | ||
| Complement C3 | P01024 | | Cancer | |||
| Complement C5 (isoform 1) | P01031 | | Cancer | |||
| Complement C5 (isoform 2) | P01031 | Cancer | ||||
| Complement Complex | Cancer | Malaria | ||||
| Complement component 1q | Cancer | |||||
| Complement factor D | P00746 | Cancer | ||||
| Complement factor H | P08603 | | Cancer | |||
| Connective tissue growth factor | P29279 | Cancer | Diabetes | |||
| Connector enhancer of kinase suppressor of ras 1 | Q969H4 | Cancer | ||||
| COP9 signalosome complex subunit 5 | Q92905 | Cancer | ||||
| COPS5 | Cancer | |||||
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | P28845 | | Cancer Diabetes | |||
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | P80365 | | Cancer | Diabetes Malaria Tuberculosis | ||
| Coxsackie virus and adenovirus receptor | P78310 | | Cancer | |||
| Creatine Kinase (nonspecified subtype) | Cancer | |||||
| CREB binding protein (isoform 1) | Q92793 | | Cancer | Schistosomiasis | ||
| CREB-binding protein (isoform 2) | Q92793 | | Cancer | Schistosomiasis | ||
| CSF3 variant 1 | Cancer | |||||
| CSNK2A1 variant 1 | Cancer | |||||
| CSNK2A1 variant 2 | Cancer | |||||
| CTCFL | Cancer | |||||
| CTGF | Diabetes | Cancer | ||||
| CTLA4 variant 1 | Cancer | |||||
| CTLA4 variant 2 | Cancer | |||||
| CTNNB1 variant 1 | Cancer | |||||
| CTNNB1 variant 2 | Cancer | |||||
| CTNNB1 variant 3 | Cancer | |||||
| CUB domain-containing protein 1 (isoform 1) | Q9H5V8 | Cancer | ||||
| CX3C chemokine receptor 1 (CX3CR1) (isoform 1) | P49238 | Cancer | ||||
| CX3C chemokine receptor 1 (CX3CR1) (isoform 2) | P49238 | Cancer | ||||
| CXCR4 variant 1 | Cancer | |||||
| CXCR4 variant 2 | Cancer | |||||
| CXCR4 variant 3 | Cancer | |||||
| Cyclic AMP-dependent transcription factor ATF-4 | P18848 | Cancer Diabetes | ||||
| Cyclic AMP-dependent transcription factor ATF-5 | Q9Y2D1 | Cancer | ||||
| cyclic AMP-responsive element-binding protein 1 (isoform A) | P16220 | Cancer | Diabetes | |||
| cyclic AMP-responsive element-binding protein 1 (isoform B) | P16220 | Cancer | Diabetes | |||
| Cyclic AMP-responsive element-binding protein 3 | O43889 | Cancer | Diabetes | |||
| Cyclic AMP-responsive element-binding protein 5 (isoform beta) | Q02930 | Cancer | Diabetes | |||
| Cyclic GMP-AMP synthase | Q8N884 | Cancer Diabetes | ||||
| Cyclin A (nonspecified subtype) | Cancer | Diabetes | ||||
| Cyclin B (nonspecified subtype) | Cancer | Diabetes Leishmaniasis Epilepsy | ||||
| Cyclin D (nonspecified subtype) | Cancer | |||||
| Cyclin-dependent kinase (nonspecified subtype) | Cancer | Diabetes Malaria | ||||
| Cyclin-dependent kinase 1 (isoform 1) | P06493 | Cancer | Diabetes Epilepsy | |||
| Cyclin-dependent kinase 1 (isoform 4) | P06493 | Cancer | Diabetes Leishmaniasis Epilepsy | |||
| Cyclin-dependent kinase 1 (soform 2) | P06493 | Cancer | Diabetes Epilepsy | |||
| Cyclin-dependent kinase 11B | P21127 | Cancer | ||||
| Cyclin-dependent kinase 12 | Q9NYV4 | Leishmaniasis | Cancer | |||
| Cyclin-dependent kinase 13 (isoform 1) | Q14004 | Cancer | ||||
| Cyclin-dependent kinase 16 (isoform 1) | Q00536 | Cancer | ||||
| Cyclin-dependent kinase 19 | Q9BWU1 | Cancer | ||||
| Cyclin-dependent kinase 2 (CDK2) (isoform 1) | P24941 | | Cancer | Diabetes | ||
| Cyclin-dependent kinase 3 (CDK3) | Q00526 | Cancer | ||||
| Cyclin-dependent kinase 4 (CDK4) | P11802 | Cancer | Diabetes | |||
| Cyclin-dependent kinase 5 (CDK5) | Q00535 | Cancer | Diabetes Epilepsy | |||
| Cyclin-dependent kinase 6 (isoform 2) | Q00534 | | Cancer | Diabetes | ||
| Cyclin-dependent kinase 6 (isoform 1) | Q00534 | | Cancer | Diabetes | ||
| Cyclin-dependent kinase 7 (CDK7) | P50613 | Cancer | Diabetes | |||
| Cyclin-dependent kinase 8 (CDK8) | P49336 | Cancer | ||||
| Cyclin-dependent kinase 9 (CDK9) | P50750 | Cancer | Diabetes | |||
| Cyclin-dependent kinase inhibitor (nonspecified subtype) | Cancer | |||||
| Cyclin-dependent kinase inhibitor 1 (isoform 1) | P38936 | | Cancer | |||
| Cyclin-dependent kinase inhibitor 1 (isoform 2) | P38936 | Cancer | ||||
| Cyclin-dependent kinase inhibitor 1B (p27) | P46527 | Cancer | Diabetes | |||
| Cyclin-dependent kinases regulatory subunit 1 | P61024 | | Cancer | |||
| Cyclin-G-associated kinase | O14976 | Cancer | ||||
| Cyclin-H | P51946 | | Cancer Diabetes | |||
| Cyclin-T1 | O60563 | Cancer | Diabetes | |||
| Cyclooxygenase (COX) (nonspecified subtype) | Cancer Diabetes Leishmaniasis | |||||
| CYP19A1 variant 1 | Cancer | |||||
| CYP19A1 variant 2 | Cancer | |||||
| CYP19A1 variant 4 | Cancer | |||||
| Cystathionine beta-synthase | P35520 | | Cancer | |||
| Cystathionine gamma-lyase (isoform 1) | P32929 | | Cancer | |||
| Cysteine Protease (nonspecified subtype) | Cancer Leishmaniasis Malaria Schistosomiasis | |||||
| Cysteine protease ATG4B (isoform a) | Q9Y4P1 | | Cancer | |||
| Cysteinyl leukotriene receptor 1 | Q9Y271 | Cancer Diabetes | Epilepsy | |||
| Cysteinyl leukotriene receptor 2 | Q9NS75 | Cancer | ||||
| Cystic fibrosis transmembrane conductance regulator | P13569 | Cancer Diabetes | ||||
| Cystine/glutamate transporter | Q9UPY5 | Cancer | ||||
| Cytidine deaminase (CDA) | P32320 | Cancer | ||||
| Cytochrome b-c1 complex subunit 7 | P14927 | Cancer | Diabetes | |||
| Cytochrome bc1 complex | Cancer | Diabetes | ||||
| Cytochrome P450 11B1, mitochondrial (isoform 1) | P15538 | Cancer Diabetes | ||||
| Cytochrome P450 11B2, mitochondrial | P19099 | | Cancer | Diabetes | ||
| Cytochrome P450 1A2 | P05177 | Cancer | ||||
| Cytochrome P450 1B1 | Q16678 | Cancer | ||||
| Cytochrome P450 26A1 (CYP26A1) | O43174 | Cancer Diabetes | ||||
| Cytochrome P450 26B1 | Q9NR63 | Cancer | ||||
| Cytochrome P450 2A13 | Q16696 | Cancer | ||||
| Cytochrome P450 2C19 | P33261 | Cancer | ||||
| Cytochrome P450 2C9 | P11712 | | Cancer Diabetes | |||
| Cytochrome P450 3A4 (isoform 1) | P08684 | Cancer Diabetes | ||||
| Cytochrome P450 3A4 (isoform 2) | P08684 | | Diabetes | Cancer | ||
| Cytochrome P450 Enzymes (nonspecified subtype) | Cancer | Diabetes | ||||
| Cytochrome P450, family 2, subfamily A, polypeptide 6 | P11509 | Cancer | ||||
| Cytohesin (nonspecified subtype) | Cancer | |||||
| Cytokine receptor common subunit beta | P32927 | | Cancer | |||
| Cytokine receptor common subunit gamma | P31785 | Cancer | ||||
| Cytoplasmic protein NCK1 | P16333 | Cancer Diabetes | ||||
| Cytoplasmic tyrosine-protein kinase BMX (isoform 1) | P51813 | Cancer | Diabetes | |||
| Cytosol aminopeptidase | P28838 | Cancer | ||||
| Cytosolic carboxypeptidase 2 | Q5U5Z8 | Cancer | ||||
| Cytosolic phospholipase A2 | P47712 | | Cancer | |||
| Cytosolic purine 5'-nucleotidase | P49902 | | Cancer | |||
| Cytotoxic and regulatory T-cell molecule | O95727 | Cancer | ||||
| Cytotoxic T-lymphocyte protein 4 (isoform 1) | P16410 | | Cancer | Diabetes | ||
| Cytotoxic T-lymphocyte protein 4 (isoform 2) | P16410 | | Cancer | Diabetes | ||
| D(1A) dopamine receptor | P21728 | Cancer Epilepsy | ||||
| D(2) dopamine receptor (isoform 1) | P14416 | Cancer Diabetes | Epilepsy | |||
| D(2) dopamine receptor (isoform 2) | P14416 | Cancer Diabetes | Epilepsy | |||
| D(3) dopamine receptor (isoform a) | P35462 | Cancer | Epilepsy | |||
| D(3) dopamine receptor (isoform f) | P35462 | Cancer | Epilepsy | |||
| D(4) dopamine receptor | P21917 | Cancer Diabetes | ||||
| D-3-phosphoglycerate dehydrogenase precursor | O43175 | Cancer | ||||
| D-Alanyl-D-Alanine Carboxypeptidase (DD-carboxypeptidase) (bacterial) | Cancer | |||||
| DANCR | Cancer | |||||
| DCN1-like protein 1 | Q96GG9 | Cancer | ||||
| dCTP pyrophosphatase 1 | Q9H773 | Cancer | ||||
| DCX (DDB1-CUL4-X-box) E3 protein ligase complex | Cancer | |||||
| DDIT3 variant 1 | Cancer | |||||
| DDIT3 variant 5 | Cancer | |||||
| DEAR | Cancer | |||||
| Death-associated protein kinase (nonspecified subtype) | Cancer | |||||
| Death-associated protein kinase 1 | P53355 | | Diabetes | Cancer | ||
| Death-associated protein kinase 2 | Q9UIK4 | | Cancer | |||
| Death-associated protein kinase 3 | O43293 | Cancer | ||||
| Decay accelerating factor for complement (CD55) | P08174 | | Cancer | |||
| delta(24)-Sterol reductase | Q15392 | Cancer | ||||
| Delta-like 4 protein | Q9NR61 | Cancer | ||||
| Delta-like protein 1 | O00548 | Cancer | ||||
| Delta-like protein 3 | Q9NYJ7 | Cancer | ||||
| delta-Opioid (DOP) receptor | P41143 | Cancer | ||||
| Deoxycytidine kinase | P27707 | | Cancer | |||
| Deoxyhypusine synthase | P49366 | Cancer Diabetes | ||||
| Deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase) (isoform 1) | P33316 | | Cancer | |||
| Deoxyuridine 5'-triphosphate nucleotidohydrolase, putative | Q8II92 | Cancer | Malaria Tuberculosis | |||
| DEP domain-containing mTOR-interacting protein | Q8TB45 | Cancer | ||||
| Dermcidin preproprotein | P81605 | Cancer | ||||
| Desmoglein-2 | Q14126 | Cancer | ||||
| DHFR | Cancer | |||||
| Diacylglycerol Acyltransferase (DGAT) (nonspecified subtype) | Cancer Diabetes | |||||
| Diacylglycerol kinase (nonspecified subtype) | Cancer | |||||
| Diacylglycerol kinase alpha | P23743 | Cancer | ||||
| Diacylglycerol kinase alpha (isoform b) | P23743 | Cancer | ||||
| Diacylglycerol O-acyltransferase 1 (DGAT1) | O75907 | Diabetes | Cancer Malaria | |||
| Diacylglycerol O-acyltransferase 2 (DGAT2) | Q96PD7 | Cancer Diabetes | ||||
| Dickkopf-related protein 1 | O94907 | Cancer | ||||
| Dickkopf-related protein 2 | Q9UBU2 | Cancer | ||||
| Dihydrofolate reductase (DHFR) | P00374 | | | Cancer | Tuberculosis | |
| Dihydrofolate reductase (DHFR) (protozoal) | Malaria | Cancer | ||||
| Dihydrofolate reductase (Escherichia coli) | P00382 | Cancer | Tuberculosis | |||
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Q02127 | | Cancer | Malaria | ||
| Dihydropyrimidine dehydrogenase (DPD) | Q12882 | Cancer | ||||
| Dimethylargininase (nonspecified subtype) | Cancer | |||||
| Dipeptidase 1 | P16444 | | Cancer | |||
| Dipeptidyl peptidase 1 (isoform b) | P53634 | | Cancer Malaria | |||
| Dipeptidyl peptidase 2 | Q9UHL4 | Cancer Diabetes | ||||
| Dipeptidyl peptidase 4 | P27487 | | Diabetes | Cancer Malaria | ||
| Dipeptidyl peptidase 8 | Q6V1X1 | Cancer Diabetes | ||||
| Dipeptidyl peptidase 9 | Q86TI2 | Cancer Diabetes | ||||
| Dipeptidyl-peptidase I (isoform a) | P53634 | | Cancer Malaria | |||
| Discoidin domain-containing receptor 2 | Q16832 | Cancer | ||||
| Disintegrin and metalloproteinase domain-containing protein 10 | O14672 | Cancer | ||||
| Disintegrin and metalloproteinase domain-containing protein 17 | P78536 | | Cancer | Diabetes | ||
| Disintegrin and metalloproteinase domain-containing protein 28 (isoform 1) | Q9UKQ2 | Cancer | ||||
| Disintegrin and metalloproteinase domain-containing protein 28 (isoform 3) | Q9UKQ2 | Cancer | ||||
| Disintegrin and metalloproteinase domain-containing protein 8 (isoform 1) | P78325 | Cancer | ||||
| Disintegrin and metalloproteinase domain-containing protein 9 | Q13443 | Cancer | ||||
| DKK1 | Cancer | |||||
| DLL4 | Cancer | |||||
| DMPK variant 2 | Cancer | |||||
| DMPK variant 3 | Cancer | |||||
| DNA (cytosine-5)-methyltransferase 1 (isoform a) | P26358 | | Cancer | Diabetes | ||
| DNA (cytosine-5)-methyltransferase 1 (isoform b) | P26358 | | Cancer | Diabetes | ||
| DNA (cytosine-5)-methyltransferase 3A (isoform 2) | Q9Y6K1 | | Cancer | |||
| DNA (cytosine-5)-methyltransferase 3A (isoform 4) | Q9Y6K1 | | Cancer | |||
| DNA (cytosine-5)-methyltransferase 3B (isoform 1) | Q9UBC3 | Cancer | ||||
| DNA (cytosine-5)-methyltransferase 3B (isoform 2) | Q9UBC3 | Cancer | ||||
| DNA (cytosine-5-)-methyltransferase 3A (isoform 1) | Q9Y6K1 | | Cancer | |||
| DNA dC->dU-editing enzyme APOBEC-3B | Q9UH17 | Cancer | ||||
| DNA excision repair protein ERCC-1 (isoform 1) | P07992 | | Cancer | |||
| DNA excision repair protein ERCC-1 (isoform 2) | P07992 | | Cancer | |||
| DNA excision repair protein ERCC-1 (isoform 3) | P07992 | | Cancer | |||
| DNA Gyrase (Staphylococcus aureus) | Cancer | |||||
| DNA gyrase subunit A (Staphylococcus aureus) | Q6GKT9 | Cancer | ||||
| DNA ligase (Haemophilus influenzae) | P43813 | Cancer | ||||
| DNA ligase (Leptospira interrogans) | Q8EYU4 | Cancer | ||||
| DNA Ligase (LigA) | Cancer | |||||
| DNA ligase 1 | P18858 | Cancer | ||||
| DNA Methyltransferase (DNMT) (nonspecified subtype) | Cancer | |||||
| DNA Polymerase (bacterial) (nonspecified subtype) | Cancer | Tuberculosis | ||||
| DNA Polymerase (viral) | Cancer | |||||
| DNA polymerase alpha catalytic subunit | P09884 | | Cancer | |||
| DNA polymerase beta | P06746 | | Cancer | Diabetes | ||
| DNA polymerase lambda (isoform a) | Q9UGP5 | | Cancer | |||
| DNA Polymerase zeta Complex | Cancer | |||||
| DNA primase | Cancer | |||||
| DNA repair protein RAD51 homolog 1 (isoform 1) | Q06609 | Cancer | ||||
| DNA repair protein RAD51 homolog 1 (isoform 2) | Q06609 | | Cancer | |||
| DNA repair protein RAD52 homolog (isoform 2) | P43351 | | Cancer | |||
| DNA repair protein RAD52 homolog (isoform 3) | P43351 | | Cancer | |||
| DNA repair protein RAD52 homolog (isoform 4) | P43351 | Cancer | ||||
| DNA repair protein RAD52 homolog (isoform 5) | P43351 | Cancer | ||||
| DNA repair protein REV1 (isoform 1) | Q9UBZ9 | Cancer | ||||
| DNA replication factor Cdt1 | Q9H211 | Cancer | ||||
| DNA topoisomerase (nonspecified subtype) | Cancer | |||||
| DNA topoisomerase 2-alpha | P11388 | Cancer | Diabetes | |||
| DNA topoisomerase 2-beta | Q02880 | Cancer | ||||
| DNA topoisomerase I | P11387 | | Cancer | Diabetes Leishmaniasis Malaria | ||
| DNA Topoisomerase II (bacterial) | Cancer | |||||
| DNA Topoisomerase II (nonspecified subtype) | Cancer | Diabetes | ||||
| DNA-(apurinic or apyrimidinic site) lyase (isoform 1) | P27695 | Cancer | ||||
| DNA-(apurinic or apyrimidinic site) lyase (isoform 4) | P27695 | | Cancer | |||
| DNA-Dependent Protein Kinase (DNA-PK) | Cancer | |||||
| DNA-Directed DNA Polymerase | Cancer | Diabetes Tuberculosis | ||||
| DNA-Directed RNA Polymerase (nonspecified subtype) | Cancer | |||||
| DNA-Directed RNA Polymerase I | Cancer | |||||
| DNA-Directed RNA Polymerase II | Cancer | |||||
| DNA-directed RNA polymerase III subunit RPC1 | O14802 | Cancer | ||||
| DnaK (bacterial) | Cancer Malaria | |||||
| DNMT1 variant 1 | Cancer | |||||
| DNMT1 variant 2 | Cancer | |||||
| DNMT3B variant 1 | Cancer | |||||
| DNMT3B variant 2 | Cancer | |||||
| DNMT3B variant 6 | Cancer | |||||
| DNMT3B variant 7 | Cancer | |||||
| DNMT3B variant 8 | Cancer | |||||
| Dopamine receptor (nonspecified subtype) | Cancer | Diabetes | ||||
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (isoform 1) | Q9HCR9 | Diabetes | Cancer | |||
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (isoform 3) | Q9HCR9 | Diabetes | Cancer | |||
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (isoform 4) | Q9HCR9 | Diabetes | Cancer | |||
| Dual oxidase 2 | Q9NRD8 | Cancer | ||||
| Dual Specificity Mitogen-Activated Protein Kinase Kinase (MEK) (nonspecified subtype) | Cancer | Diabetes | ||||
| Dual specificity mitogen-activated protein kinase kinase 1 (MEK 1) | Q02750 | | Cancer | Diabetes | ||
| Dual specificity mitogen-activated protein kinase kinase 2 (MEK 2) | P36507 | Cancer | ||||
| Dual specificity mitogen-activated protein kinase kinase 4 | P45985 | | Cancer | |||
| Dual specificity mitogen-activated protein kinase kinase 5 (isoform 3) | Q13163 | | Cancer | |||
| Dual specificity mitogen-activated protein kinase kinase 5 (isoform A) | Q13163 | Cancer | ||||
| Dual specificity mitogen-activated protein kinase kinase 5 (isoform B) | Q13163 | Cancer | ||||
| Dual specificity mitogen-activated protein kinase kinase 5 (isoform C) | Q13163 | Cancer | ||||
| Dual specificity mitogen-activated protein kinase kinase 7 | O14733 | Cancer | ||||
| Dual specificity phosphatase 22 | Q9NRW4 | Cancer Diabetes | ||||
| Dual specificity protein kinase CLK1 | P49759 | Cancer | Diabetes | |||
| Dual specificity protein kinase CLK2 (isoform 1) | P49760 | Cancer Diabetes | ||||
| Dual specificity protein kinase CLK2 (isoform 2) | P49760 | Cancer Diabetes | ||||
| Dual specificity protein kinase CLK2 (isoform 3) | P49760 | Cancer Diabetes | ||||
| Dual specificity protein kinase CLK4 | Q9HAZ1 | Cancer | ||||
| Dual specificity protein kinase TTK (isoform 1) | P33981 | Cancer | ||||
| Dual specificity protein kinase TTK (isoform 2) | P33981 | | Cancer | |||
| Dual specificity protein phosphatase 1 | P28562 | Cancer | ||||
| Dual specificity protein phosphatase 3 | P51452 | | Cancer Diabetes | |||
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A (isoform 1) | Q13627 | Cancer | Diabetes | |||
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A (isoform 2) | Q13627 | | Cancer | Diabetes | ||
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B (isoform a) | Q9Y463 | Cancer | Diabetes | |||
| Dual specificity tyrosine-phosphorylation-regulated kinase 3 (isoform a) | O43781 | Cancer | ||||
| Dual specificity tyrosine-phosphorylation-regulated kinase 3 (isoform b) | O43781 | Cancer | ||||
| Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (isoform 1) | Q92630 | Cancer | ||||
| Dynamin 1-like protein (isoform 1) | O00429 | Cancer | ||||
| Dynamin-1 | Q05193 | Cancer | Epilepsy | |||
| Dynamin-1-like protein (isoform 4) | O00429 | | Cancer | |||
| Dynamin-1-like protein (isoform 5) | O00429 | | Cancer | |||
| E-selectin | P16581 | | Cancer | |||
| E2F Transcription Factor (nonspecified subtype) | Cancer | |||||
| E2F transcription factor 1 | Q01094 | Cancer | ||||
| E2F1 | Cancer | |||||
| E2F2 | Cancer | |||||
| E2F3 variant 1 | Cancer | |||||
| E3 SUMO-protein ligase CBX4 | O00257 | | Cancer | |||
| E3 ubiquitin-protein ligase (nonspecified subtype) | Cancer | Diabetes | ||||
| E3 ubiquitin-protein ligase CBL-B | Q13191 | Cancer Diabetes | ||||
| E3 ubiquitin-protein ligase CHFR | Q96EP1 | | Cancer | |||
| E3 ubiquitin-protein ligase Mdm2 (isoform 1) | Q00987 | | Cancer | Diabetes | ||
| E3 ubiquitin-protein ligase Mdm2 (isoform 3) | Q00987 | | Cancer | Diabetes | ||
| E3 ubiquitin-protein ligase NEDD4 (isoform 1) | P46934 | Cancer | ||||
| E3 ubiquitin-protein ligase NEDD4 (isoform 2) | P46934 | Cancer | ||||
| E3 ubiquitin-protein ligase parkin (isoform 1) | O60260 | Cancer Diabetes | ||||
| E3 ubiquitin-protein ligase parkin (isoform 2) | O60260 | | Cancer Diabetes | |||
| E3 ubiquitin-protein ligase parkin (isoform 3) | O60260 | | Cancer Diabetes | |||
| E3 ubiquitin-protein ligase RING2 | Q99496 | Cancer | ||||
| E3 ubiquitin-protein ligase RNF187 | Q5TA31 | Cancer | ||||
| E3 ubiquitin-protein ligase synoviolin | Q86TM6 | Cancer | ||||
| E3 ubiquitin-protein ligase TRIM33 (isoform alpha) | Q9UPN9 | Cancer | ||||
| E6 | Cancer | |||||
| E7 | Cancer | |||||
| Echinoderm microtubule-associated protein-like 4 (isoform 1) | Q9HC35 | Cancer | ||||
| Echinoderm microtubule-associated protein-like 4 (isoform 2) | Q9HC35 | Cancer | ||||
| Ecto-NOX disulfide-thiol exchanger 1 | Q8TC92 | Cancer | ||||
| Ecto-NOX disulfide-thiol exchanger 2 (soform 1) | Q16206 | Cancer | ||||
| Ectonucleoside triphosphate diphosphohydrolase 1 (isoform 1) | P49961 | Cancer | Diabetes | |||
| Ectonucleoside triphosphate diphosphohydrolase 1 (isoform 2) | P49961 | Cancer | Diabetes | |||
| Ectonucleoside triphosphate diphosphohydrolase 2 (isoform 1) | Q9Y5L3 | Cancer Diabetes | ||||
| Ectonucleoside triphosphate diphosphohydrolase 3 | O75355 | Cancer Diabetes | ||||
| Ectonucleoside triphosphate diphosphohydrolase 5 | O75356 | Cancer | ||||
| Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) (nonspecified subtype) | Cancer Diabetes | |||||
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | P22413 | Cancer | Diabetes | |||
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Q13822 | Cancer | Diabetes | |||
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 | O14638 | Cancer Diabetes | ||||
| EED variant 1 | Cancer | |||||
| EED variant 3 | Cancer | |||||
| EGFR variant 1 | Cancer | Diabetes | ||||
| EGFR variant 2 | Cancer | Diabetes | ||||
| EGFR variant 3 | Cancer | Diabetes | ||||
| EGFR variant 4 | Cancer | Diabetes | ||||
| EGFR variant 6 | Cancer | Diabetes | ||||
| Egl nine homolog 1 | Q9GZT9 | Cancer Diabetes | ||||
| EGR1 | Cancer Diabetes | |||||
| EIF2AK2 variant 1 | Cancer | |||||
| EIF4E variant 1 | Cancer | |||||
| EIF4F translation-initiation complex | Cancer | |||||
| EIF5A variant A | Cancer | |||||
| EIF5A variant B | Cancer | |||||
| Elastase (nonspecified subtype) | Cancer Leishmaniasis | |||||
| ELAV-like protein 1 | Q15717 | Cancer | ||||
| ELAVL1 | Cancer | |||||
| ELAVL4 variant 1 | Cancer | |||||
| ELAVL4 variant 4 | Cancer | |||||
| ELAVL4 variant 7 | Cancer | |||||
| Electroneutral sodium bicarbonate exchanger 1 | Q2Y0W8 | Cancer | ||||
| Elongation Factor 1 Complex | Cancer | |||||
| Elongation factor 1-alpha 1 (EF-1-alpha-1) | P68104 | Cancer | ||||
| Enah/Vasp-like | Q9UI08 | Cancer | ||||
| Endoglin (isoform 1) | P17813 | Cancer | ||||
| Endoglin (isofrom 2) | P17813 | Cancer | ||||
| Endoplasmic reticulum aminopeptidase 1 | Q9NZ08 | Cancer | ||||
| Endoplasmic reticulum aminopeptidase 1 (isoform b) | Q9NZ08 | | Cancer | |||
| Endoplasmic reticulum aminopeptidase 2 | Q6P179 | Cancer | ||||
| Endoplasmic reticulum chaperone BiP | P11021 | | Cancer | |||
| Endoplasmin | P14625 | Cancer | Diabetes | |||
| Endosialin | Q9HCU0 | Cancer | ||||
| Endothelial PAS domain-containing protein 1 | Q99814 | Cancer | ||||
| Endothelin B receptor (ET-B) (isoform 1) | P24530 | Cancer | ||||
| Endothelin B receptor (ET-B) (isoform 4) | P24530 | Cancer | ||||
| Endothelin receptor (nonspecified subtype) | Cancer Diabetes | |||||
| Endothelin-1 receptor (ET-A) | P25101 | Cancer | ||||
| Endothelin-converting enzyme 1 | P42892 | Cancer | ||||
| Endothelin-converting enzyme 2 | O60344 | Cancer | ||||
| Endothelin-Converting Enzymes (ECE) (nonspecified subtype) | Cancer | |||||
| ENG variant 1 | Cancer | |||||
| ENG variant 2 | Cancer | |||||
| Enoyl-(acyl carrier protein) reductase | P71079 | | Cancer Tuberculosis | Malaria | ||
| Enoyl-(Acyl Carrier Protein) Reductase (Fabl) | Cancer Tuberculosis | Malaria | ||||
| ENTPD1 variant 1 | Cancer | |||||
| ENTPD1 variant 2 | Cancer | |||||
| EP300 | Cancer | |||||
| EPAS1 | Cancer | |||||
| EPHA2 | Cancer | |||||
| EPHA8 variant 1 | Cancer | |||||
| Ephrin Receptor (nonspecified subtype) | Cancer | |||||
| Ephrin Type-A Receptor 1 (EphA1) | P21709 | Cancer | ||||
| Ephrin Type-A Receptor 2 (EphA2) | P29317 | Cancer | ||||
| Ephrin type-A receptor 3 (isoform a) | P29320 | Cancer | ||||
| Ephrin type-A receptor 3 (isoform b) | P29320 | | Cancer | |||
| Ephrin type-A receptor 4 | P54764 | Cancer | ||||
| Ephrin type-A receptor 5 (isoform 1) | P54756 | Cancer | ||||
| Ephrin type-A receptor 5 (isoform 2) | P54756 | Cancer | ||||
| Ephrin type-A receptor 5 (isoform 3) | P54756 | Cancer | ||||
| Ephrin type-A receptor 7 (isoform 1) | Q15375 | Cancer | ||||
| Ephrin type-A receptor 7 (isoform 2) | Q15375 | | Cancer | |||
| Ephrin type-A receptor 8 (isoform 1) | P29322 | Cancer | ||||
| Ephrin type-B receptor 2 (isoform 1) | P29323 | Cancer | ||||
| Ephrin type-B receptor 2 (isoform 2) | P29323 | | Cancer | |||
| Ephrin type-B receptor 3 | P54753 | Cancer | ||||
| Ephrin type-B receptor 4 (EphB4) | P54760 | Cancer | ||||
| Ephrin type-B receptor 6 (isoform 1) | O15197 | Cancer | ||||
| Epidermal growth factor receptor (isoform 1) | P00533 | | Cancer | Diabetes | ||
| Epidermal growth factor receptor (isoform 2) | P00533 | | Cancer | Diabetes | ||
| Epidermal growth factor receptor (isoform 3) | P00533 | | Cancer | Diabetes | Malaria | |
| Epidermal growth factor receptor (isoform 4) | P00533 | | Cancer | Diabetes | Malaria | |
| Epidermal growth factor receptor (isoform 6) | P00533 | Cancer | Diabetes | |||
| Epidermal growth factor-like protein 6 precursor (isoform 1) | Q8IUX8 | Cancer | ||||
| Epidermal growth factor-like protein 7 | Q9UHF1 | Cancer | ||||
| Epidermal retinal dehydrogenase 2 | Q8N3Y7 | Cancer | ||||
| Epithelial Cell Adhesion Molecule (Ep-CAM) | P16422 | Cancer | ||||
| Epithelial discoidin domain-containing receptor 1 (isoform 1) | Q08345 | Cancer | ||||
| Epithelial discoidin domain-containing receptor 1 (isoform 2) | Q08345 | Cancer | ||||
| Epithelial discoidin domain-containing receptor 1 (isoform 3) | Q08345 | Cancer | ||||
| Epithelial discoidin domain-containing receptor 1 (isoform 4) | Q08345 | | Cancer | |||
| Epithelial discoidin domain-containing receptor 1 (isoform 6) | Q08345 | | Cancer | |||
| Epithelial membrane protein 2 | P54851 | Cancer | ||||
| Epithelial Sodium Channel (ENaC) | Cancer | |||||
| Epoxide Hydrolase (nonspecified subtype) | Cancer | Diabetes | Epilepsy Tuberculosis | |||
| Equilibrative nucleoside transporter 1 (isoform 1) | Q99808 | Cancer | Malaria | |||
| Equilibrative nucleoside transporter 1 (isoform 4) | Q99808 | Cancer | ||||
| Equilibrative nucleoside transporter 1 (isoform 6) | Q99808 | Cancer | Malaria | |||
| Equilibrative nucleoside transporter 2 | Q14542 | Cancer | ||||
| ERBB2 variant 1 | Cancer | |||||
| ERBB2 variant 2 | Cancer | |||||
| ERBB2 variant 4 | Cancer | |||||
| ERBB3 variant 1 | Cancer | |||||
| ERG variant 1 | Cancer | |||||
| ERG variant 2 | Cancer | |||||
| ERG variant 3 | Cancer | |||||
| Erythropoietin | P01588 | | Cancer | |||
| Erythropoietin receptor | P19235 | | Diabetes | Cancer | ||
| Estradiol 17-beta-dehydrogenase 1 | P14061 | Cancer | Diabetes | |||
| Estradiol 17-beta-dehydrogenase 2 | P37059 | Cancer | Diabetes | |||
| Estrogen receptor (isoform 1) | P03372 | | Cancer | Diabetes | ||
| Estrogen receptor (isoform 5) | P03372 | Cancer | Diabetes | |||
| Estrogen receptor (isoform 7) | P03372 | | Cancer | Diabetes | ||
| Estrogen receptor (isoform X1) | P03372 | | Cancer | Diabetes | ||
| Estrogen receptor (nonspecified subtype) | Cancer | Diabetes | ||||
| Estrogen receptor-beta (isoform a) | Q92731 | | Cancer | Diabetes | ||
| Estrogen-related receptor (ERR) (nonspecifed subtype) | Cancer | |||||
| Estrogen-related receptor gamma (isoform 1) | P62508 | | Cancer | Diabetes | ||
| Estrogen-related receptor gamma (isoform 2) | P62508 | Cancer | Diabetes | |||
| ETS domain-containing protein Elk-1 | P19419 | Cancer | ||||
| ETS translocation variant 1 (isoform 1) | P50549 | Cancer | ||||
| ETS translocation variant 1 (isoform 4) | P50549 | | Cancer | |||
| ETS2 variant 1 | Cancer | |||||
| ETS2 variant 2 | Cancer | |||||
| Euchromatic histone methyltransferase 1 | Q9H9B1 | Cancer | ||||
| Euchromatic histone-lysine N-methyltransferase 2 (isoform a) | Q96KQ7 | Cancer Malaria | ||||
| Eukaryotic elongation factor 2 kinase | O00418 | Cancer | ||||
| Eukaryotic initiation factor 4A-I (isoform 1) | P60842 | Cancer | ||||
| Eukaryotic initiation factor 4A-III | P38919 | Cancer | ||||
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (isoform 1) | P15170 | Cancer | ||||
| Eukaryotic translation initiation factor 2-alpha kinase 1 (isoform a) | Q9BQI3 | Cancer | Diabetes | |||
| Eukaryotic translation initiation factor 2-alpha kinase 3 | Q9NZJ5 | Cancer | Diabetes | |||
| Eukaryotic translation initiation factor 2-alpha kinase 4 | Q9P2K8 | Cancer | ||||
| Eukaryotic translation initiation factor 2B | Cancer | |||||
| Eukaryotic translation initiation factor 4 gamma 1 (isoform 1) | Q04637 | Cancer | ||||
| Eukaryotic translation initiation factor 4 gamma 1 (isoform 3) | Q04637 | Cancer | ||||
| Eukaryotic translation initiation factor 4 gamma 1 (isoform 4) | Q04637 | Cancer | ||||
| Eukaryotic translation initiation factor 4 gamma 1 (isoform 5) | Q04637 | Cancer | ||||
| Eukaryotic translation initiation factor 4 gamma 1 (isoform 6) | Q04637 | | Cancer | |||
| Eukaryotic translation initiation factor 4 gamma 2 | P78344 | Cancer | ||||
| Eukaryotic translation initiation factor 4 gamma 3 (isoform 1) | O43432 | Cancer | ||||
| Eukaryotic Translation Initiation Factor 4A (eIF-4A) | Cancer | |||||
| Eukaryotic translation initiation factor 4E (isoform 1) | P06730 | | Cancer | |||
| Eukaryotic translation initiation factor 5A-2 | Q9GZV4 | Cancer Diabetes | ||||
| Eukaryotict translation initiation factor 4 gamma 3 (isoform 3) | O43432 | Cancer | ||||
| Excitatory amino acid transporter 2 (isoform 2) | P43004 | Cancer Epilepsy | ||||
| EXO5 | Cancer | |||||
| Exportin-1 | O14980 | Cancer | ||||
| Extracellular calcium-sensing receptor (CaSR) (isoform 2) | P41180 | Cancer | Diabetes | |||
| EYA2 | Cancer | |||||
| EZH2 variant 1 | Cancer | |||||
| EZH2 variant 2 | Cancer | |||||
| EZH2 variant 3 | Cancer | |||||
| EZH2 variant 4 | Cancer | |||||
| EZH2 variant 5 | Cancer | |||||
| F-box only protein 3 (isoform 1) | Q9UK99 | Cancer Malaria | ||||
| F3 variant 1 | Cancer | |||||
| FABP5 | Cancer | |||||
| FACT complex | Cancer | |||||
| FAD-linked sulfhydryl oxidase ALR | P55789 | Cancer | ||||
| Far upstream element-binding protein 1 | Q96AE4 | | Cancer | |||
| Farnesyl pyrophosphate synthase | P14324 | Cancer | ||||
| Fas-activated serine/threonine kinase (isoform 1) | Q14296 | Cancer | ||||
| Fascin | Q16658 | Cancer | ||||
| FASLG variant 1 | Cancer Diabetes | |||||
| FASLG variant 2 | Cancer Diabetes | |||||
| FASN | Cancer | |||||
| Fatty acid amide hydrolase | O00519 | Cancer | Diabetes Malaria Epilepsy | |||
| Fatty acid binding protein 4, adipocyte | P15090 | | Diabetes | Cancer | ||
| Fatty acid desaturase 1 | O60427 | Diabetes | Cancer | |||
| Fatty acid synthase | P49327 | | Cancer | Diabetes Leishmaniasis Malaria | ||
| Fatty acid-binding protein, epidermal | Q01469 | | Diabetes | Cancer | ||
| FBXO31 | Cancer | |||||
| Fc alpha receptor (isoform a) | P24071 | | Cancer | |||
| Fc-gamma Receptor (FCGR) (nonspecified subtype) | Cancer | |||||
| Ferritin | Cancer | |||||
| FGFR3 variant 1 | Cancer | |||||
| FGFR3 variant 2 | Cancer | |||||
| FGFR3 variant 3 | Cancer | |||||
| Fibroblast growth factor (FGF) (nonspecified subtype) | Cancer | |||||
| Fibroblast growth factor 14 (isoform 1) | Q92915 | Cancer | ||||
| Fibroblast growth factor 14 (isoform 2) | Q92915 | Cancer | ||||
| Fibroblast growth factor 23 | Q9GZV9 | Cancer | ||||
| Fibroblast growth factor 8 precursor (isoform A) | P55075 | Cancer | ||||
| Fibroblast Growth Factor Receptor (FGFR) (nonspecified subtype) | Cancer | |||||
| Fibroblast growth factor receptor 1 (isoform 1) | P11362 | | Cancer Diabetes | |||
| Fibroblast growth factor receptor 1 (isoform 10) | P11362 | | Cancer Diabetes | |||
| Fibroblast growth factor receptor 1 (isoform 11) | P11362 | | Cancer Diabetes | |||
| Fibroblast growth factor receptor 1 (isoform 14) | P11362 | | Cancer Diabetes | |||
| Fibroblast growth factor receptor 1 (isoform 2) | P11362 | | Cancer Diabetes | |||
| Fibroblast growth factor receptor 1 (isoform 3) | P11362 | | Cancer Diabetes | |||
| Fibroblast growth factor receptor 1 (isoform 4) | P11362 | | Cancer Diabetes | |||
| Fibroblast growth factor receptor 2 (isoform 1) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 11) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 2) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 3) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 4) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 5) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 6) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 7) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 8) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 2 (isoform 9) | P21802 | | Cancer | |||
| Fibroblast growth factor receptor 3 (FGFR-3) (isoform 1) | P22607 | Cancer | ||||
| Fibroblast growth factor receptor 3 (FGFR-3) (isoform 2) | P22607 | Cancer | ||||
| Fibroblast growth factor receptor 3 (FGFR-3) (isoform 3) | P22607 | Cancer | ||||
| Fibroblast growth factor receptor 4 (isoform 1) | P22455 | Cancer | ||||
| Fibroblast growth factor receptor 4 (isoform 2) | P22455 | Cancer | ||||
| Fibronectin (isoform 1) | P02751 | Cancer | ||||
| Fibronectin (isoform 3) | P02751 | | Cancer | |||
| Fibronectin (isoform 4) | P02751 | Cancer | ||||
| Fibronectin type III domain-containing protein 1 precursor | Q4ZHG4 | Cancer | ||||
| FK506 binding protein 4 | Q02790 | | Cancer | |||
| Flap endonuclease 1 | P39748 | Cancer | ||||
| FLT1 variant 1 | Cancer | |||||
| FLT1 variant 2 | Cancer | |||||
| FLT1 variant 3 | Cancer | |||||
| fMet-Leu-Phe receptor | P21462 | Cancer | ||||
| Focal adhesion kinase 1 (isoform 1) | Q05397 | | Cancer | |||
| Focal adhesion kinase 1 (isoform 2) | Q05397 | | Cancer | |||
| Focal Adhesion Kinases (FAK) (nonspecified subtype) | Cancer | |||||
| Folate Receptor (nonspecified subtype) | Cancer Diabetes | |||||
| Folate receptor alpha | P15328 | Cancer | ||||
| Folate receptor beta precursor | P14207 | Cancer | ||||
| Follicle-stimulating hormone receptor (isoform 1) | P23945 | | Cancer | Diabetes | ||
| Folylpolyglutamate synthase, mitochondrial | Q05932 | Cancer | ||||
| Forkhead box protein M1 (isoform 1) | Q08050 | Cancer | ||||
| Forkhead box protein M1 (isoform 2) | Q08050 | Cancer | ||||
| Forkhead box protein M1 (isoform 3) | Q08050 | Cancer | ||||
| Forkhead box protein O3 | O43524 | Cancer | ||||
| Forkhead box protein O4 (isoform 1) | P98177 | | Cancer | |||
| Forkhead box protein P3 (isoform a) | Q9BZS1 | Cancer | ||||
| Forkhead box protein P3 (isoform b) | Q9BZS1 | Cancer | ||||
| Formin homology 2 domain-containing proteins (nonspecified subtype) | Cancer | |||||
| FOS | Cancer | |||||
| FOXG1 | Cancer | |||||
| FOXM1 variant 1 | Cancer | |||||
| FOXM1 variant 2 | Cancer | |||||
| FOXM1 variant 3 | Cancer | |||||
| FOXP3 variant 1 | Cancer | |||||
| FOXP3 variant 2 | Cancer | |||||
| Free fatty acid receptor 1 (GPR40) | O14842 | Diabetes | Cancer | |||
| Free fatty acid receptor 2 | O15552 | Diabetes | Cancer | |||
| Free fatty acid receptor 4 (isoform GPR120-L) | Q5NUL3 | Diabetes | Cancer | |||
| Friend leukemia integration 1 transcription factor (isoform 1) | Q01543 | | Cancer | |||
| Frizzled-5 | Q13467 | Cancer | ||||
| Frizzled-7 receptor | O75084 | Cancer | ||||
| Fructose-Bisphosphate Aldolase (nonspecified subtype) | Cancer | |||||
| Fructose-bisphosphate aldolase C | P09972 | Cancer | ||||
| FSCN1 | Cancer | |||||
| Fucosyl GM1 | Cancer | |||||
| Furin | P09958 | Cancer Diabetes | ||||
| G protein-activated inward rectifier potassium channel 1 (isoform 1) | P48549 | Epilepsy | Cancer Diabetes | |||
| G protein-activated inward rectifier potassium channel 1 (isoform 2) | P48549 | Epilepsy | Cancer Diabetes | |||
| G protein-activated inward rectifier potassium channel 4 | P48544 | Cancer Diabetes Epilepsy | ||||
| G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) (nonspecified subtype) | Cancer Diabetes Epilepsy | |||||
| G protein-coupled receptor 23 | Q99677 | Cancer | ||||
| G protein-coupled receptor 39 | O43194 | Diabetes Epilepsy | Cancer | |||
| G protein-coupled receptor kinase 5 (GRK5) | P34947 | Cancer Diabetes | ||||
| G protein-coupled receptor kinase 6 (GRK6) (isoform b) | P43250 | Cancer Diabetes | ||||
| G protein-coupled receptor kinase 6 (GRK6) (isoform c) | P43250 | | Cancer Diabetes | |||
| G-protein coupled bile acid receptor 1 (isoform 1) | Q8TDU6 | Diabetes | Cancer | |||
| G-protein coupled bile acid receptor 1 (isoform 3) | Q8TDU6 | Diabetes | Cancer | |||
| G-protein coupled estrogen receptor 1 | Q99527 | Diabetes | Cancer | |||
| G-protein coupled receptor 182 | O15218 | Cancer | ||||
| G-protein coupled receptor 183 | P32249 | Cancer Diabetes | ||||
| G-protein coupled receptor 35 (isoform a) | Q9HC97 | Cancer Diabetes | ||||
| G-protein coupled receptor 4 | P46093 | Cancer | ||||
| G-protein coupled receptor 55 | Q9Y2T6 | Cancer | ||||
| G-protein coupled receptor 84 | Q9NQS5 | Cancer | ||||
| G1/S-specific cyclin-D1 | P24385 | | Cancer | Malaria | ||
| G1/S-specific cyclin-D3 (isoform 2) | P30281 | Cancer | ||||
| G1/S-specific cyclin-D3 (isoform 4) | P30281 | Cancer | ||||
| G1/S-specific cyclin-D3 (isoform 5) | P30281 | Cancer | ||||
| G1/S-specific cyclin-E (nonspecified subtype) | Cancer | Diabetes | ||||
| G1/S-specific cyclin-E1 | P24864 | | Cancer | Diabetes | ||
| G1/S-specific cyclin-E2 | O96020 | Cancer | ||||
| GABA(A) receptor | Epilepsy | Cancer | Diabetes | |||
| Galactokinase | P51570 | Cancer | ||||
| Galactoside 3(4)-L-fucosyltransferase | P21217 | Cancer | Diabetes | |||
| Galanin receptor type 1 | P47211 | Epilepsy | Cancer | |||
| Galectin 9 (long isoform) | O00182 | Cancer | ||||
| Galectin-1 | P09382 | | Cancer | |||
| Galectin-3 (isoform 1) | P17931 | | Cancer | |||
| Galectin-3 (isoform 2) | P17931 | | Cancer | |||
| Galectin-3-binding protein | Q08380 | Cancer | ||||
| Galectin-4 | P56470 | Cancer | ||||
| Galectin-8 (isoform 1) | O00214 | Cancer | ||||
| Galectin-9 (isoform 2) | O00182 | Cancer | ||||
| Gamma-aminobutyric acid (GABA) A receptor subunit alpha-1 | P14867 | Diabetes Epilepsy | Cancer | |||
| Gamma-aminobutyric acid (GABA) A receptor subunit alpha-6 | Q16445 | Cancer Epilepsy | ||||
| Gamma-aminobutyric acid receptor subunit beta-2 (isoform 1) | P47870 | Diabetes | Cancer Epilepsy | |||
| Gamma-aminobutyric acid receptor subunit beta-2 (isoform 2) | P47870 | Diabetes | Cancer Epilepsy | |||
| Gamma-aminobutyric acid receptor subunit beta-3 (isoform 1) | P28472 | Epilepsy | Cancer | |||
| Gamma-aminobutyric acid receptor subunit beta-3 (isoform 2) | P28472 | Epilepsy | Cancer | |||
| Gamma-aminobutyric acid receptor subunit beta-3 (isoform 3) | P28472 | Epilepsy | Cancer | |||
| Gamma-aminobutyric acid receptor subunit beta-3 (isoform 4) | P28472 | Epilepsy | Cancer | |||
| Gamma-aminobutyric acid receptor subunit gamma-2 (isoform 1) | P18507 | Diabetes Epilepsy | Cancer | |||
| Gamma-aminobutyric acid receptor subunit gamma-2 (isoform 2) | P18507 | Diabetes Epilepsy | Cancer | |||
| Gamma-aminobutyric acid receptor subunit gamma-2 (isoform 3) | P18507 | Diabetes Epilepsy | Cancer | |||
| Gamma-Aminobutyric acid type B receptor | Cancer Epilepsy | |||||
| Gamma-enolase | P09104 | | Cancer | |||
| gamma-Glutamylcyclotransferase | O75223 | Cancer | ||||
| Gamma-Glutamyltranspeptidase 1 | P19440 | Cancer | ||||
| gamma-Secretase | Cancer | Diabetes | ||||
| Gap junction alpha-1 protein | P17302 | Epilepsy | ||||
| Gap junction alpha-8 protein | P48165 | Cancer | ||||
| Gap junction Connexin ( (nonspecified subtype) | Cancer Epilepsy | Diabetes | ||||
| Gap junction delta-2 protein | Q9UKL4 | Cancer | ||||
| Gap Junction Protein (nonspecified subtype) | Cancer Epilepsy | Diabetes | ||||
| GAPDH | Cancer | |||||
| GAST | Cancer | |||||
| Gastric H+/K+-ATPase | Cancer Diabetes | |||||
| Gastric Inhibitory Polypeptide Receptor (GIP-R) | P48546 | Diabetes | Cancer | |||
| Gastric Inhibitory Polypeptide Receptor (GIP-R) (isoform 2) | P48546 | Diabetes | Cancer | |||
| Gastrin-releasing peptide receptor | P30550 | Cancer | ||||
| Gastrin/cholecystokinin type B receptor | P32239 | Cancer | Diabetes | |||
| GDNF family receptor alpha-like | Q6UXV0 | Cancer | ||||
| Geminin | O75496 | Cancer | ||||
| Geranylgeranyl transferase type-2 subunit alpha | Q92696 | Cancer | ||||
| GFM2 variant 1 | Cancer | |||||
| GHR variant 1 | Cancer | |||||
| Ghrelin receptor (isoform 1a) | Q92847 | Cancer | Diabetes | |||
| Ghrelin receptor (isoform 1b) | Q92847 | Cancer | Diabetes | |||
| Gingipain R2 | P95493 | | Cancer | |||
| GLI1 variant 1 | Cancer | |||||
| GLI1 variant X1 | Cancer | |||||
| GLI2 | Cancer | |||||
| GLS variant 1 | Cancer | |||||
| Glucagon-like peptide 1 receptor | P43220 | | Diabetes | Cancer | ||
| Glucagon-like peptide 2 receptor | O95838 | Diabetes | Cancer | |||
| Glucocorticoid receptor (isoform 6) | P04150 | | Cancer | Diabetes | ||
| Glucocorticoid receptor (isoform 7) | P04150 | Cancer | Diabetes | |||
| Glucocorticoid receptor (isoform 8) | P04150 | Cancer | Diabetes | |||
| Glucocorticoid receptor (isoform alpha) | P04150 | | Cancer | Diabetes | ||
| Glucocorticoid receptor (isoform alpha-C2) | P04150 | Cancer | Diabetes | |||
| Glucocorticoid receptor (isoform X2) | P04150 | Cancer | Diabetes | |||
| Glucose-6-phosphatase (isoform 1) | P35575 | Cancer Diabetes | ||||
| Glucose-6-phosphatase (isoform 2) | P35575 | Cancer Diabetes | ||||
| Glucose-6-phosphate dehydrogenase (isoform a) | P11413 | | Cancer | |||
| Glucose-6-phosphate dehydrogenase (isoform b) | P11413 | | Cancer | |||
| Glucose-dependent insulinotropic receptor | Q8TDV5 | Diabetes | Epilepsy | Cancer | ||
| Glucosylceramidase (isoform 1) | P04062 | | Cancer Diabetes | |||
| Glucosylceramidase (isoform 3) | P04062 | Cancer Diabetes | ||||
| Glucosylceramidase (isoform 4) | P04062 | | Cancer Diabetes | |||
| Glucosylceramidase (isoform 5) | P04062 | | Cancer Diabetes | |||
| Glutamate carboxypeptidase II (isoform 1) | Q04609 | | Cancer | Epilepsy | ||
| Glutamate carboxypeptidase II (isoform 2) | Q04609 | | Cancer | Epilepsy | ||
| Glutamate carboxypeptidase II (isoform 3) | Q04609 | | Cancer | Epilepsy | ||
| Glutamate dehydrogenase 1, mitochondrial | P00367 | | Cancer | |||
| Glutamate Receptor Ionotropic (nonspecified subtype) | Epilepsy | Cancer | ||||
| Glutamate Receptor Ionotropic AMPA Receptor | Diabetes Epilepsy | Cancer | ||||
| Glutamate receptor ionotropic, NMDA 2A (isoform 1) | Q12879 | Epilepsy | Cancer Diabetes | |||
| Glutamate receptor ionotropic, NMDA 2A (isoform 2) | Q12879 | Epilepsy | Cancer Diabetes | |||
| Glutamate receptor ionotropic, NMDA 2A (isoform 3) | Q12879 | Epilepsy | Cancer Diabetes | |||
| Glutamate receptor ionotropic, NMDA 2B | Q13224 | Epilepsy | Cancer Diabetes | |||
| Glutamate Transporter (nonspecified subtype) | Cancer Epilepsy | |||||
| Glutaminase (nonspecified subtype) | Cancer | Malaria | ||||
| Glutaminase kidney isoform, mitochondrial (isoform 1) | O94925 | | Cancer | |||
| Glutaminyl-peptide cyclotransferase | Q16769 | | Cancer | |||
| Glutathione peroxidase (nonspecified subtype) | Diabetes | Cancer | ||||
| Glutathione reductase, mitochondrial (isoform 1) | P00390 | | Cancer | Diabetes | Malaria Schistosomiasis | |
| Glutathione S-Transferase (GST) (nonspecified subtype) | Cancer | Diabetes | ||||
| Glutathione S-transferase A1 | P08263 | | Cancer | |||
| Glutathione S-transferase M2 | P28161 | Cancer | ||||
| Glutathione S-transferase Mu 2 (isoform 2) | P28161 | | Cancer | |||
| Glutathione S-transferase omega-1 (isoform 1) | P78417 | Cancer | ||||
| Glutathione S-transferase omega-1 (isoform 2) | P78417 | | Cancer | |||
| Glutathione S-transferase omega-1 (isoform 3) | P78417 | | Cancer | |||
| Glutathione S-transferase pi | P09211 | | Cancer | |||
| Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) | P04406 | Cancer | Leishmaniasis | |||
| Glycine dehydrogenase (decarboxylating), mitochondrial | P23378 | Cancer | ||||
| Glycine receptor | Cancer Diabetes Epilepsy | |||||
| Glycogen phosphorylase (nonspecified subtype) | Diabetes | Cancer | ||||
| Glycogen phosphorylase, liver form (isoform 1) | P06737 | | Diabetes | Cancer | ||
| Glycogen synthase kinase 3 (GSK-3) (nonspecified subtype) | Epilepsy | Cancer Diabetes | ||||
| Glycogen synthase kinase 3 beta (isoform 1) | P49841 | | Cancer | Diabetes | Leishmaniasis Malaria Epilepsy | |
| Glycogen synthase kinase-3 alpha | P49840 | Cancer | Diabetes | |||
| Glycogen synthase kinase-3 beta (isoform 2) | P49841 | | Cancer | Diabetes | Leishmaniasis Malaria Epilepsy | |
| Glycoprotein A33 | Q99795 | Cancer | ||||
| Glycoprotein Ib, beta polypeptide | P13224 | Cancer | ||||
| Glycylpeptide N-tetradecanoyltransferase (nonspecified subtype) | Cancer | |||||
| Glycylpeptide N-tetradecanoyltransferase 1 | P30419 | | Cancer | |||
| Glypican-1 | P35052 | Cancer | ||||
| Glypican-3 (isoform 1) | P51654 | Cancer | ||||
| Glypican-3 (isoform 2) | P51654 | Cancer | ||||
| GM-CSF Receptor (GM-CSF-R) | Cancer | |||||
| GNAI3 | Cancer | |||||
| GNAS | Cancer | |||||
| GNAS variant 1 | Cancer | |||||
| GNAS variant 2 | Cancer | |||||
| GNAS variant 3 | Cancer | |||||
| GNAS variant 4 | Cancer | |||||
| GNAS variant 7 | Cancer | |||||
| GNB2L1 | Cancer | |||||
| Golgi apparatus protein 1 | Q92896 | Cancer | ||||
| Golgi reassembly-stacking protein 2 (isoform 1) | Q9H8Y8 | | Cancer | |||
| Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (isoform 1) | Q92538 | Cancer | ||||
| Gonadotropin-releasing hormone receptor (isoform 1) | P30968 | Cancer | ||||
| GPC3 variant 1 | Cancer | |||||
| GPC3 variant 2 | Cancer | |||||
| GPR137B | Cancer | |||||
| GPR160 | Cancer | |||||
| GPR4 | Cancer | |||||
| Granulin (GP88) (isoform 1) | P28799 | Cancer | ||||
| Granulocyte colony-stimulating factor precursor (isoform a) | P09919 | | Cancer | |||
| Granulocyte colony-stimulating factor receptor (isoform a) | Q99062 | Cancer | ||||
| Granulocyte-macrophage colony-stimulating factor | P04141 | | Cancer | |||
| Granzyme B | P10144 | | Cancer | |||
| Granzyme H precursor | P20718 | Cancer | ||||
| GRB2 variant 1 | Cancer | |||||
| GRB2 variant 2 | Cancer | |||||
| GRIN2D | Cancer | |||||
| Group IID secretory phospholipase A2 (sPLA2) | Q9UNK4 | Cancer | ||||
| Growth arrest-specific 6 | Q14393 | Cancer | ||||
| Growth differentiation factor 11 | O95390 | Cancer | ||||
| Growth differentiation factor 15 | Q99988 | Cancer | ||||
| Growth factor receptor-bound protein 2 (isoform 1) | P62993 | | Cancer | Diabetes | ||
| Growth factor receptor-bound protein 2 (isoform 2) | P62993 | Cancer | Diabetes | |||
| Growth factor receptor-bound protein 7 (isoform a) | Q14451 | | Cancer | |||
| Growth factor receptor-bound protein 7 (isoform b) | Q14451 | | Cancer | |||
| Growth hormone receptor (isoform 1) | P10912 | | Cancer Diabetes | |||
| Growth hormone-releasing hormone receptor precursor | Q02643 | Cancer | ||||
| Growth-regulated alpha protein | P09341 | Cancer | ||||
| Growth/differentiation factor 2 | Q9UK05 | Cancer | ||||
| Growth/differentiation factor 8 | O14793 | Cancer Diabetes | ||||
| GSTP1 | Cancer | |||||
| GTP-binding protein Rheb | Q15382 | | Cancer | |||
| GTPase HRas (isoform 1) | P01112 | | Cancer | |||
| GTPase HRas (isoform 2) | P01112 | | Cancer | |||
| GTPase KRas (isoform a) | P01116 | Cancer | ||||
| GTPase KRas (isoform b) | P01116 | Cancer | ||||
| GTPase NRas | P01111 | Cancer | ||||
| Guanine deaminase (isoform a) | Q9Y2T3 | | Cancer | |||
| Guanine deaminase (isoform b) | Q9Y2T3 | | Cancer | |||
| Guanine nucleotide-binding protein G(q) subunit alpha | P50148 | Cancer | ||||
| Guanylate cyclase (nonspecified subtype) | Cancer | Diabetes | ||||
| Guanylate cyclase 2C | P25092 | Cancer | ||||
| Guanylate-binding protein 1 | P32455 | | Cancer | |||
| GZMB | Cancer | |||||
| H1 | P35367 | Cancer | Malaria Epilepsy | |||
| H19 | Cancer | |||||
| H3 | Q9Y5N1 | Diabetes Epilepsy | Cancer Malaria | |||
| Haspin | Q8TF76 | Cancer | ||||
| HAVCR2 | Cancer | |||||
| HDAC1 | Cancer | |||||
| HDGFRP3 | Cancer | |||||
| Heat shock 70 kDa protein 1A | P0DMV8 | | Cancer | |||
| Heat Shock Protein 27 (Hsp27) (nonspecified subtype) | Cancer | |||||
| Heat shock protein 70 (nonspecified subtype) | Cancer | Diabetes | ||||
| Heat shock protein 75 kDa, mitochondrial | Q12931 | Cancer | ||||
| Heat shock protein 90 (nonspecified subtype) | Cancer | Diabetes | Malaria Epilepsy | |||
| Heat shock protein HSP 90-alpha (isoform 1) | P07900 | Cancer | ||||
| Heat shock protein HSP 90-alpha (isoform 2) | P07900 | | Cancer | |||
| Heat shock protein HSP 90-beta (isoform a) | P08238 | | Cancer | |||
| Heat shock protein HSP 90-beta (isoform b) | P08238 | | Cancer | |||
| Heat shock protein HSP 90-beta (isoform c) | P08238 | | Cancer | |||
| Heat shock transcription factor 1 | Q00613 | Cancer | ||||
| Hedgehog Protein (nonspecified subtype) | Cancer | Diabetes | ||||
| Hemagglutinin (nonspecified subtype) (Influenza virus) | Cancer | |||||
| Hemagglutinin (viral) | Cancer | |||||
| Hemagglutinin protein (MeV) | Q786F2 | Cancer | ||||
| Heme oxygenase (decyclizing) 2 | P30519 | Cancer Diabetes | ||||
| Heme Oxygenase (HO) (nonspecified subtype) | Cancer Diabetes | |||||
| Heme oxygenase 1 (HO-1) | P09601 | | Cancer Diabetes | |||
| Heparanase (isoform 1) | Q9Y251 | Cancer | Diabetes | |||
| Heparin-binding growth factor 1 (isoform 1) | P05230 | | Cancer | |||
| Heparin-binding growth factor 2 | P09038 | | Cancer | Epilepsy | ||
| Hepatitis A virus cellular receptor 1 | Q96D42 | Cancer | ||||
| Hepatitis A virus cellular receptor 2 (TIM-3) | Q8TDQ0 | Cancer | ||||
| Hepatocyte growth factor (HGF) (isoform 1) | P14210 | | Cancer | |||
| Hepatocyte growth factor (HGF) (isoform 3) | P14210 | | Cancer | |||
| Hepatocyte growth factor activator (HGFA) | Q04756 | Cancer | ||||
| Hepatocyte growth factor receptor (isoform 1) | P08581 | | Cancer | Diabetes | ||
| Hepatocyte growth factor receptor (isoform 2) | P08581 | Cancer | Diabetes | |||
| Hepatocyte growth factor receptor (isoform 4) | P08581 | Cancer | Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 1) | P41235 | | Cancer Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 2) | P41235 | | Cancer Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 3) | P41235 | | Cancer Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 4) | P41235 | | Cancer Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 5) | P41235 | | Cancer Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 6) | P41235 | | Cancer Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 7) | P41235 | | Cancer Diabetes | |||
| Hepatocyte nuclear factor 4-alpha (isoform 9) | P41235 | Cancer Diabetes | ||||
| Hepatoma-derived growth factor (high-mobility group protein 1-like) | P51858 | Cancer | ||||
| Hepcidin | P81172 | | Cancer | |||
| HER (erbB) (nonspecified subtype) | Cancer | |||||
| HEXIM1 | Cancer | |||||
| Hexokinase-2 | P52789 | Cancer | ||||
| HIF1A variant 1 | Cancer | |||||
| HIF1A variant 2 | Cancer | |||||
| HIF1A variant 3 | Cancer | |||||
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (isoform 3) | Q13946 | | Cancer Leishmaniasis | |||
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A precursor (isoform 1) | Q13946 | | Cancer Leishmaniasis | |||
| High affinity immunoglobulin gamma Fc receptor I (CD64) | P12314 | Cancer | ||||
| High affinity nerve growth factor receptor (Trk-A) (isoform 1) | P04629 | | Cancer | |||
| High affinity nerve growth factor receptor (Trk-A) (isoform 2) | P04629 | | Cancer | |||
| High affinity nerve growth factor receptor (Trk-A) (isoform 3) | P04629 | | Cancer | |||
| High mobility group box protein 1 (HMGB1) | P09429 | Cancer Diabetes | ||||
| Histamine H2 receptor | P25021 | Cancer | Diabetes | |||
| Histamine H2 receptor (isoform 2) | P25021 | Cancer | Diabetes | |||
| Histamine H2 receptor (isoform X1) | P25021 | Cancer | Diabetes | |||
| Histamine H4 receptor (isoform 1) | Q9H3N8 | Cancer Epilepsy | ||||
| Histamine H4 receptor (isoform 2) | Q9H3N8 | Cancer Diabetes Epilepsy | ||||
| Histamine H4 receptor (isoform 3) | Q9H3N8 | Cancer Diabetes Epilepsy | ||||
| Histamine Receptor (HR) (nonspecified subtype) | Cancer | Epilepsy | ||||
| Histidine decarboxylase | P19113 | Cancer | ||||
| Histidine--tRNA ligase, cytoplasmic (isoform 1) | P12081 | Cancer | ||||
| Histidine--tRNA ligase, cytoplasmic (isoform 7) | P12081 | | Cancer | |||
| Histone acetyltransferase (HAT) (nonspecified subtype) | Cancer | Diabetes Schistosomiasis | ||||
| Histone acetyltransferase KAT2A | Q92830 | | Cancer | Schistosomiasis | ||
| Histone acetyltransferase KAT2B | Q92831 | Cancer Schistosomiasis | ||||
| Histone acetyltransferase KAT5 | Q92993 | Cancer | ||||
| Histone acetyltransferase KAT6A (isoform 1) | Q92794 | Cancer | ||||
| Histone acetyltransferase KAT6B (isoform 1) | Q8WYB5 | Cancer | ||||
| Histone acetyltransferase KAT6B (isoform 2) | Q8WYB5 | Cancer | ||||
| Histone acetyltransferase KAT6B (isoform 3) | Q8WYB5 | Cancer | ||||
| Histone acetyltransferase p300 | Q09472 | | Cancer | Schistosomiasis | ||
| Histone deacetylase (nonspecified subtype) | Cancer Epilepsy | Diabetes | Leishmaniasis Malaria | |||
| Histone deacetylase 1 (HDAC1) | Q13547 | Cancer Epilepsy | Diabetes | |||
| Histone deacetylase 10 | Q969S8 | Cancer | Diabetes | |||
| Histone deacetylase 11 | Q96DB2 | Cancer | ||||
| Histone deacetylase 2 (HDAC2) | Q92769 | Cancer | Diabetes | |||
| Histone deacetylase 3 | O15379 | Cancer | Diabetes | |||
| Histone deacetylase 4 | P56524 | | Cancer | Diabetes | ||
| Histone deacetylase 5 (isoform 3) | Q9UQL6 | Cancer | Diabetes | |||
| Histone deacetylase 6 (HDAC6) | Q9UBN7 | Cancer | Diabetes Leishmaniasis Schistosomiasis | |||
| Histone deacetylase 7 (isoform 1) | Q8WUI4 | Cancer | ||||
| Histone deacetylase 7 (isoform 4) | Q8WUI4 | | Cancer | |||
| Histone deacetylase 8 | Q9BY41 | Cancer | Diabetes Leishmaniasis | |||
| Histone deacetylase 9 (isoform 1) | Q9UKV0 | Cancer | Diabetes | |||
| Histone deacetylase 9 (isoform 3) | Q9UKV0 | Cancer | Diabetes | |||
| Histone deacetylase 9 (isoform 4) | Q9UKV0 | Cancer | Diabetes | |||
| Histone deacetylase 9 (isoform 5) | Q9UKV0 | Cancer | Diabetes | |||
| Histone deacetylase 9 (isoform 6) | Q9UKV0 | Cancer | Diabetes | |||
| Histone Lysine Demethylase (nonspecified subtype) | Cancer | |||||
| Histone methyltransferase (nonspecified subtype) | Cancer | |||||
| Histone-arginine methyltransferase CARM1 | Q86X55 | | Cancer Epilepsy | |||
| Histone-binding protein RBBP4 | Q09028 | Cancer | ||||
| Histone-lysine N-methyltransferase 2A (isoform 1) | Q03164 | | Cancer | Diabetes | ||
| Histone-lysine N-methyltransferase 2A (isoform 2) | Q03164 | Cancer | Diabetes | |||
| Histone-lysine N-methyltransferase ASH1L | Q9NR48 | | Cancer | |||
| Histone-lysine N-methyltransferase EZH1 | Q92800 | Cancer | ||||
| Histone-lysine N-methyltransferase EZH2 (isoform a) | Q15910 | Cancer | Diabetes | |||
| Histone-lysine N-methyltransferase EZH2 (isoform b) | Q15910 | | Cancer | Diabetes | ||
| Histone-lysine N-methyltransferase EZH2 (isoform c) | Q15910 | | Cancer | Diabetes | ||
| Histone-lysine N-methyltransferase EZH2 (isoform d) | Q15910 | Cancer | Diabetes | |||
| Histone-lysine N-methyltransferase EZH2 (isoform e) | Q15910 | Cancer | Diabetes | |||
| Histone-lysine N-methyltransferase KMT5B | Q4FZB7 | Cancer | ||||
| Histone-lysine N-methyltransferase KMT5C | Q86Y97 | Cancer | ||||
| Histone-lysine N-methyltransferase NSD2 (isoform 1) | O96028 | Cancer | ||||
| Histone-lysine N-methyltransferase NSD2 (isoform 10) | O96028 | Cancer | ||||
| Histone-lysine N-methyltransferase SETD2 | Q9BYW2 | Cancer | ||||
| Histone-lysine N-methyltransferase SETD7 | Q8WTS6 | | Cancer | |||
| Histone-lysine N-Methyltransferase SMYD3 | Q9H7B4 | | Cancer | |||
| Histone-lysine N-methyltransferase SUV39H1 | O43463 | Cancer | ||||
| Histone-lysine N-methyltransferase SUV39H2 | Q9H5I1 | Cancer | ||||
| Histone-lysine N-methyltransferase SUV39H2 (isoform 1) | Q9H5I1 | Cancer | ||||
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Q8TEK3 | Cancer | Diabetes | |||
| HLA class I histocompatibility antigen, A-2 alpha | P01892 | Cancer | ||||
| HLA class I histocompatibility antigen, B-7 alpha chain | P01889 | Cancer Tuberculosis | ||||
| HLA Class I Histocompatibility Complex, A (nonspecified subtype) | Cancer | |||||
| HLA Class II Histocompatibility Antigen DQ8 | Diabetes | Cancer | ||||
| HLA class II histocompatibility antigen DR (HLA-DR) | Cancer | |||||
| HLA class II histocompatibility antigen gamma chain | P04233 | Cancer | ||||
| HLA class II histocompatibility antigen, DR alpha chain | P01903 | | Cancer | |||
| HLA class II histocompatibility antigen, DR beta 3 chain | P79483 | Cancer | ||||
| HLA class II histocompatibility antigen, DR beta 5 chain | Q30154 | Cancer | ||||
| HLA class II histocompatibility antigen, DRB1-1 beta chain | P04229 | Cancer | ||||
| HLA-DRB2 | Cancer | |||||
| HLA-DRB6 | Cancer | |||||
| HLA-DRB7 | Cancer | |||||
| HLA-DRB8 | Cancer | |||||
| HLA-DRB9 | Cancer | |||||
| HMGA1 variant 1 | Cancer | |||||
| HMGA1 variant 2 | Cancer | |||||
| HMGA1 variant 7 | Cancer | |||||
| HMGCR variant 1 | Cancer | |||||
| HMOX1 | Cancer | Diabetes | ||||
| HNRNPA1 variant 1 | Cancer | |||||
| Homeodomain-interacting protein kinase 1 (isoform 1) | Q86Z02 | Cancer | ||||
| HOTAIR variant 2 | Cancer | |||||
| HOXA1 transcript variant 1 | Cancer | |||||
| HOXB7 | Cancer | |||||
| HPRT1 | Cancer | |||||
| HPSE variant 1 | Cancer | |||||
| HRAS variant 1 | Cancer | |||||
| HRAS variant 2 | Cancer | |||||
| HRAS variant 3 | Cancer | |||||
| HSD11B1 variant 1 | Diabetes | |||||
| HSD11B1 variant 2 | Diabetes | |||||
| HSD11B1 variant 3 | Diabetes | |||||
| HSPA12A | Cancer | |||||
| HSPA12B | Cancer | |||||
| HSPA12B variant 2 | Cancer | |||||
| HSPA14 variant 1 | Cancer | |||||
| HSPA1A | Cancer | |||||
| HSPA1B | Cancer | |||||
| HSPA1L | Cancer | |||||
| HSPA2 | Cancer | |||||
| HSPA4 | Cancer | |||||
| HSPA4L | Cancer | |||||
| HSPA5 | Cancer | |||||
| HSPA6 | Cancer | |||||
| HSPA7 | Cancer | |||||
| HSPA8 variant 1 | Cancer | |||||
| HSPA9 | Cancer | |||||
| HSPB1 | Cancer | |||||
| HSPB2 | Cancer | |||||
| HSPH1 | Cancer | |||||
| HYAL1 variant 2 | Cancer | |||||
| HYAL1 variant 3 | Cancer | |||||
| HYAL1 variant 5 | Cancer | |||||
| HYAL1 variant 7 | Cancer | |||||
| Hydroxycarboxylic acid receptor 2 | Q8TDS4 | Diabetes | Cancer | |||
| Hydroxymethylglutaryl-CoA reductase (NADPH) (isoform 1) | P04035 | | Cancer Diabetes | Leishmaniasis | Malaria | |
| Hypoxanthine-guanine phosphoribosyltransferase | P00492 | | Cancer Malaria | |||
| Hypoxia-inducible factor 1-alpha (isoform 1) | Q16665 | | Cancer | Diabetes | ||
| Hypoxia-inducible factor 1-alpha (isoform 2) | Q16665 | Cancer | Diabetes | |||
| Hypoxia-inducible factor 1-alpha (isoform 3) | Q16665 | | Cancer | Diabetes | Malaria | |
| Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified subtype) | Cancer | Diabetes | ||||
| I-kappa-B-kinase (IKK) complex | Cancer | Diabetes | ||||
| ICAM1 | Cancer | Malaria Tuberculosis | ||||
| ID1 variant 1 | Cancer | |||||
| ID1 variant 2 | Cancer | |||||
| IDNK variant 1 | Cancer | |||||
| IDO1 | Cancer | Diabetes | ||||
| IgE Receptors (nonspecified subtype) | Cancer | |||||
| IGF1R | Cancer | |||||
| IGFBP2 | Cancer | |||||
| IGFBP5 | Cancer | |||||
| IgG receptor FcRn large subunit p51 | P55899 | | Cancer | |||
| IL-1 Receptor (nonspecified subtype) | Diabetes | Cancer | ||||
| IL-1 receptor-associated kinase 1 (IRAK1) | P51617 | Cancer | Diabetes | |||
| IL-13 receptor | Cancer | |||||
| IL-15 receptor | Cancer | Diabetes | ||||
| IL-2 receptor | Cancer | Diabetes | ||||
| IL-20 receptor | Cancer | |||||
| IL-23 receptor complex | Cancer | |||||
| IL-3 receptor | Cancer | |||||
| IL-4 receptor | Cancer | Diabetes | ||||
| IL-6 receptor | Cancer | Diabetes | ||||
| IL-6 receptor alpha (isoform 1) | P08887 | | Diabetes | Cancer | ||
| IL-7 Receptor | Cancer | Diabetes | ||||
| IL33 variant 1 | Cancer | |||||
| IL33 variant 2 | Cancer | |||||
| IL33 variant 4 | Cancer | |||||
| IL33 variant 7 | Cancer | |||||
| IL6 | Cancer Diabetes | |||||
| IL8 | Cancer | |||||
| Imidazoline I3 receptor (I3) | Diabetes | Cancer | ||||
| Immunoglobulin heavy constant epsilon (IgE) | P01854 | Cancer | Diabetes | |||
| Immunoglobulin-like domain containing receptor 2 | Q71H61 | Cancer | ||||
| Immunoproteasome | Cancer | Malaria | ||||
| Importin alpha-7/beta-1 | Cancer | |||||
| Importin subunit alpha-1 | P52292 | | Cancer | |||
| Importin subunit beta-1 | Q14974 | | Cancer | |||
| Inactive caspase-12 | Q6UXS9 | Cancer | ||||
| Inactive tyrosine-protein kinase 7 (PTK7) (isoform 1) | Q13308 | Cancer | ||||
| Inactive tyrosine-protein kinase 7 (PTK7) (isoform 6) | Q13308 | Cancer | ||||
| Inactive tyrosine-protein kinase PRAG1 | Q86YV5 | Cancer | ||||
| Inactive tyrosine-protein kinase transmembrane receptor ROR1 | Q01973 | Cancer | ||||
| Indoleamine 2,3-dioxygenase 1 | P14902 | Cancer | Diabetes | |||
| Indoleamine 2,3-dioxygenase 2 | Q6ZQW0 | Cancer | ||||
| Induced myeloid leukemia cell differentiation protein Mcl-1 (isoform 1) | Q07820 | | Cancer | |||
| Induced myeloid leukemia cell differentiation protein Mcl-1 (isoform 2) | Q07820 | Cancer | ||||
| Induced myeloid leukemia cell differentiation protein Mcl-1 (isoform 3) | Q07820 | | Cancer | |||
| Inducible T-cell costimulator | Q9Y6W8 | Cancer | ||||
| Inhibin beta A chain | P08476 | Cancer | ||||
| Inhibitor of Apoptosis Proteins (IAPs) (nonspecified subtype) | Cancer | |||||
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | O15111 | Diabetes | Cancer | |||
| Inhibitor of nuclear factor kappa-B kinase subunit beta (isoform 1) | O14920 | | Cancer | Diabetes | ||
| Inhibitor of nuclear factor kappa-B kinase subunit beta (isoform 2) | O14920 | | Cancer | Diabetes | ||
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKK-E) | Q14164 | Cancer Diabetes | ||||
| Inhibitory kappaB Kinase (IKK) (nonspecified subtype) | Cancer | Diabetes | ||||
| INO80 complex | Cancer | |||||
| Inosine 5'-monophosphate dehydrogenase (IMPDH) (nonspecified subtype) | Cancer | Diabetes | ||||
| Inosine-5'-monophosphate dehydrogenase 1 (isoform 1) | P20839 | Cancer | ||||
| Inosine-5'-monophosphate dehydrogenase 1 (isoform 5) | P20839 | Cancer | ||||
| Inosine-5'-monophosphate dehydrogenase 2 | P12268 | | Cancer | |||
| Inositol 1,4,5-Trisphosphate Receptor (InsP3R) (nonspecified subtype) | Cancer | |||||
| Inositol 1,4,5-trisphosphate receptor type 2 | Q14571 | Cancer | ||||
| Inositol 1,4,5-trisphosphate receptor type 3 | Q14573 | Cancer | ||||
| INS variant 1 | Diabetes | Cancer | ||||
| INS variant 3 | Diabetes | Cancer | ||||
| INS variant 4 | Diabetes | Cancer | ||||
| Insulin | P01308 | | Cancer Diabetes | Epilepsy | ||
| Insulin receptor (isoform 1) | P06213 | | Diabetes | Cancer | ||
| Insulin receptor (isoform 2) | P06213 | | Diabetes | Cancer | ||
| Insulin-like growth factor 1 (isoform 1) | P05019 | | Cancer | |||
| Insulin-like growth factor 1 (isoform 2) | P05019 | | Cancer | |||
| Insulin-like growth factor 1 (isoform 4) | P05019 | | Cancer | |||
| Insulin-like growth factor 1 receptor | P08069 | | Cancer | Diabetes | ||
| Insulin-like growth factor 1(isoform 3) | P05019 | | Cancer | |||
| Insulin-like growth factor 2 mRNA binding protein 1 (isoform 1) | Q9NZI8 | Cancer | ||||
| Insulin-like growth factor 2 mRNA-binding protein 1 (isoform 2) | Q9NZI8 | Cancer | ||||
| Insulin-like growth factor 2 receptor | P11717 | | Cancer Diabetes | |||
| Insulin-like growth factor II (isoform 1) | P01344 | | Cancer | |||
| Insulin-like growth factor II (isoform 2) | P01344 | | Cancer | |||
| Insulin-like growth factor-binding protein 2 | P18065 | Cancer | ||||
| Insulin-like growth factor-binding protein 3 receptor | Q86XT9 | Cancer | ||||
| Integrin alpha 3 (isoform a) | P26006 | Cancer | ||||
| Integrin alpha-6 (isoform 1) | P23229 | Cancer | ||||
| Integrin alpha-6 (isoform 2) | P23229 | Cancer | ||||
| Integrin alpha-8/beta-1 receptor | Cancer | |||||
| Integrin alpha-M precursor (isoform 1) | P11215 | | Cancer | |||
| Integrin alpha1beta1 (VLA-1) receptor | Cancer | |||||
| Integrin alpha2beta1 (VLA-2) receptor | Cancer | |||||
| Integrin alpha2beta3 Receptor | Cancer | |||||
| Integrin alpha3beta1 receptor | Cancer | |||||
| Integrin alpha4beta1 (VLA-4) receptor | Cancer | Diabetes | ||||
| Integrin alpha4beta7 (LPAM-1) receptor | Cancer | Diabetes | ||||
| Integrin alpha5beta1 (VLA-5) receptor | Cancer | |||||
| Integrin alpha6beta1 Receptor | Cancer | |||||
| Integrin alpha6beta4 receptor | Cancer | |||||
| Integrin alphaIIbbeta3 (fibrinogen gpIIb/IIIa) receptor | Cancer | |||||
| Integrin alphaLbeta2 (LFA-1) receptor | Cancer | Diabetes | ||||
| Integrin alphaMbeta2 (MAC-1) Receptor | Cancer | |||||
| Integrin alphavbeta1 | Cancer Diabetes | |||||
| Integrin alphavbeta3 (vitronectin) receptor | Cancer | Tuberculosis | ||||
| Integrin alphavbeta5 receptor | Cancer | |||||
| Integrin alphavbeta6 receptor | Cancer | |||||
| Integrin alphavbeta8 Receptor | Cancer | |||||
| Integrin beta 1 | P05556 | Cancer | ||||
| Integrin beta-2 | P05107 | | Cancer | |||
| Integrin beta-3 | P05106 | | Cancer | |||
| Integrin Receptor (nonspecified subtype) | Cancer | |||||
| Integrin-linked protein kinase | Q13418 | Cancer | ||||
| Intercellular adhesion molecule 1 | P05362 | | Cancer | |||
| Interferon (nonspecified subtype) | Cancer | Leishmaniasis | Malaria Tuberculosis | |||
| Interferon alpha-1/13 precursor | P01562 | Cancer | ||||
| Interferon alpha/beta receptor 1 | P17181 | | Cancer | |||
| Interferon alpha/beta receptor 2 (isoform b) | P48551 | | Cancer | |||
| Interferon gamma receptor 1 | P15260 | | Cancer | |||
| Interferon gamma receptor 2 | P38484 | Cancer | ||||
| Interferon-alpha (IFN-alpha) (nonspecified subtype) | Cancer | Diabetes | ||||
| Interferon-gamma | P01579 | | Cancer Diabetes Malaria | |||
| Interferon-induced helicase C domain-containing protein 1 | Q9BYX4 | Cancer | ||||
| Interferon-induced, double-stranded RNA-activated protein kinase (isoform 1) | P19525 | | Cancer | |||
| Interleukin 13 (IL-13) | P35225 | | Cancer | Diabetes | ||
| Interleukin 15 | P40933 | Cancer Diabetes | ||||
| Interleukin 17 (nonspecified subtype) | Cancer | Diabetes | ||||
| Interleukin 17F | Q96PD4 | Cancer | ||||
| Interleukin 2 (IL-2) | P60568 | | Cancer | Diabetes | ||
| Interleukin 21 | Q9HBE4 | Diabetes | ||||
| Interleukin 23 complex (IL-23) | Cancer | |||||
| Interleukin 6 (IL-6) | P05231 | | Cancer | Diabetes Malaria | Epilepsy | |
| Interleukin-1 (nonspecified subtype) | Cancer | Diabetes | ||||
| Interleukin-1 alpha | P01583 | | Cancer Diabetes | |||
| Interleukin-1 beta | P01584 | | Cancer | Diabetes Malaria | Epilepsy Schistosomiasis | |
| Interleukin-1 receptor accessory protein (isoform 1) | Q9NPH3 | Cancer | ||||
| Interleukin-1 receptor antagonist protein (isoform 1) | P18510 | | Diabetes | Cancer | ||
| Interleukin-1 receptor antagonist protein (isoform 2) | P18510 | | Diabetes | Cancer | ||
| Interleukin-1 receptor antagonist protein (isoform 3) | P18510 | | Diabetes | Cancer | ||
| Interleukin-1 receptor antagonist protein (isoform 4) | P18510 | | Diabetes | Cancer | ||
| Interleukin-1 receptor-associated kinase (IRAK) (nonspecified subtype) | Cancer Diabetes | |||||
| Interleukin-1 Receptor-Associated Kinase 4 (IRAK-4) | Q9NWZ3 | Cancer | Diabetes | |||
| Interleukin-10 | P22301 | | Cancer Leishmaniasis | Diabetes Epilepsy | ||
| Interleukin-10 receptor subunit alpha | Q13651 | | Cancer | |||
| Interleukin-11 receptor subunit alpha (isoform 1) | Q14626 | Cancer | ||||
| Interleukin-11 receptor subunit alpha (isoform 3) | Q14626 | Cancer | ||||
| Interleukin-12 (IL-12) | Cancer | Diabetes Epilepsy | ||||
| Interleukin-12 subunit alpha (IL-12A) | P29459 | Cancer | ||||
| Interleukin-12 subunit beta (IL-12B) | P29460 | | Cancer | |||
| Interleukin-13 receptor subunit alpha-1 | P78552 | Cancer | ||||
| Interleukin-13 receptor subunit alpha-1 (isoform X1) | P78552 | | Cancer | |||
| Interleukin-13 receptor subunit alpha-2 | Q14627 | Cancer | ||||
| Interleukin-17 receptor A (isoform 1) | Q96F46 | Cancer | ||||
| Interleukin-17 receptor A (isoform 2) | Q96F46 | | Cancer | |||
| Interleukin-18 receptor accessory protein | O95256 | Cancer | ||||
| Interleukin-2 (IL-2) (isoform X1) | P60568 | Cancer | Diabetes | |||
| Interleukin-2 receptor subunit beta | P14784 | | Cancer | |||
| Interleukin-20 | Q9NYY1 | Cancer | ||||
| Interleukin-23 receptor (isoform X3) | Q5VWK5 | Cancer | ||||
| Interleukin-23 receptor precursor | Q5VWK5 | Cancer | ||||
| Interleukin-23 subunit alpha precursor | Q9NPF7 | | Cancer | |||
| Interleukin-3 receptor subunit alpha | P26951 | Cancer | ||||
| Interleukin-34 (isoform 1) | Q6ZMJ4 | Cancer | ||||
| Interleukin-37 (isoform 1) | Q9NZH6 | Cancer | ||||
| Interleukin-4 (isoform 1) | P05112 | | Tuberculosis | Cancer | Diabetes | |
| Interleukin-5 | P05113 | Cancer | ||||
| Interleukin-7 receptor subunit alpha | P16871 | Cancer | Diabetes | |||
| Interleukin-8 | P10145 | | | Cancer | Diabetes Leishmaniasis Tuberculosis | |
| Interleukin-9 precursor | P15248 | Cancer | ||||
| Intermediate conductance calcium-activated potassium channel protein 4 | O15554 | Epilepsy | Cancer | |||
| Interstitial collagenase (MMP-1) (isoform 1) | P03956 | | Cancer | Tuberculosis | ||
| Interstitial collagenase (MMP-1) (isoform 2) | P03956 | | Cancer | Tuberculosis | ||
| Intestinal-type alkaline phosphatase (IAP) | P09923 | Cancer | ||||
| Invariant T Cell Receptor | Cancer | |||||
| Inward Rectifier Potassium Channel (nonspecified subtype) | Cancer | |||||
| IPF1 | Cancer | |||||
| IRF4 variant 1 | Cancer | |||||
| IRF4 variant 2 | Cancer | |||||
| IRS1 | Cancer | |||||
| Isocitrate dehydrogenase [NADP] cytoplasmic | O75874 | | Cancer | Diabetes | ||
| Isocitrate dehydrogenase [NADP], mitochondrial (isoform 1) | P48735 | Cancer | ||||
| Isocitrate dehydrogenase [NADP], mitochondrial (isoform 2) | P48735 | Cancer | ||||
| ITCH | Cancer | |||||
| ITCH variant 1 | Cancer | |||||
| ITGB3 | Cancer | |||||
| ITGB4 variant 1 | Cancer | |||||
| ITGB4 variant 3 | Cancer | |||||
| Janus Kinase (nonspecified subtype) | Cancer | Diabetes | ||||
| K(ATP) Channel (nonspecified subtype) | Diabetes | Cancer | ||||
| K(ir) 3.1/3.4 (GIRK1/4; KCNJ3/5) | Cancer | |||||
| Kainate Receptor (GluR) (nonspecified subtype) | Epilepsy | |||||
| Kallikrein (nonspecified subtype) | Cancer | |||||
| Kallikrein-1 (Tissue Kallikrein; KLK1) | P06870 | Cancer | ||||
| Kallikrein-2 (isoform 3) | P20151 | | Cancer | |||
| Kallikrein-2 preproprotein (isoform 1) | P20151 | | Cancer | |||
| Kallikrein-2 preproprotein (isoform 2) | P20151 | | Cancer | |||
| Kallikrein-4 | Q9Y5K2 | | Cancer | |||
| Kallikrein-5 | Q9Y337 | Cancer | ||||
| Kallikrein-6 | Q92876 | | Cancer | |||
| Kallikrein-7 | P49862 | | Cancer | |||
| kappa-Opioid (KOP) receptor | P41145 | Cancer | Diabetes Epilepsy | |||
| KCNQ Channels (K(v) 7) (nonspecified subtype) | Epilepsy | Cancer | ||||
| KDM5A-GATAD1-EMSY chromatin complex | Cancer | |||||
| KDR | Cancer | |||||
| Kelch-like ECH-associated protein 1 (isoform 1) | Q14145 | | Cancer | Diabetes | ||
| Kelch-like ECH-associated protein 1 (isoform 2) | Q14145 | | Cancer | Diabetes | ||
| Keratin, type I cytoskeletal 19 | P08727 | Cancer | ||||
| Keratin, type II cytoskeletal 8 (isoform 1) | P05787 | Cancer | ||||
| Keratin, type II cytoskeletal 8 (isoform 2) | P05787 | Cancer | ||||
| Keratin, type II cytoskeletal 8 (isoform 3) | P05787 | Cancer | ||||
| Kidney-associated antigen 1 | Q9UBP8 | Cancer | ||||
| KIF11 | Cancer | |||||
| Killer Cell Immunoglobulin-Like Receptor 2DL1 | P43626 | Cancer | ||||
| Killer cell immunoglobulin-like receptor 2DL2 | P43627 | | Cancer | |||
| Killer cell immunoglobulin-like receptor 2DL3 | P43628 | Cancer | ||||
| Kinase suppressor of Ras 2 | Q6VAB6 | Cancer | ||||
| Kinesin-like protein KIF11 | P52732 | | Cancer | |||
| Kinesin-like protein KIF20B | Q96Q89 | Cancer | ||||
| Kinesin-like protein KIFC1 | Q9BW19 | Cancer | ||||
| KiSS-1 receptor | Q969F8 | Cancer | Diabetes | |||
| KLF4 | Cancer | |||||
| KLF5 | Cancer | |||||
| KLF8 variant 1 | Cancer | |||||
| KLK3 variant 1 | Cancer | |||||
| KLK3 variant 3 | Cancer | |||||
| KRAS variant a | Cancer | |||||
| KRAS variant b | Cancer | |||||
| KRR1 small subunit processome component homolog | Q13601 | Cancer | ||||
| Kruppel-like factor 10 (isoform a) | Q13118 | Cancer | ||||
| L-Lactate dehydrogenase A chain (isoform 1) | P00338 | Cancer Malaria | ||||
| L-lactate dehydrogenase B chain | P07195 | | Cancer | |||
| L-selectin precursor | P14151 | Cancer | ||||
| L-Type calcium channel (nonspecified subtype) | Cancer Epilepsy | Diabetes Tuberculosis | ||||
| L-type voltage-dependent calcium channel complex | Cancer Epilepsy | Diabetes Tuberculosis | ||||
| L1CAM variant 1 | Cancer | |||||
| L1CAM variant 3 | Cancer | |||||
| L1CAM variant 4 | Cancer | |||||
| Lactadherin | Q08431 | Cancer | ||||
| Lactate Dehydrogenase (LDH) | Epilepsy | Cancer | ||||
| Lactotransferrin precursor (isoform 1) | P02788 | | Cancer | |||
| Lactoylglutathione lyase | Q04760 | | Cancer | |||
| LAG3 | Cancer | |||||
| LAMB3 variant 1 | Cancer | |||||
| LAMB3 variant 2 | Cancer | |||||
| Lanosterol synthase (isoform 1) | P48449 | | Cancer | |||
| Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) (nonspecified subtype) | Cancer Diabetes | Epilepsy | ||||
| Large neutral amino acids transporter small subunit 1 | Q01650 | Cancer | Epilepsy | |||
| LDHA variant 1 | Cancer | |||||
| LDHA variant 3 | Cancer | |||||
| LDL-associated phospholipase A2 (Lp-PLA2) | Q13093 | Cancer Diabetes | ||||
| Legumain | Q99538 | Cancer | ||||
| Leptin receptor (OB-R) (isoform 1) | P48357 | Cancer Diabetes | ||||
| Leptin receptor (OB-R) (isoform 2) | P48357 | Cancer Diabetes | ||||
| Leptin receptor (OB-R) (isoform 3) | P48357 | Cancer Diabetes | ||||
| Leucine rich repeat containing 32 | Q14392 | Cancer | ||||
| Leucine--tRNA ligase, cytoplasmic | Q9P2J5 | Cancer | ||||
| Leucine-rich PPR motif-containing protein, mitochondrial | P42704 | Cancer | ||||
| Leucine-rich repeat serine/threonine-protein kinase 1 | Q38SD2 | Cancer | ||||
| Leucine-rich repeat serine/threonine-protein kinase 2 | Q5S007 | | Cancer | |||
| Leucine-rich repeat-containing G-protein coupled receptor 4 | Q9BXB1 | Cancer | ||||
| Leucine-rich repeat-containing G-protein coupled receptor 5 | O75473 | Cancer | ||||
| Leucine-rich repeat-containing protein 15 | Q8TF66 | Cancer | ||||
| Leucyl-cystinyl aminopeptidase (isoform 1) | Q9UIQ6 | | Cancer | |||
| Leucyl-cystinyl aminopeptidase (isoform 2) | Q9UIQ6 | | Cancer | |||
| Leukemia inhibitory factor (LIF) (isoform 1) | P15018 | | Cancer | |||
| Leukemia inhibitory factor (LIF) (isoform 2) | P15018 | | Cancer | |||
| Leukocyte immunoglobulin-like receptor subfamily B member 2 (isoform 1) | Q8N423 | Cancer | ||||
| Leukocyte immunoglobulin-like receptor subfamily B member 4 (isoform 1) | Q8NHJ6 | Cancer | ||||
| Leukocyte immunoglobulin-like receptor subfamily B member 4 (isoform 4) | Q8NHJ6 | Cancer | ||||
| Leukocyte immunoglobulin-like receptor, subfamily B, member 3 (isoform 1) | O75022 | Cancer | ||||
| Leukocyte surface antigen CD47 | Q08722 | | Cancer | |||
| Leukosialin | P16150 | Cancer | ||||
| Leukotriene B4 receptor (LTB4-R) (nonspecified subtype) | Cancer Diabetes | |||||
| Leukotriene B4 receptor 2 | Q9NPC1 | Cancer | ||||
| Leukotriene-A4 hydrolase (isoform 1) | P09960 | | Cancer | |||
| Leukotriene-A4 hydrolase (isoform 2) | P09960 | | Cancer | |||
| Leukotriene-A4 hydrolase (isoform 3) | P09960 | | Cancer | |||
| LGALS1 | Cancer | |||||
| LIM domain kinase 1 (isoform 1) | P53667 | Cancer | ||||
| LIM domain kinase 1 (isoform 2) | P53667 | Cancer | ||||
| LIM domain kinase 1 (isoform dLIMK) | P53667 | Cancer | ||||
| LIM domain kinase 2 (isoform 1) | P53671 | Cancer | ||||
| LIM domain kinase 2 (isoform 2a) | P53671 | Cancer | ||||
| LINC00273 | Cancer | |||||
| LINC00673 | Cancer | |||||
| LINC01814 | Cancer | |||||
| Linear Ubiquitin Chain Assembly Complex (LUBAC) | Cancer | |||||
| Lipolysis-stimulated lipoprotein receptor (isoform 2) | Q86X29 | Cancer | ||||
| Lipoxygenase (nonspecified subtype) | Cancer Epilepsy | Diabetes Leishmaniasis | ||||
| Liver carboxylesterase 1 (isoform 1) | P23141 | | Cancer | |||
| Liver carboxylesterase 1 (isoform 2) | P23141 | Cancer | ||||
| Liver carboxylesterase 1 (isoform 3) | P23141 | Cancer | ||||
| Low affinity immunoglobulin gamma Fc region receptor II-a (isoform 1) | P12318 | | Cancer | Diabetes | ||
| Low affinity immunoglobulin gamma Fc region receptor II-a (isoform 2) | P12318 | | Cancer | Diabetes | ||
| Low affinity immunoglobulin gamma Fc region receptor II-b (isoform 1) | P31994 | | Cancer | Diabetes | ||
| Low affinity immunoglobulin gamma Fc region receptor II-b (isoform 2) | P31994 | | Cancer | Diabetes | ||
| Low affinity immunoglobulin gamma Fc region receptor III-A (isoform 1) | P08637 | | Cancer | |||
| Low affinity immunoglobulin gamma Fc region receptor III-A (isoform 2) | P08637 | | Cancer | |||
| Low affinity immunoglobulin gamma Fc region receptor III-A (isoform 3) | P08637 | | Cancer | |||
| Low affinity immunoglobulin gamma Fc region receptor III-A (isoform 5) | P08637 | | Cancer | |||
| Low density lipoprotein receptor-related protein 6 | O75581 | Cancer | ||||
| Low molecular weight phosphotyrosine protein phosphatase | P24666 | Diabetes | Cancer | |||
| Low-density lipoprotein receptor (isoform 1) | P01130 | | Cancer | Diabetes | ||
| Low-density lipoprotein receptor (isoform 2) | P01130 | | Cancer | Diabetes | ||
| Low-density lipoprotein receptor (isoform 3) | P01130 | | Cancer | Diabetes | ||
| Lupus La protein | P05455 | | Cancer | |||
| Lymphocyte antigen 6E | Q16553 | Cancer | ||||
| Lymphocyte antigen 75 | O60449 | Cancer | ||||
| Lymphocyte antigen 96 (MD-2 protein) | Q9Y6Y9 | Cancer Diabetes | ||||
| Lymphocyte-activation protein 3 | P18627 | Cancer | ||||
| Lymphokine-activated killer T-cell-originated protein kinase | Q96KB5 | Cancer | ||||
| Lysine (K)-specific demethylase 6B | O15054 | Cancer | ||||
| Lysine--tRNA ligase (isoform 1) | Q15046 | Cancer | ||||
| Lysine--tRNA ligase (isoform 2) | Q15046 | Cancer | ||||
| Lysine-specific demethylase 2A | Q9Y2K7 | Cancer | ||||
| Lysine-specific demethylase 2B (isoform a) | Q8NHM5 | Cancer | ||||
| Lysine-specific demethylase 3A | Q9Y4C1 | Cancer | ||||
| Lysine-specific demethylase 4A | O75164 | | Cancer | |||
| Lysine-specific demethylase 4B | O94953 | Cancer | ||||
| Lysine-specific demethylase 4C (isoform 1) | Q9H3R0 | Cancer | ||||
| Lysine-specific demethylase 4D | Q6B0I6 | | Cancer | |||
| Lysine-specific demethylase 4E | B2RXH2 | Cancer | ||||
| Lysine-specific demethylase 5A | P29375 | Cancer | ||||
| Lysine-specific demethylase 5B | Q9UGL1 | Cancer | ||||
| Lysine-specific demethylase 5C | P41229 | Cancer | ||||
| Lysine-specific demethylase 5D (isoform 1) | Q9BY66 | Cancer | ||||
| Lysine-specific demethylase 5D (isoform 2) | Q9BY66 | | Cancer | |||
| Lysine-specific demethylase 5D (isoform 3) | Q9BY66 | Cancer | ||||
| Lysine-specific demethylase 6A (isoform 1) | O15550 | Cancer | ||||
| Lysine-specific demethylase 6A (isoform 3) | O15550 | Cancer | ||||
| Lysine-specific demethylase 7 | Q6ZMT4 | | Cancer | |||
| Lysine-specific histone demethylase 1A (isoform a) | O60341 | | Cancer | Epilepsy | ||
| Lysine-specific histone demethylase 1A (isoform b) | O60341 | | Cancer | Epilepsy | ||
| Lysine-specific histone demethylase 1B | Q8NB78 | Cancer | ||||
| Lysophosphatidic acid receptor 1 | Q92633 | Cancer | ||||
| Lysophosphatidic acid receptor 2 | Q9HBW0 | Cancer | ||||
| Lysophosphatidic acid receptor 3 | Q9UBY5 | Cancer | ||||
| Lysophosphatidic acid receptor 5 | Q9H1C0 | Cancer | ||||
| Lysophospholipid (edg) Receptors (nonspecified subtype) | Cancer | |||||
| Lysosomal acid lipase/cholesteryl ester hydrolase | P38571 | Cancer Diabetes | ||||
| Lysosomal alpha-glucosidase | P10253 | | Diabetes | Cancer | Leishmaniasis Malaria Tuberculosis | |
| Lysosomal-associated membrane protein 1 | P11279 | Cancer | ||||
| Lysosomal-associated transmembrane protein 4B | Q86VI4 | Cancer | ||||
| Lysyl oxidase homolog 3 | P58215 | Cancer | ||||
| Lysyl oxidase-like 2 | Q9Y4K0 | Cancer | ||||
| Lysyl oxidase-like 4 | Q96JB6 | Cancer | ||||
| M-phase inducer phosphatase 1 (isoform a) | P30304 | Diabetes | Cancer | |||
| M-phase inducer phosphatase 2 (isoform 1) | P30305 | | Cancer | |||
| M-phase inducer phosphatase 2 (isoform 3) | P30305 | | Cancer | |||
| M-phase inducer phosphatase 3 | P30307 | Cancer | ||||
| M1-family aminopeptidase | Q8IEK1 | | Malaria | Cancer | ||
| Macrophage colony-stimulating factor 1 receptor (CSF-1R) | P07333 | Cancer | Diabetes | |||
| Macrophage mannose receptor 1 | P22897 | | | Cancer Diabetes | Tuberculosis | |
| Macrophage metalloelastase | P39900 | | Cancer | |||
| Macrophage Migration Inhibitory Factor (MIF) | P14174 | | Cancer Diabetes | Malaria | ||
| Macrophage receptor MARCO | Q9UEW3 | Cancer | ||||
| Macrophage-stimulating protein receptor (isoform 1) | Q04912 | | Cancer | |||
| Macrosialin (isoform 1) | P34810 | Cancer | ||||
| MAGEA9B | Cancer | |||||
| Major histocompatibility complex, class I, G | P17693 | Cancer | ||||
| MALAT1 | Cancer | |||||
| Malate dehydrogenase, cytoplasmic | P40925 | Cancer | ||||
| Malate dehydrogenase, mitochondrial | P40926 | Cancer | ||||
| Malonyl-CoA decarboxylase, mitochondrial | O95822 | Cancer Diabetes | ||||
| MALT1 variant 1 | Cancer | |||||
| Mannose-6-phosphate isomerase | P34949 | Cancer | ||||
| MANSC domain-containing protein 1 precursor | Q9H8J5 | Cancer | ||||
| MAP kinase-activated protein kinase 2 (isoform 1) | P49137 | | Cancer | Diabetes | ||
| MAP kinase-activated protein kinase 2 (isoform 2) | P49137 | | Cancer | Diabetes | ||
| MAP Kinase-Interacting Serine/Threonine-Protein Kinase (nonspecified subtype) | Cancer Diabetes | |||||
| MAP kinase-interacting serine/threonine-protein kinase 1 (isoform 1) | Q9BUB5 | Cancer | Diabetes | |||
| MAP kinase-interacting serine/threonine-protein kinase 1 (isoform 2) | Q9BUB5 | Cancer | Diabetes | |||
| MAP kinase-interacting serine/threonine-protein kinase 2 (isoform 1) | Q9HBH9 | | Cancer Diabetes | |||
| MAP kinase-interacting serine/threonine-protein kinase 2 (isoform 2) | Q9HBH9 | | Cancer Diabetes | |||
| MAP2K7 | Cancer | |||||
| MAP3K3 variant 1 | Cancer | |||||
| MAP3K3 variant 2 | Cancer | |||||
| MAP3K4 variant 1 | Cancer | |||||
| MAP3K4 variant 2 | Cancer | |||||
| MAP3K7 variant A | Cancer | |||||
| MAP3K7 variant B | Cancer | |||||
| MAP3K7 variant C | Cancer | |||||
| MAP4K1 variant 1 | Cancer | |||||
| MAP4K1 variant 2 | Cancer | |||||
| MAP4K4 variant 1 | Cancer | |||||
| MAP4K4 variant 2 | Cancer | |||||
| MAP4K4 variant 4 | Cancer | |||||
| Mast cell-expressed membrane protein 1 | Q8IX19 | Cancer | ||||
| Mast/stem cell growth factor receptor Kit (isoform 1) | P10721 | Cancer | Diabetes | |||
| Mast/stem cell growth factor receptor Kit (isoform 2) | P10721 | Cancer | Diabetes | |||
| Maternal embryonic leucine zipper kinase (isoform 1) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 2) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 3) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 4) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 5) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 6) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 7) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 8) | Q14680 | Cancer | ||||
| Maternal embryonic leucine zipper kinase (isoform 9) | Q14680 | Cancer | ||||
| Matrilysin (MMP-7) | P09237 | | Cancer | |||
| Matrix Metalloproteinase (MMP) (nonspecified subtype) | Cancer | Diabetes | ||||
| Matrix metalloproteinase 14 (MMP-14) | P50281 | | Cancer | |||
| Matrix metalloproteinase-16 preproprotein (isoform 1) | P51512 | Cancer | ||||
| Matrix metalloproteinase-9 | P14780 | | Cancer | Epilepsy | Diabetes | |
| MCL1 variant 1 | Cancer | |||||
| MCL1 variant 2 | Cancer | |||||
| MCL1 variant 3 | Cancer | |||||
| MCM2 | Cancer | |||||
| MCM7 variant 1 | Cancer | |||||
| MDK variant 1 | Cancer | |||||
| MDK variant 3 | Cancer | |||||
| MDM2 variant 1 | Cancer | |||||
| MDM2 variant 3 | Cancer | |||||
| MECOM variant 1 | Cancer | |||||
| MECOM variant 2 | Cancer | |||||
| MECOM variant 3 | Cancer | |||||
| MECOM variant 4 | Cancer | |||||
| MECOM variant 6 | Cancer | |||||
| MECOM variant 7 | Cancer | |||||
| Melanin-concentrating hormone receptor 1 | Q99705 | Cancer Diabetes | ||||
| Melanocortin receptor (nonspecified subtype) | Cancer Diabetes | |||||
| Melanocortin receptor 4 | P32245 | Cancer Diabetes | ||||
| Melanocyte-stimulating hormone receptor | Q01726 | Cancer Diabetes | ||||
| Melanoma-associated antigen 1 | P43355 | Cancer | ||||
| Melanoma-associated antigen 3 | P43357 | | Cancer | |||
| Melanoma-associated antigen 6 | P43360 | Cancer | ||||
| Melanoma-associated antigen C1 | O60732 | Cancer | ||||
| Melatonin Receptor type 1A (Mel1A) | P48039 | Epilepsy | Cancer Diabetes | |||
| Melatonin Receptor type 1B (Mel1B) | P49286 | Cancer Diabetes Epilepsy | ||||
| MELK variant 1 | Cancer | |||||
| MELK variant 2 | Cancer | |||||
| MELK variant 3 | Cancer | |||||
| MELK variant 4 | Cancer | |||||
| MELK variant 5 | Cancer | |||||
| MELK variant 6 | Cancer | |||||
| MELK variant 7 | Cancer | |||||
| MELK variant 8 | Cancer | |||||
| MELK variant 9 | Cancer | |||||
| Membrane cofactor protein (CD46) (isoform a) | P15529 | Cancer | ||||
| Membrane cofactor protein (CD46) (isoform d) | P15529 | Cancer | ||||
| Membrane primary amine oxidase (VAP-1) | Q16853 | Diabetes | Cancer | |||
| Membrane-associated progesterone receptor component 1 | O00264 | Cancer | Epilepsy | |||
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (isoform 1) | Q99640 | Cancer | ||||
| Membrane-bound transcription factor site-1 protease | Q14703 | Cancer | ||||
| MEN1 variant 1 | Cancer | |||||
| MEN1 variant 2 | Cancer | |||||
| MEN1 variant e1C | Cancer | |||||
| MEN1 variant e1F1 | Cancer | |||||
| Menin (isoform 1) | O00255 | | Cancer | Diabetes | ||
| Menin (isoform 2) | O00255 | | Cancer | Diabetes | ||
| Meprin A subunit alpha | Q16819 | Cancer | ||||
| Meprin A subunit beta | Q16820 | Cancer | ||||
| Mesothelin (isoform 1) | Q13421 | Cancer | ||||
| Mesothelin (isoform 2) | Q13421 | Cancer | ||||
| MET variant 1 | Cancer | |||||
| MET variant 2 | Cancer | |||||
| MET variant 4 | Cancer | |||||
| Metabotropic glutamate (mGluR) receptor (nonspecified subtype) | Epilepsy | |||||
| Metabotropic glutamate receptor 1 (isoform 1) | Q13255 | Cancer Epilepsy | ||||
| Metabotropic glutamate receptor 1 (isoform 3) | Q13255 | | Cancer Epilepsy | |||
| Metabotropic glutamate receptor 2 (isoform a) | Q14416 | Epilepsy | Cancer Diabetes | |||
| Metabotropic glutamate receptor 3 | Q14832 | Cancer Epilepsy | ||||
| Metabotropic glutamate receptor 4 | Q14833 | Cancer Diabetes Epilepsy | ||||
| Metabotropic glutamate receptor 5 (isoform b) | P41594 | Epilepsy | Cancer Diabetes | |||
| Metabotropic glutamate receptor 8 (isoform 1) | O00222 | Epilepsy | ||||
| Metabotropic glutamate receptor 8 (isoform 2) | O00222 | Epilepsy | ||||
| Metalloreductase STEAP1 | Q9UHE8 | Cancer | ||||
| Metastasis-suppressor KiSS-1 | Q15726 | Cancer | Diabetes | |||
| Methionine adenosyltransferase (nonspecified subtype) | Cancer | |||||
| Methionine synthase | Q99707 | Cancer | ||||
| Methionyl aminopeptidase 1 | P53582 | Cancer | Leishmaniasis Tuberculosis | |||
| Methionyl aminopeptidase 2 (MetAP2) | P50579 | | Cancer Diabetes | |||
| Methyl-CpG-binding domain protein 2 (isoform 1) | Q9UBB5 | Cancer | ||||
| Methylated-DNA-protein-cysteine methyltransferase (MGMT) | P16455 | | Cancer | |||
| MFAP5 | Cancer | |||||
| MHC class I polypeptide-related sequence A (isoform 1) | Q29983 | | Cancer | |||
| MHC class I polypeptide-related sequence A (isoform 2) | Q29983 | | Cancer | |||
| MHC class I polypeptide-related sequence A (isoform 3) | Q29983 | | Cancer | |||
| MHC class I polypeptide-related sequence A (isoform 4) | Q29983 | | Cancer | |||
| Microtubule-associated protein 4 (isoform 1) | P27816 | Cancer | ||||
| Microtubule-associated protein tau (isoform 1) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform 2) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform 3) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform 4) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform 5) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform 6) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform 7) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform 8) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform X1) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform X2) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform X3) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform X4) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform X5) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform X6) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform X7) | P10636 | Cancer | Diabetes | |||
| Microtubule-associated protein tau (isoform X8) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated protein tau (isoform X9) | P10636 | | Cancer | Diabetes | ||
| Microtubule-associated proteins 1A/1B light chain 3B | Q9GZQ8 | Cancer | ||||
| Midkine (isoform a) | P21741 | Cancer | ||||
| MIG7 | Cancer | |||||
| Mineralocorticoid receptor (isoform 1) | P08235 | | Diabetes | Cancer | ||
| MIR10B | Cancer | |||||
| MIR122 | Cancer | Diabetes | ||||
| MIR132 | Cancer | |||||
| MIR140 | Cancer | |||||
| MIR146A | Cancer | |||||
| MIR148A | Cancer | |||||
| MIR155 | Cancer | Epilepsy | ||||
| MIR17 | Cancer | |||||
| MIR197 | Cancer | |||||
| MIR20A | Cancer | |||||
| MIR21 | Cancer | |||||
| MIR210 | Cancer | |||||
| MIR214 | Cancer | |||||
| MIR221 | Cancer | |||||
| MIR24-2 | Cancer | |||||
| MIR26A1 | Cancer | |||||
| MIR29A | Cancer | |||||
| MIR365-2 | Cancer | |||||
| MIR424 | Cancer | |||||
| MIR4454 | Cancer | |||||
| MIR9-1 | Cancer | |||||
| MIR92A1 | Cancer | |||||
| MIR92A2 | Cancer | |||||
| MIR96 | Cancer | |||||
| MIRN185 | Cancer | |||||
| MIRN23B | Cancer | |||||
| MIRN24-1 | Cancer | |||||
| MITF variant 1 | Cancer | |||||
| MITF variant 2 | Cancer | |||||
| MITF variant 4 | Cancer | |||||
| MITF variant 5 | Cancer | |||||
| MITF variant 7 | Cancer | |||||
| MITF variant 9 | Cancer | |||||
| Mitochondrial import inner membrane translocase subunit TIM16 | Q9Y3D7 | Cancer | ||||
| Mitochondrial pyruvate carrier complex (MPC) | Cancer | |||||
| Mitochondrial uncoupling protein 2 | P55851 | Cancer Diabetes | ||||
| Mitogen-activated protein kinase (JNK) (nonspecified subtype) | Cancer | Diabetes Epilepsy | ||||
| Mitogen-Activated Protein Kinase (MAP Kinase)-Activated Protein Kinase (nonspecified subtype) | Diabetes | Cancer | ||||
| Mitogen-Activated Protein Kinase (MAPK; ERK) (nonspecified subtype) | Cancer | Diabetes | Epilepsy | |||
| Mitogen-activated protein kinase 1 (isoform 1) | P28482 | | Cancer | Diabetes | ||
| Mitogen-activated protein kinase 1 (isoform 2) | P28482 | Cancer | Diabetes | |||
| Mitogen-activated protein kinase 11 | Q15759 | | Diabetes | Cancer | ||
| Mitogen-activated protein kinase 12 | P53778 | Cancer | ||||
| Mitogen-activated protein kinase 3 (isoform 1) | P27361 | | Cancer | Diabetes | ||
| Mitogen-activated protein kinase 3 (isoform 2) | P27361 | | Cancer | Diabetes | ||
| Mitogen-activated protein kinase 7 (isoform 1) | Q13164 | Cancer | ||||
| Mitogen-activated protein kinase 7 (isoform 3) | Q13164 | Cancer | ||||
| Mitogen-activated protein kinase 8 (isoform 1) | P45983 | | Cancer Diabetes | |||
| Mitogen-activated protein kinase 8 (isoform 2) | | Cancer Diabetes | ||||
| Mitogen-activated protein kinase 9 (isoform JNK2 alpha1) | P45984 | Cancer | Diabetes Epilepsy | |||
| Mitogen-activated protein kinase 9 (isoform JNK2 alpha2) | P45984 | Cancer | Diabetes Epilepsy | |||
| Mitogen-activated protein kinase kinase kinase 10 | Q02779 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase 11 | Q16584 | Cancer Diabetes Epilepsy | ||||
| Mitogen-activated protein kinase kinase kinase 14 | Q99558 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase 19 (isoform 1) | Q56UN5 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase 19 (isoform 3) | Q56UN5 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase 20 (isoform 1) | Q9NYL2 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase 20 (isoform 2) | Q9NYL2 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase 5 (ASK-1) | Q99683 | Cancer | Diabetes Tuberculosis | |||
| Mitogen-activated protein kinase kinase kinase 7 (isoform A) | O43318 | Cancer | Malaria | |||
| Mitogen-activated protein kinase kinase kinase 7 (isoform B) | O43318 | Cancer | Malaria | |||
| Mitogen-activated protein kinase kinase kinase 7 (isoform C) | O43318 | Cancer | Malaria | |||
| Mitogen-activated protein kinase kinase kinase 8 | P41279 | Cancer Diabetes | ||||
| Mitogen-activated protein kinase kinase kinase 9 (isoform 1) | P80192 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase 9 (isoform 2) | P80192 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase kinase 1 (isoform 1) | Q92918 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase kinase 1 (isoform 2) | Q92918 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase kinase 2 | Q12851 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase kinase 3 | Q8IVH8 | Cancer | ||||
| Mitogen-activated protein kinase kinase kinase kinase 4 (isoform 1) | O95819 | Cancer Diabetes | ||||
| Mitogen-activated protein kinase kinase kinase kinase 4 (isoform 2) | O95819 | Cancer Diabetes | ||||
| Mitogen-activated protein kinase kinase kinase kinase 4 (isoform 4) | O95819 | Cancer Diabetes | ||||
| Mitogen-activated protein kinase p38 (MAPK p38) (nonspecified subtype) | Cancer Epilepsy | Diabetes | ||||
| Mitogen-activated protein kinase p38 alpha (MAPK p38 alpha CSBP1 isoform) | Q16539 | | Cancer | Diabetes | ||
| Mitogen-activated protein kinase p38 alpha (MAPK p38 alpha Exip form) | Q16539 | | Cancer | Diabetes | ||
| MKI67 variant 1 | Cancer | |||||
| MKI67 variant 2 | Cancer | |||||
| MLF2 | Cancer | |||||
| MLL/SET1 Complex | Cancer | Diabetes | ||||
| MLL1/MLL Complex | Cancer | |||||
| MMP1 variant 1 | Cancer | |||||
| MMP1 variant 2 | Cancer | |||||
| MMP13 | Cancer | |||||
| MMP2 variant 1 | Cancer | |||||
| MMP2 variant 2 | Cancer | |||||
| MMP9 | Cancer | |||||
| Monoacylglycerol lipase ABHD12 (isoform a) | Q8N2K0 | Cancer Leishmaniasis | ||||
| Monoacylglycerol lipase ABHD12 (isoform b) | Q8N2K0 | Cancer Leishmaniasis | ||||
| Monoamine oxidase (MAO) (nonspecified subtype) | Cancer Diabetes Malaria Epilepsy | Tuberculosis | ||||
| Monocarboxylate transporter 1 | P53985 | Cancer | Diabetes | |||
| Monocarboxylate transporter 2 | O60669 | Cancer | ||||
| Monocarboxylate transporter 4 | O15427 | Cancer | ||||
| Monoglyceride lipase (isoform 1) | Q99685 | Diabetes Epilepsy | Cancer Leishmaniasis | |||
| Monoglyceride lipase (isoform 2) | Q99685 | Diabetes Epilepsy | Cancer Leishmaniasis | |||
| Monoglyceride lipase (isoform 3) | Q99685 | Diabetes Epilepsy | Cancer Leishmaniasis | |||
| Motile sperm domain-containing protein 2 (isoform 1) | Q8NHP6 | Cancer | ||||
| Motile sperm domain-containing protein 2 (isoform 2) | Q8NHP6 | Cancer | ||||
| Motilin receptor | O43193 | Cancer | ||||
| MPPE1 | Cancer | |||||
| MreB | Cancer | |||||
| MRPL17 | Cancer | |||||
| MSLN variant 1 | Cancer | |||||
| MSLN variant 2 | Cancer | |||||
| MTDH | Cancer | |||||
| MTF1 | Cancer | |||||
| MTOR | Cancer | |||||
| mTOR complex 1 | Cancer | Epilepsy | Diabetes | |||
| mTOR complex 2 | Cancer | Epilepsy | ||||
| mu-Calpain (calpain 1) | Cancer Epilepsy | |||||
| Mu-type opioid receptor (isoform MOR-1) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1A) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1A2) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1B1) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1B2) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1B3) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1B4) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1B5) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1G1) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1G2) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1i) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1O) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1S) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR-1X) | P35372 | Cancer | Diabetes | Epilepsy | ||
| Mu-type opioid receptor (isoform MOR1-K1) | P35372 | Cancer | Diabetes | Epilepsy | ||
| MUC13 | Cancer | |||||
| Mucin (nonspecified subtype) | Cancer | Diabetes | ||||
| Mucin-1 (isoform 1) | P15941 | | Cancer | |||
| Mucin-1 (isoform 10) | P15941 | Cancer | ||||
| Mucin-1 (isoform 2) | P15941 | | Cancer | |||
| Mucin-1 (isoform 5 ) | P15941 | | Cancer | |||
| Mucin-16 | Q8WXI7 | Cancer | ||||
| Mucin-5AC | P98088 | Cancer | ||||
| Mucin-5B | Q9HC84 | Cancer | ||||
| Mucolipin-1 | Q9GZU1 | Cancer | ||||
| Mucosa associated lymphoid tissue lymphoma translocation protein 1 (isoform a) | Q9UDY8 | Cancer | ||||
| Multidrug resistance protein 1 (MDR-1) (isoform 1) | P08183 | Cancer Diabetes Epilepsy | ||||
| Multidrug resistance protein 1 (MDR-1) (isoform 3) | P08183 | Cancer Diabetes Epilepsy | ||||
| Multidrug resistance-associated protein 1 | P33527 | Cancer Diabetes | ||||
| Multifunctional protein ADE2 (isoform 1) | P22234 | Cancer | ||||
| Multifunctional protein ADE2 (isoform 2) | P22234 | Cancer | ||||
| Muscarinic Acetylcholine Receptor (mAChR) (nonspecified subtype) | Cancer | Epilepsy | Diabetes | |||
| Muscarinic acetylcholine receptor M1 | P11229 | Epilepsy | Diabetes | Cancer | ||
| Muscarinic acetylcholine receptor M2 | P08172 | Cancer Epilepsy | ||||
| Muscarinic acetylcholine receptor M3 | P20309 | Cancer | Diabetes Epilepsy | |||
| Muscarinic acetylcholine receptor M4 | P08173 | Cancer Diabetes | ||||
| Muscarinic Acetylcholine Receptor M5 | P08912 | Cancer | ||||
| MYC | Cancer | Diabetes | ||||
| Myc box-dependent-interacting protein 1 (isoform 1) | O00499 | | Cancer | |||
| Myc box-dependent-interacting protein 1 (isoform 10) | O00499 | Cancer | ||||
| Myc box-dependent-interacting protein 1 (isoform 8) | O00499 | Cancer | ||||
| Myc proto-oncogene protein | P01106 | | Cancer | Diabetes | ||
| MYCN | Cancer | |||||
| Myelin protein zero-like 2 | O60487 | Cancer | ||||
| Myeloid cell surface antigen CD33 (isoform 1) | P20138 | Cancer | ||||
| Myeloid cell surface antigen CD33 (isoform 2) | P20138 | Cancer | ||||
| Myeloid cell surface antigen CD33 (isoform X1) | P20138 | Cancer | ||||
| Myeloid differentiation primary response protein MyD88 (isoform 1) | Q99836 | | Cancer | |||
| Myeloid differentiation primary response protein MyD88 (isoform 2) | Q99836 | Cancer | ||||
| Myeloid differentiation primary response protein MyD88 (isoform 4) | Q99836 | | Cancer | |||
| Myeloid differentiation primary response protein MyD88 (isoform 5) | Q99836 | Cancer | ||||
| Myeloid zinc finger 1 (isoform 1) | P28698 | Cancer | ||||
| Myeloid zinc finger 1 (isoform 2) | P28698 | Cancer | ||||
| Myeloperoxidase (MPO) | P05164 | | Malaria | Cancer Diabetes | ||
| Myoferlin (isoform a) | Q9NZM1 | | Cancer | |||
| Myosin-2 (isoform 1) | Q9UKX2 | Cancer | ||||
| Myosin-2 (isoform 2) | Q9UKX2 | Cancer | ||||
| Myosin-light-chain kinase (MLCK) | Q15746 | Cancer | ||||
| Myotonin-protein kinase (isoform 2) | Q09013 | Cancer | ||||
| Myristoylated alanine-rich C-kinase substrate | P29966 | Cancer | ||||
| N | Cancer | |||||
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) | O94760 | Cancer | ||||
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (isoform 2) | O94760 | | Cancer | |||
| N-acetyltransferase Eis | P9WFK6 | | Tuberculosis | |||
| N-acylethanolamine-hydrolyzing acid amidase precursor (isoform 1) | Q02083 | Epilepsy | Cancer | |||
| N-acylethanolamine-hydrolyzing acid amidase precursor (isoform 2) | Q02083 | Epilepsy | Cancer | |||
| N-arachidonyl glycine receptor | Q14330 | Cancer | ||||
| N-formyl peptide receptor 2 (FMLP-R-I) | P25090 | | Tuberculosis | Cancer Diabetes Epilepsy | ||
| N-glycosylase/DNA lyase (isoform 1a) | O15527 | | Cancer | |||
| N-glycosylase/DNA lyase (isoform X1) | O15527 | | Cancer | |||
| N-lysine methyltransferase KMT5A | Q9NQR1 | | Cancer | |||
| N-lysine methyltransferase SMYD2 | Q9NRG4 | Cancer | ||||
| N-Terminal Xaa-Pro-Lys N-methyltransferase 1 | Q9BV86 | Cancer | ||||
| Na+/H+ Exchanger (NHE) (nonspecified subtype) | Cancer | Malaria | ||||
| Na+/K+-ATPase (nonspecified subtype) | Cancer | Epilepsy | Leishmaniasis | |||
| NACHT, LRR and PYD domains-containing protein 3 (isoform 1) | Q96P20 | Cancer | Diabetes | Epilepsy | ||
| NACHT, LRR and PYD domains-containing protein 3 (isoform 2) | Q96P20 | Cancer | Diabetes | Epilepsy | ||
| NACHT, LRR and PYD domains-containing protein 3 (isoform 3) | Q96P20 | Cancer | Diabetes | Epilepsy | ||
| NACHT, LRR and PYD domains-containing protein 3 (isoform 5) | Q96P20 | | Cancer | Diabetes | Epilepsy | |
| NACHT, LRR and PYD domains-containing protein 3 (isoform 6) | Q96P20 | Cancer | Diabetes | Epilepsy | ||
| NAD(P)H dehydrogenase [quinone] 1 (isoform 1) | P15559 | | Cancer | Diabetes | ||
| NAD(P)H dehydrogenase [quinone] 1 (isoform 2) | P15559 | | Cancer | Diabetes | ||
| NAD+ ADP-Ribosyltransferase (poly(ADP-ribose)polymerase; PARP) (nonspecified subtype) | Cancer Diabetes | Epilepsy | ||||
| NAD-dependent deacetylase sirtuin-2 (isoform 1) | Q8IXJ6 | Cancer | Diabetes | |||
| NAD-dependent deacetylase sirtuin-2 (isoform 2) | Q8IXJ6 | Cancer | Diabetes | |||
| NAD-dependent deacetylase sirtuin-2 (isoform 3) | Q8IXJ6 | Cancer | Diabetes | |||
| NAD-dependent deacetylase sirtuin-3, mitochondrial (isoform 1) | Q9NTG7 | | Cancer | |||
| NAD-dependent deacetylase sirtuin-3, mitochondrial (isoform 2) | Q9NTG7 | | Cancer | |||
| NAD-dependent deacetylase sirtuin-5 (isoform 1) | Q9NXA8 | | Cancer Diabetes | |||
| NAD-dependent deacetylase sirtuin-5 (isoform 2) | Q9NXA8 | | Cancer Diabetes | |||
| NAD-dependent deacetylase sirtuin-5 (isoform 3) | Q9NXA8 | | Cancer Diabetes | |||
| NAD-dependent protein deacetylase sirtuin-1 (isoform 1) | Q96EB6 | Cancer | Diabetes | Tuberculosis | ||
| NAD-dependent protein deacetylase sirtuin-1 (isoform 2) | Q96EB6 | Cancer | Diabetes | Tuberculosis | ||
| NAD-dependent protein deacetylase sirtuin-6 (isoform 1) | Q8N6T7 | | Cancer | Diabetes | ||
| NAD-dependent protein deacetylase sirtuin-6 (isoform 2) | Q8N6T7 | | Cancer | Diabetes | ||
| NADH dehydrogenase (Complex I) | Cancer | Diabetes | ||||
| NADPH Oxidase (nonspecified subtype) | Cancer | Diabetes | ||||
| NADPH oxidase 1 (isoform 1) | Q9Y5S8 | Cancer | ||||
| NADPH oxidase 1 (isoform 2) | Q9Y5S8 | Cancer | ||||
| NADPH oxidase 3 | Q9HBY0 | Cancer | Diabetes | |||
| NADPH oxidase 4 (isoform 1) | Q9NPH5 | Diabetes | Cancer | |||
| NADPH oxidase 5 | Q96PH1 | Cancer | ||||
| NADPH Oxidase Complex | Cancer | Diabetes | ||||
| NAMPT | Cancer | |||||
| NANOGP8 | Cancer | |||||
| Natural cytotoxicity triggering receptor 1 (isoform a) | O76036 | | Diabetes | Cancer | ||
| Natural cytotoxicity triggering receptor 3 ligand 1 | Q68D85 | | Cancer | |||
| Natural resistance-associated macrophage protein 2 (isoform 1) | P49281 | Cancer | ||||
| Natural resistance-associated macrophage protein 2 (isoform 2) | P49281 | Cancer | ||||
| NCOA1 variant 1 | Cancer | |||||
| NCOA1 variant 2 | Cancer | |||||
| NCOA1 variant 3 | Cancer | |||||
| NCOA2 variant 2 | Cancer | |||||
| NCOA3 variant 1 | Cancer | |||||
| NDC80 kinetochore complex | Cancer | |||||
| Nectin-2 (isoform alpha) | Q92692 | Cancer | ||||
| Nectin-2 (isoform delta) | Q92692 | Cancer | ||||
| Nectin-4 | Q96NY8 | Cancer | ||||
| NEDD8-activating enzyme E1 | Cancer | Diabetes | ||||
| NEDD8-activating enzyme E1 catalytic subunit (isoform 1) | Q8TBC4 | | Cancer | Diabetes | ||
| NEDD8-activating enzyme E1 catalytic subunit (isoform 2) | Q8TBC4 | Cancer | Diabetes | |||
| NEDD8-activating enzyme E1 regulatory subunit (isoform 1) | Q13564 | | Cancer | Diabetes | ||
| NEDD8-activating enzyme E1 regulatory subunit (isoform 2) | Q13564 | Cancer | Diabetes | |||
| NEDD9 variant 1 | Cancer | |||||
| NEDD9 variant 3 | Cancer | |||||
| NEDD9 variant 4 | Cancer | |||||
| NEK2 variant 1 | Cancer | |||||
| Neprilysin | P08473 | | Cancer Epilepsy | |||
| Neural cell adhesion molecule 1 (isoform 1) | P13591 | | Cancer | |||
| Neural cell adhesion molecule L1 (isoform 1) | P32004 | Cancer | ||||
| Neural cell adhesion molecule L1 (isoform 3) | P32004 | Cancer | ||||
| Neural cell adhesion molecule L1 (isoform 4) | P32004 | Cancer | ||||
| Neurogenic locus notch homolog protein 1 (isoform 1) | P46531 | | Cancer | |||
| Neurogenic locus notch homolog protein 1 (isoform X1) | P46531 | | Cancer | |||
| Neurogenic locus notch homolog protein 2 (isoform 1) | Q04721 | Cancer | ||||
| Neurogenic locus notch homolog protein 2 (isoform 2) | Q04721 | Cancer | ||||
| Neurogenic locus notch homolog protein 3 | Q9UM47 | Cancer | ||||
| Neurogenic locus notch homolog protein 4 | Q99466 | Cancer | ||||
| Neuromedin-B receptor (isoform 1) | P28336 | Cancer | ||||
| Neuromedin-B receptor (isoform X2) | P28336 | Cancer | ||||
| Neuromedin-K receptor | P29371 | Cancer | ||||
| Neuronal acetylcholine receptor subunit alpha-3 (isoform 1) | P32297 | Cancer | ||||
| Neuronal acetylcholine receptor subunit alpha-3 (isoform 2) | P32297 | Cancer | ||||
| Neuronal acetylcholine receptor subunit alpha-7 (isoform 1) | P36544 | Cancer Diabetes | Epilepsy | |||
| Neuronal PAS domain-containing protein 2 | Q99743 | Cancer | ||||
| Neuropeptide FF receptor 2 (isoform 1) | Q9Y5X5 | Cancer Diabetes | ||||
| Neuropeptide S receptor (isoform 1) | Q6W5P4 | Cancer | ||||
| Neuropeptide S receptor (isoform 2) | Q6W5P4 | Cancer | ||||
| Neuropeptide S receptor (isoform 3) | Q6W5P4 | Cancer | ||||
| Neuropeptide Y receptor type 1 (NPY1-R) | P25929 | Cancer Diabetes | ||||
| Neuropeptide Y receptor type 2 | P49146 | Diabetes Epilepsy | Cancer | |||
| Neuropeptide Y receptor type 4 | P50391 | Cancer Diabetes | ||||
| Neuropilin-1 (isoform 1) | O14786 | Cancer | ||||
| Neuropilin-1 (isoform 2) | O14786 | | Cancer | |||
| Neuropilin-1 (isoform 4) | Q59F20 | | Cancer | |||
| Neuropilin-2 (isoform 1) | O60462 | | Cancer | |||
| Neuropilin-2 (isoform 2) | O60462 | | Cancer | |||
| Neurotensin receptor (nonspecified subtype) | Cancer | |||||
| Neurotensin receptor type 1 | P30989 | Cancer | Epilepsy | |||
| Neurotensin receptor type 2 | O95665 | Cancer | ||||
| Neurotensin/neuromedin N preproprotein | P30990 | Cancer | ||||
| Neurotrophic Factor (nonspecified subtype) | Cancer | Diabetes Epilepsy | ||||
| Neurotrophic Tyrosine Kinase Receptor (TRK) (nonspecified subtype) | Cancer | |||||
| Neutral amino acid transporter A | P43007 | Cancer | ||||
| Neutral amino acid transporter B(0) (isoform 1) | Q15758 | Cancer | ||||
| Neutral amino acid transporter B(0) (isoform 2) | Q15758 | Cancer | ||||
| Neutral amino acid transporter B(0) (isoform X1) | Q15758 | Cancer | ||||
| Neutral cholesterol ester hydrolase 1 | Q6PIU2 | Cancer | ||||
| Neutrophil collagenase (MMP-8) | P22894 | | Cancer | Diabetes | ||
| Neutrophil elastase | P08246 | | | Cancer | Diabetes Malaria Tuberculosis | |
| NF-kappa-B essential modulator (isoform 2) | Q9Y6K9 | Cancer | ||||
| NF-kappa-B essential modulator (isoform 3) | Q9Y6K9 | Cancer | ||||
| NF-kappaB (NFkB) | Cancer Diabetes | Epilepsy | Leishmaniasis | |||
| NFE2L2 variant 1 | Cancer | |||||
| NFE2L2 variant 2 | Cancer | |||||
| NGF | Cancer | |||||
| Nicotinamide N-methyltransferase | P40261 | Cancer Diabetes | ||||
| Nicotinamide phosphoribosyltransferase | P43490 | | Cancer | Diabetes | ||
| Nicotinamide phosphoribosyltransferase (isoform X1) | P43490 | Cancer | Diabetes | |||
| Nicotinic alpha3beta4 Receptor | Cancer Epilepsy | |||||
| Nicotinic alpha4beta2 receptor | Cancer Epilepsy | |||||
| Nicotinic alpha9 receptor | Q9UGM1 | Cancer | ||||
| Nicotinic alpha9alpha10 Receptor | Cancer | |||||
| Nicotinic beta2 receptor | P17787 | Cancer Epilepsy | ||||
| Nitric oxide synthase (NOS) (nonspecified subtype) | Diabetes | Cancer | Epilepsy | |||
| Nitric oxide synthase, brain | P29475 | Cancer | ||||
| Nitric oxide synthase, endothelial (isoform 1) | P29474 | | Cancer | |||
| Nitric oxide synthase, inducible | P35228 | | Cancer Epilepsy | Diabetes | ||
| NKG2-A/NKG2-B type II integral membrane protein (isoform C) | P26715 | | Cancer | |||
| NKG2-A/NKG2-B type II integral membrane protein (isoform NKG2-A) | P26715 | | Cancer | |||
| NKG2-A/NKG2-B type II integral membrane protein (isoform NKG2-B) | P26715 | | Cancer | |||
| NKG2-D type II integral membrane protein | P26718 | | Cancer | Diabetes | ||
| NKX3-1 | Cancer | |||||
| NLK | Cancer | |||||
| NLRP3 Inflammsome | Cancer | Diabetes | Epilepsy | |||
| NMDA receptor | Cancer Epilepsy | Diabetes | ||||
| NOB1 | Cancer | |||||
| Non-receptor tyrosine-protein kinase TYK2 | P29597 | Cancer | Diabetes | |||
| NOP2 variant 2 | Cancer | |||||
| NOS2 | Cancer | Diabetes | ||||
| NOS2 variant X1 | Cancer | Diabetes | ||||
| NOS3 variant 1 | Cancer Diabetes | |||||
| Notch receptor (nonspecified subtype) | Cancer | |||||
| NOTCH1 | Cancer | |||||
| NOTCH1 variant 1 X1 | Cancer | |||||
| NPM1 variant 1 | Cancer Diabetes Malaria | |||||
| NPM1 variant 2 | Cancer Diabetes Malaria | |||||
| NPR1 | Cancer | |||||
| NR2F6 | Cancer | |||||
| NRAS | Cancer | |||||
| NRP1 variant 1 | Cancer | |||||
| NRP1 variant 2 | Cancer | |||||
| NRP1 variant 4 | Cancer | |||||
| NS5A protein (Hepatitis C virus genotype 1) | Cancer | |||||
| NSD2 variant 1 | Cancer | |||||
| NSD2 variant 10 | Cancer | |||||
| NT-3 growth factor receptor (isoform 1) | Q16288 | Cancer | ||||
| NT-3 growth factor receptor (isoform 2) | Q16288 | | Cancer | |||
| NT-3 growth factor receptor (isoform 3) | Q16288 | | Cancer | |||
| NT-3 growth factor receptor (isoform 4) | X5DNW6 | Cancer | ||||
| NT5E | Cancer | |||||
| NuA4 histone acetyltransferase (HAT) complex | Cancer | |||||
| NUAK Family SNF1-like Kinase (nonspcified subtype) | Cancer | |||||
| NUAK family SNF1-like kinase 1 | O60285 | Cancer | ||||
| Nuclear factor erythroid 2-related factor 2 (Nrf2) (isoform 1) | Q16236 | Cancer | Diabetes Epilepsy | |||
| Nuclear factor erythroid 2-related factor 2 (Nrf2) (isoform 2) | Q16236 | Cancer | Diabetes Epilepsy | |||
| Nuclear receptor coactivator 1 (isoform 1) | Q15788 | Cancer | ||||
| Nuclear receptor coactivator 1 (isoform 2) | Q15788 | | Cancer | |||
| Nuclear receptor coactivator 1 (isoform 3) | Q15788 | | Cancer | |||
| Nuclear receptor coactivator 2 (isoform a) | Q15596 | Cancer | ||||
| Nuclear receptor coactivator 2 (isoform b) | Q15596 | | Cancer | |||
| Nuclear receptor coactivator 3 (isoform a) | Q9Y6Q9 | Cancer | ||||
| Nuclear Receptor ROR (nonspecified subtype) | Cancer | |||||
| Nuclear receptor ROR-alpha (isoform a) | P35398 | | Cancer Diabetes | |||
| Nuclear receptor ROR-alpha (isoform b) | P35398 | | Cancer Diabetes | |||
| Nuclear receptor ROR-alpha (isoform c) | P35398 | | Cancer Diabetes | |||
| Nuclear receptor ROR-alpha (isoform d) | P35398 | | Cancer Diabetes | |||
| Nuclear receptor ROR-beta | Q92753 | Cancer | Diabetes Epilepsy | |||
| Nuclear receptor ROR-gamma (isoform a) | P51449 | Cancer | Diabetes | Leishmaniasis | ||
| Nuclear receptor ROR-gamma (isoform b) | P51449 | | Cancer | Diabetes | Leishmaniasis | |
| Nuclear receptor subfamily 0 group B member 2 (SHP) | Q15466 | Cancer | ||||
| Nuclear receptor subfamily 1 group I member 2 (isoform 1) | O75469 | | Cancer | Diabetes Epilepsy | ||
| Nuclear receptor subfamily 1 group I member 2 (isoform 2) | O75469 | | Cancer | Diabetes Epilepsy | ||
| Nuclear receptor subfamily 1 group I member 2 (isoform 3) | O75469 | | Cancer | Diabetes Epilepsy | ||
| Nuclear receptor subfamily 1 group I member 3 (isoform 1) | Q14994 | | Diabetes | Cancer | ||
| Nuclear receptor subfamily 1 group I member 3 (isoform 3) | Q14994 | | Diabetes | Cancer | ||
| Nuclear receptor subfamily 1 group I member 3 (isoform 6) | Q14994 | | Diabetes | Cancer | ||
| Nuclear receptor subfamily 1, group D, member 1 | P20393 | Cancer | Diabetes | |||
| Nuclear receptor subfamily 1, group D, member 2 | Q14995 | Cancer | ||||
| Nuclear receptor subfamily 2 group F member 6 | P10588 | Cancer | ||||
| Nuclear receptor subfamily 4 group A member 1 (isoform a) | P22736 | Cancer Diabetes | ||||
| Nuclear receptor subfamily 4 group A member 2 | P43354 | Cancer | Epilepsy | |||
| Nuclear receptor subfamily 5 group A member 2 (isoform 1) | O00482 | Cancer Diabetes | ||||
| Nuclear receptor subfamily 5 group A member 2 (isoform 2) | O00482 | | Cancer Diabetes | |||
| Nucleolin | P19338 | Cancer | ||||
| Nucleophosmin (isoform 1) | P06748 | Cancer | ||||
| Nucleophosmin (isoform 2) | P06748 | Cancer | ||||
| Nucleoside diphosphate kinase B | P22392 | | Cancer | |||
| Nucleosome-remodeling factor subunit BPTF (isoform 1) | Q12830 | | Cancer | |||
| Nucleosome-remodeling factor subunit BPTF (isoform 2) | Q12830 | | Cancer | |||
| Nucleotide-binding oligomerization domain-containing protein 1 | Q9Y239 | Cancer | ||||
| Nucleotide-binding oligomerization domain-containing protein 2 (isoform 2) | Q9HC29 | Cancer | ||||
| Nucleotide-binding oligomerization domain-containing protein 2 (soform 1) | Q9HC29 | Cancer | ||||
| Nucleus accumbens-associated protein 1 | Q96RE7 | Cancer | ||||
| NUF2 variant 2 | Cancer | |||||
| NUS1 | Cancer | |||||
| OGT variant1 | Cancer | |||||
| OLFM4 | Cancer | |||||
| Oligodendrocyte transcription factor 2 | Q13516 | Cancer | ||||
| Oligosaccharyltransferase complex | Cancer | |||||
| Oncostatin M | P13725 | Cancer | ||||
| Oncostatin-M Receptor | Cancer | |||||
| Oncostatin-M-specific receptor subunit beta (isoform 1) | Q99650 | Cancer | ||||
| Opioid receptor (nonspecified subtype) | Cancer Diabetes | |||||
| Orexin receptor type 1 | O43613 | Cancer Diabetes Epilepsy | ||||
| Orexin receptor type 2 | O43614 | Cancer Diabetes Epilepsy | ||||
| Ornithine aminotransferase, mitochondria | P04181 | | Cancer | |||
| Ornithine decarboxylase (isoform 1) | P11926 | Cancer | ||||
| Ornithine decarboxylase (isoform 2) | P11926 | | Cancer | |||
| Osteopontin (isoform 1) | P10451 | Cancer | ||||
| Osteopontin (isoform 2) | P10451 | Cancer | ||||
| Osteopontin (isoform 3) | P10451 | Cancer | ||||
| Osteopontin (isoform 5) | P10451 | Cancer | ||||
| OT-R | P30559 | Cancer Diabetes | ||||
| OTU domain-containing protein 7B | Q6GQQ9 | Cancer | ||||
| OTUB1 variant 1 | Cancer | |||||
| Oxoeicosanoid receptor 1 | Q8TDS5 | Cancer | ||||
| Oxysterols receptor LXR (nonspecified subtype) | Cancer | Diabetes | ||||
| Oxysterols receptor LXR-alpha | Q13133 | | Cancer | Epilepsy | Diabetes | |
| Oxysterols receptor LXR-alpha (isoform 1) | Q13133 | | Cancer | Epilepsy | Diabetes | |
| Oxysterols receptor LXR-alpha (isoform 2) | Q13133 | | Cancer | Epilepsy | Diabetes | |
| Oxysterols receptor LXR-alpha (isoform 3) | Q13133 | | Cancer | Epilepsy | Diabetes | |
| Oxysterols receptor LXR-beta (isoform 1) | P55055 | | Cancer | Diabetes | ||
| Oxysterols receptor LXR-beta (isoform 2) | P55055 | | Cancer | Diabetes | ||
| P-selectin precursor | P16109 | | Cancer | |||
| P2X purinoceptor 4 (isoform 1) | Q99571 | Cancer | ||||
| P2X purinoceptor 4 (isoform 2) | Q99571 | Cancer | ||||
| P2X purinoceptor 7 (P2X7) | Q99572 | | Cancer | Epilepsy | Diabetes Tuberculosis | |
| P2X Receptor (nonspecified subtype) | Cancer | |||||
| P2Y purinoceptor 12 | Q9H244 | | Cancer | |||
| P2Y purinoceptor 13 | Q9BPV8 | Cancer Diabetes | ||||
| P2Y purinoceptor 2 | P41231 | Cancer | ||||
| P4HB | Cancer | |||||
| PAEP variant 1 | Cancer | |||||
| Paired amphipathic helix protein Sin3a | Q96ST3 | | Cancer | |||
| Palmitoleoyl-protein carboxylesterase NOTUM | Q6P988 | Cancer | ||||
| Palmitoyltransferase (nonspecified subtype) | Cancer | |||||
| Pancreatic elastase | Q9UNI1 | Cancer | ||||
| Pancreatic triacylglycerol lipase | P16233 | | Diabetes Leishmaniasis | Cancer | ||
| Pantetheinase | O95497 | Cancer | ||||
| Parathyroid hormone preproprotein | P01270 | | Cancer | |||
| Parathyroid Hormone Receptors (PTHR) (nonspecified subtype) | Cancer | |||||
| Parathyroid hormone-like hormone (isoform 1) | P12272 | Cancer | ||||
| Parathyroid hormone/parathyroid hormone-related peptide receptor | Q03431 | | Cancer | |||
| PARP1 | Cancer | |||||
| PARP2 variant 1 | Cancer Diabetes | |||||
| PARP2 variant 2 | Cancer Diabetes | |||||
| PAS domain-containing serine/threonine kinase | Q96RG2 | Cancer Diabetes | ||||
| PBX1 | Cancer | |||||
| PCBP2-OT1 | Cancer | |||||
| PCGEM1 | Cancer | |||||
| PCSK9 | Cancer Diabetes | |||||
| PDCD1 | Cancer | |||||
| PDCD1LG2 | Cancer | |||||
| PDGFR (nonspecified subtype) | Cancer | Diabetes | ||||
| PDGFRA variant 1 | Cancer | |||||
| PDGFRA variant 5 | Cancer | |||||
| PEBP4 | Cancer | |||||
| Peptidase inhibitor 3, skin-derived (Elafin) | P19957 | Cancer Leishmaniasis | ||||
| Peptide deformylase, mitochondrial | Q9HBH1 | Cancer | ||||
| Peptidyl arginine deiminase (PAD) (nonspecified subtype) | Cancer | |||||
| Peptidyl-glycine alpha-amidating monooxygenase (isoform a) | P19021 | Cancer | ||||
| Peptidyl-prolyl cis-trans isomerase FKBP1A (Rotamase) | P62942 | | Cancer Epilepsy | Diabetes | ||
| Peptidyl-prolyl cis-trans isomerase FKBP5 (isoform 1) | Q13451 | Cancer | ||||
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Q13526 | | Cancer | |||
| Peptidylprolyl Isomerase (Cyclophilin) (nonspecified subtype) | Cancer | |||||
| Peptidylprolyl isomerase A (isoform 1) (Cyclophilin A) | P62937 | | Cancer | Diabetes | ||
| Peptidylprolyl isomerase D (Cyclophilin D) | Q08752 | Diabetes | Cancer | |||
| Peregrin | P55201 | | Cancer | |||
| Perilipin-1 | O60240 | Cancer Diabetes | ||||
| Period circadian protein homolog 2 (isoform 1) | O15055 | Cancer | ||||
| Periostin (isoform 1) | Q15063 | Cancer | ||||
| Periostin (isoform 2) | Q15063 | Cancer | ||||
| Periostin (isoform 3) | Q15063 | Cancer | ||||
| Periostin (isoform 4) | Q15063 | Cancer | ||||
| Peroxiredoxin-1 | Q06830 | Cancer | ||||
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (isoform 1) | Q6QHF9 | Cancer | ||||
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (isoform 5) | Q6QHF9 | Cancer | ||||
| Peroxisome proliferative activated receptor gamma (isoform 1) | P37231 | | Cancer | Diabetes | Leishmaniasis Malaria Epilepsy | |
| Peroxisome proliferative activated receptor gamma (isoform X2) | P37231 | Cancer Diabetes | Leishmaniasis Epilepsy | |||
| Peroxisome proliferator-activated receptor alpha | Q07869 | | Cancer Diabetes | |||
| Peroxisome proliferator-activated receptor delta (isoform 1) | Q03181 | | Cancer Diabetes | |||
| Peroxisome proliferator-activated receptor gamma (isoform 2) | P37231 | | Cancer | Diabetes | Leishmaniasis Epilepsy | |
| Peroxisome Proliferator-Activated Receptors (PPAR) (nonspecified subtype) | Cancer Diabetes | |||||
| PGAM5-KEAP1-NRF2 Complex | Cancer Diabetes | |||||
| PHD finger protein 8 | Q9UPP1 | Cancer | ||||
| Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (isoform 1) | Q8WUK0 | Cancer | Diabetes | |||
| Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (isoform a) | Q92835 | Cancer | ||||
| Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | Cancer | Epilepsy | Diabetes Leishmaniasis Malaria | |||
| Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 | Q8NEB9 | Cancer | Diabetes | |||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P42338 | Cancer | Diabetes Epilepsy | |||
| Phosphatidylinositol 4-Kinase (PI4K) (nonspecified subtype) | Cancer | |||||
| Phosphatidylinositol 4-kinase alpha (isoform 1) | P42356 | Cancer | ||||
| Phosphatidylinositol 4-kinase alpha (isoform 2) | P42356 | Cancer | ||||
| Phosphatidylinositol 4-kinase beta | Q9UBF8 | Cancer Malaria | ||||
| Phosphatidylinositol 4-Kinase beta (PI4K-beta) (nonspecified subtype) | Cancer | |||||
| Phosphatidylinositol 4-kinase type 2-beta | Q8TCG2 | Cancer | ||||
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | P48426 | Cancer | ||||
| Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | P42336 | | Cancer | Diabetes Epilepsy | ||
| Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta isoform | O00329 | Cancer | Diabetes Epilepsy | |||
| Phosphatidylinositol-5-phosphate 4-kinase type-2 beta | P78356 | Cancer | ||||
| Phosphodiesterase (nonspecified subtype) | Leishmaniasis | Cancer Diabetes Malaria | ||||
| Phosphodiesterase 8 (nonspecified subtype) | Cancer Diabetes | |||||
| Phosphodiesterase IV (PDE4) (nonspecified subtype) | Cancer | Diabetes | ||||
| Phosphodiesterase VII (PDEVII; PDE7) (nonspecified protein) | Cancer Diabetes | |||||
| Phosphoglycerate kinase 1 | P00558 | | Cancer | |||
| Phosphoglycerate mutase 1 (brain) | P18669 | Cancer | ||||
| Phosphoinositide-3-kinase, catalytic, gamma polypeptide | P48736 | | Cancer | Malaria | Diabetes Epilepsy | |
| Phospholipase A2 (nonspecified subtype) | Tuberculosis | Cancer Diabetes Leishmaniasis | ||||
| Phospholipase A2, Cytosolic (nonspecified subtype) | Cancer | |||||
| Phospholipase A2, membrane associated | P14555 | | Cancer | Diabetes | ||
| Phospholipase A2, Secretory (sPLA2) (nonspecified subtype) | Cancer | Diabetes | ||||
| Phospholipase C (nonspecified subtype) | Cancer | |||||
| Phospholipase D1 (isoform a) | Q13393 | Cancer | ||||
| Phospholipase D2 | O14939 | Cancer | ||||
| Phospholipid hydroperoxide glutathione peroxidase, mitochondrial (isoform A) | P36969 | Cancer | ||||
| Phospholipid hydroperoxide glutathione peroxidase, mitochondrial (isoform B) | P36969 | | Cancer | |||
| Photoreceptor-specific nuclear receptor (isoform 1) | Q9Y5X4 | Cancer | ||||
| Photoreceptor-specific nuclear receptor (isoform 2) | Q9Y5X4 | Cancer | ||||
| Phylloquinone omega-hydroxylase CYP4F2 | P78329 | Cancer | ||||
| PIK3CA | Cancer | |||||
| PIK3CB | Cancer | |||||
| PIK3CD | Cancer | |||||
| PIK3R1 variant 1 | Cancer | |||||
| PIK3R1 variant 2 | Cancer | |||||
| PIK3R1 variant 3 | Cancer | |||||
| PIK3R1 variant 4 | Cancer | |||||
| PIK3R2 | Cancer | |||||
| Pim Kinase (nonspecified subtype) | Cancer | |||||
| Pirin | O00625 | | Cancer | |||
| Pituitary adenylate cyclase-activating polypeptide type I receptor (isoform 1) | P41586 | | Cancer | Diabetes | ||
| Pituitary adenylate cyclase-activating polypeptide type I receptor (isoform 3) | P41586 | | Cancer | Diabetes | ||
| PIWIL4 | Cancer | |||||
| PKN3 | Cancer | |||||
| Placental growth factor (isoform 1) | P49763 | Cancer | ||||
| Plasma kallikrein | P03952 | | Cancer | |||
| Plasma protease C1 inhibitor | P05155 | Cancer | ||||
| Plasminogen | P00747 | | Cancer | |||
| Plasminogen activator inhibitor 1 | P05121 | Cancer | Diabetes | |||
| Plasminogen activator, tissue type (isoform 1) | P00750 | | Cancer | |||
| Platelet Endothelial Cell adhesion Molecule (PECAM-1) | P16284 | Cancer | ||||
| Platelet glycoprotein 4 (isoform 1) | P16671 | Cancer | ||||
| Platelet glycoprotein 4 (isoform 2) | P16671 | Cancer | ||||
| Platelet glycoprotein Ib alpha chain | P07359 | | Diabetes | |||
| Platelet glycoprotein VI | Q9HCN6 | Cancer | ||||
| Platelet-activating factor acetylhydrolase isoform 1B complex | Cancer | |||||
| Platelet-activating factor receptor | P25105 | Cancer | Diabetes | |||
| Platelet-Derived Growth Factor (PDGF) (nonspecified subtype) | Cancer | Diabetes | ||||
| Platelet-derived growth factor C | Q9NRA1 | Cancer | ||||
| Platelet-derived growth factor D (isoform 1) | Q9GZP0 | Cancer | ||||
| Platelet-derived growth factor receptor alpha (isoform 5) | P16234 | Cancer | Diabetes | |||
| Platelet-derived growth factor receptor alpha (isoform 1) | P16234 | Cancer | Diabetes | |||
| Platelet-derived growth factor receptor alpha (isoform 4) | Cancer | Diabetes | ||||
| Platelet-derived growth factor receptor beta (isoform 1) | P09619 | Cancer | Diabetes | |||
| Platelet-derived growth factor subunit B (isoform 1) | P01127 | Cancer | ||||
| Platelet-derived growth factor subunit B (isoform 2) | P01127 | | Cancer | |||
| PLAU variant 1 | Cancer | |||||
| PLAU variant 2 | Cancer | |||||
| PLAUR variant 1 | Cancer | |||||
| PLAUR variant 2 | Cancer | |||||
| PLCE1 variant 1 | Cancer | |||||
| PLCE1 variant 2 | Cancer | |||||
| Plectin (isoform 1) | Q15149 | | Cancer | |||
| Plectin (isoform 1a) | Q15149 | Cancer | ||||
| Plectin (isoform 1f) | Q15149 | | Cancer | |||
| PLEKHO1 | Cancer | |||||
| PLK1 | Cancer | |||||
| PMEPA1 variant 2 | Cancer | |||||
| Podocalyxin | O00592 | Cancer | ||||
| Podocalyxin (isoform 2) | O00592 | Cancer | ||||
| Podoplanin (isoform a) | Q86YL7 | Cancer | ||||
| Podoplanin (isoform b) | Q86YL7 | Cancer | ||||
| POLD1 variant 1 | Cancer | |||||
| POLD1 variant 2 | Cancer | |||||
| POLD1 variant 4 | Cancer | |||||
| Poly (ADP-ribose) polymerase family, member 1 (PARP-1) | P09874 | Cancer | Diabetes | |||
| Poly [ADP-ribose] polymerase 10 (PARP-10) | Q53GL7 | | Cancer | |||
| Poly [ADP-ribose] polymerase 14 | Q460N5 | | Cancer | |||
| Poly [ADP-ribose] polymerase 2 (isoform 1) | Q9UGN5 | | Cancer | Diabetes | ||
| Poly [ADP-ribose] polymerase 2 (isoform 2) | Q9UGN5 | | Cancer | Diabetes | ||
| Poly [ADP-ribose] polymerase 3 (isoform a) | Q9Y6F1 | | Cancer | |||
| Poly [ADP-ribose] polymerase 6 | Q2NL67 | Cancer | ||||
| Poly(ADP-ribose) glycohydrolase | Q86W56 | | Cancer | |||
| Polycomb complex protein BMI-1 | P35226 | Cancer | ||||
| Polycomb protein EED (isoform 1) | O75530 | | Cancer | |||
| Polycomb protein EED (isoform 3) | O75530 | Cancer | ||||
| Polycomb Repressive Complex 2 (PRC2)/EED-EZH2 Complex | Cancer | |||||
| Potassium channel subfamily K member 18 | Q7Z418 | Cancer | ||||
| Potassium channel subfamily K member 2 | O95069 | Cancer Diabetes Epilepsy | ||||
| Potassium channel subfamily K member 9 (isoform 1) | Q9NPC2 | | Cancer | Epilepsy | ||
| Potassium channel, subfamily K, member 3 | O14649 | Cancer Epilepsy | ||||
| Potassium Channels (nonspecified subtype) | Epilepsy | Cancer Diabetes | Malaria | |||
| Potassium voltage-gated channel subfamily A member 2 (isoform 1) | P16389 | Cancer | ||||
| Potassium voltage-gated channel subfamily A member 2 (isoform 2) | P16389 | Cancer | ||||
| Potassium voltage-gated channel subfamily A member 3 | P22001 | Cancer Diabetes | Epilepsy | |||
| Potassium voltage-gated channel subfamily A member 4 | P22459 | Cancer | ||||
| Potassium voltage-gated channel subfamily A member 5 (Kv1.5) | P22460 | Cancer | Diabetes Epilepsy | |||
| Potassium voltage-gated channel subfamily C member 2 (isoform a) | Q96PR1 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily C member 3 | Q14003 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily D member 3 (isoform 1) | Q9UK17 | | Cancer | Epilepsy | ||
| Potassium voltage-gated channel subfamily D member 3 (isoform 2) | Q9UK17 | | Cancer | Epilepsy | ||
| Potassium voltage-gated channel subfamily E member 1 | P15382 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily E member 2 | Q9Y6J6 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily E member 3 | Q9Y6H6 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily E member 4 | Q8WWG9 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily H member 1 (isoform 1) | O95259 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily H member 1 (isoform 2) | O95259 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily H member 2 (isoform 1) | Q12809 | | Cancer | |||
| Potassium voltage-gated channel subfamily H member 2 (isoform 2) | Q12809 | | Cancer | |||
| Potassium voltage-gated channel subfamily H member 2 (isoform 3) | Q12809 | | Cancer | |||
| Potassium voltage-gated channel subfamily KQT member 1 (isoform 1) | P51787 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily KQT member 1 (isoform 2) | P51787 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel subfamily KQT member 3 (Kv7.3) | O43525 | Cancer Epilepsy | ||||
| Potassium voltage-gated channel subfamily S member 3 | Q9BQ31 | Cancer | Epilepsy | |||
| Potassium voltage-gated channel, Shaw-related subfamily, member 2 (isoform b) | Q96PR1 | Cancer | Epilepsy | |||
| POU domain, class 5, transcription factor 1 (isoform 1) | Q01860 | Cancer | ||||
| POU domain, class 5, transcription factor 1 (isoform 2) | Q01860 | Cancer | ||||
| POU domain, class 5, transcription factor 1 (isoform 3) | Q01860 | Cancer | ||||
| POU domain, class 5, transcription factor 1 (isoform 4) | F2Z381 | Cancer | ||||
| POU5F1 variant 1 | Cancer | |||||
| POU5F1 variant 3 | Cancer | |||||
| POU5F1 variant 4 | Cancer | |||||
| POU5F1 variant 5 | Cancer | |||||
| PPARG variant 1 | Cancer | |||||
| PPARG variant 2 | Cancer | |||||
| PPARG variant 3 | Cancer | |||||
| PPARG variant 4 | Cancer | |||||
| PPARG variant X2 | Cancer | |||||
| PPARGC1A variant 1 | Cancer Diabetes | |||||
| PPARGC1A variant 2 | Cancer Diabetes | |||||
| PPARGC1A variant 3 | Cancer Diabetes | |||||
| PPP5C variant 1 | Cancer | |||||
| PPP5C variant 2 | Cancer | |||||
| PRDM14 | Cancer | |||||
| PRDM15 variant 1 | Cancer | |||||
| PRDM15 variant 2 | Cancer | |||||
| PRDX2 variant 1 | Cancer | |||||
| Prenyltransferase (nonspecified subtype) | Cancer | |||||
| PRF1 variant 1 | Cancer | Malaria | ||||
| PRF1 variant 2 | Cancer | |||||
| PRKC apoptosis WT1 regulator protein | Q96IZ0 | Cancer | ||||
| PRKCA | Cancer | |||||
| PRKCI | Cancer | |||||
| Pro-epidermal growth factor (isoform 1) | P01133 | | Cancer | Diabetes | ||
| Pro-epidermal growth factor (isoform 2) | P01133 | | Cancer | Diabetes | ||
| Pro-epidermal growth factor (isoform 3) | P01133 | | Cancer | Diabetes | ||
| Pro-neuregulin-1, membrane-bound isoform (isoform (III-2) | Q02297 | | Cancer | |||
| Pro-neuregulin-1, membrane-bound isoform (isoform alpha 1) | Q02297 | | Cancer | |||
| Pro-neuregulin-1, membrane-bound isoform (isoform GGF) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform GGF2) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform HRG-beta1) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform HRG-beta1c) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform HRG-beta2) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform HRG-beta3) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform HRG-gamma) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform ndf43) | Q02297 | Cancer | ||||
| Pro-neuregulin-1, membrane-bound isoform (isoform ndf43c) | Q02297 | | Cancer | |||
| Pro-neuregulin-1, membrane-bound isoform (isoform SMDF) | Q02297 | | Cancer | |||
| Pro-platelet basic protein | P02775 | Cancer | ||||
| Probable ATP-dependent RNA helicase DDX5 | P17844 | Cancer | ||||
| Probable ATP-dependent RNA helicase DDX58 | O95786 | Cancer | Diabetes | |||
| Probable global transcription activator SNF2L2 (isoform a) | P51531 | Cancer | ||||
| Probable global transcription activator SNF2L2 (isoform b) | P51531 | Cancer | ||||
| Probable ubiquitin carboxyl-terminal hydrolase FAF-X (isoform 1) | Q93008 | Cancer | ||||
| Probable ubiquitin carboxyl-terminal hydrolase FAF-X (isoform 3) | Q93008 | Cancer | ||||
| Proepiregulin | O14944 | | Cancer | |||
| Progesterone receptor (isoform 1) | P06401 | | Cancer | Diabetes | ||
| Progesterone receptor (isoform 2) | P06401 | | Cancer | |||
| Progonadoliberin-1 (isoform 1) | P01148 | Cancer | ||||
| Programmed cell death 1 (PD-1) | Q15116 | Cancer | Diabetes Malaria | |||
| Programmed cell death 1 ligand 1 (PD-L1) | Q9NZQ7 | Cancer | ||||
| Proheparin-binding EGF-like growth factor | Q99075 | Cancer | ||||
| Prohibitin-2 (isoform 1) | Q99623 | Cancer | ||||
| Prokineticin Receptor (PK-R) (nonspecified subtype) | Cancer | |||||
| Prokineticin receptor 1 | Q8TCW9 | Cancer Diabetes | ||||
| Prokineticin receptor 2 | Q8NFJ6 | Cancer Diabetes | ||||
| Prolactin (isoform 1) | P01236 | | Cancer Diabetes | |||
| Prolactin (isoform 2) | P01236 | Cancer Diabetes | ||||
| Prolactin receptor | P16471 | Cancer | ||||
| Proliferating cell nuclear antigen | P12004 | | Cancer | |||
| Proline-, glutamic acid-, leucine-rich protein 1 | Q8IZL8 | Cancer | ||||
| Prolow-density lipoprotein receptor-related protein 1 | Q07954 | | Cancer | |||
| Prolyl 4-hydroxylase | Cancer Diabetes | |||||
| Prolyl 4-hydroxylase subunit alpha-1 | P13674 | Cancer | ||||
| Prolyl 4-hydroxylase subunit alpha-2 | O15460 | Cancer Diabetes | ||||
| Prolyl 4-hydroxylase subunit alpha-3 | Q7Z4N8 | Cancer Diabetes | ||||
| Prolyl 4-hydroxylase subunit beta | P07237 | Cancer Diabetes | ||||
| Prolyl endopeptidase FAP | Q12884 | Cancer | Diabetes | |||
| Prolyl oligopeptidase | P48147 | Cancer | Diabetes Tuberculosis | |||
| Prominin-1 (isoform 1) | O43490 | Cancer | ||||
| Prominin-1 (isoform 2) | O43490 | Cancer | ||||
| Prominin-1 (isoform 3) | O43490 | Cancer | ||||
| Prominin-1 (isoform 5) | O43490 | Cancer | ||||
| Proprotein convertase subtilisin/kexin type 6 preproprotein (isoform PACE4-AI) | P29122 | Cancer | Diabetes | |||
| Proprotein convertase subtilisin/kexin type 9 | Q8NBP7 | Diabetes | Cancer | |||
| Prostaglandin D2 receptor | Q13258 | Cancer | ||||
| Prostaglandin D2 receptor 2 | Q9Y5Y4 | Cancer | ||||
| Prostaglandin E2 receptor EP2 subtype | P43116 | Epilepsy | Cancer | |||
| Prostaglandin E2 receptor EP3 subtype (isoform 4) | P43115 | Cancer Diabetes | ||||
| Prostaglandin E2 receptor EP3 subtype (isoform 5) | P43115 | Cancer Diabetes | ||||
| Prostaglandin E2 receptor EP3 subtype (isorform 1) | P43115 | Cancer Diabetes | ||||
| Prostaglandin E2 receptor EP4 subtype | P35408 | Cancer | ||||
| Prostaglandin EP Receptor (nonspecified subtype) | Cancer | |||||
| Prostaglandin G/H synthase 1 (isoform 1) | P23219 | Cancer | Diabetes Schistosomiasis | Epilepsy Tuberculosis | ||
| Prostaglandin G/H synthase 1 (isoform 2) | P23219 | Cancer | Diabetes Schistosomiasis | Epilepsy | ||
| Prostaglandin G/H synthase 2 (COX-2) | P35354 | | Cancer Diabetes Tuberculosis | Epilepsy | ||
| Prostaglandin-E synthase | O14684 | | Cancer | Diabetes | ||
| Prostanoid EP1 receptor | P34995 | Cancer | ||||
| Prostanoid Receptor (nonspecified subtype) | Cancer | |||||
| Prostanoid TP receptor (Thromboxane A2 receptor; TXA2-R) (nonspecified subtype) | Cancer Diabetes | |||||
| Prostasin | Q16651 | Cancer | ||||
| Prostate stem cell antigen | O43653 | Cancer | ||||
| Prostate-specific antigen (isoform 1) | P07288 | | Cancer | |||
| Prostatic acid phosphatasen (PAP) | P15309 | | Cancer | |||
| Proteasome Complex | Cancer | Diabetes Malaria | Tuberculosis | |||
| Proteasome subunit beta type-1 | P20618 | Cancer | ||||
| Proteasome subunit beta type-2 (isoform 1) | P49721 | Cancer | ||||
| Proteasome subunit beta type-2 (isoform 2) | P49721 | | Cancer | |||
| Proteasome subunit beta type-5 | P28074 | Cancer | ||||
| Proteasome subunit beta type-8 | P28062 | Cancer | ||||
| Proteasome subunit beta type-9 | P28065 | Cancer | ||||
| Protein ABHD11 | Q8NFV4 | Cancer | ||||
| Protein arginine methyltransferase 5 (isoform a) | O14744 | Cancer | Diabetes | |||
| Protein arginine methyltransferase 7 | Q9NVM4 | Cancer | ||||
| Protein arginine N-methyltransferase 1 (isoform 1) | Q99873 | Cancer | ||||
| Protein arginine N-methyltransferase 3 (isoform 1) | O60678 | Cancer | ||||
| Protein arginine N-methyltransferase 6 | Q96LA8 | Cancer | ||||
| Protein arginine N-methyltransferase 8 (isoform 1) | Q9NR22 | Cancer | ||||
| Protein BTG3 | Q14201 | Cancer | ||||
| Protein cereblon (isoform 1) | Q96SW2 | Cancer | ||||
| Protein cereblon (isoform 2) | Q96SW2 | | Cancer | |||
| Protein CIP2A | Q8TCG1 | Cancer | ||||
| Protein delta homolog 1 | P80370 | Cancer | ||||
| Protein disulfide-isomerase A2 | Q13087 | Cancer | ||||
| Protein disulfide-isomerase A3 | P30101 | Cancer | ||||
| Protein ENL | Q03111 | Cancer | ||||
| Protein farnesyltransferase | Cancer | Malaria | Leishmaniasis | |||
| Protein geranylgeranyltransferase type I | Cancer | |||||
| Protein geranylgeranyltransferase type II | Cancer | |||||
| Protein jagged-1 | P78504 | Cancer | ||||
| Protein jagged-2 | Q9Y219 | Cancer | ||||
| Protein Kinase B (PKB/Akt) (nonspecified subtype) | Cancer | Diabetes Epilepsy | Tuberculosis | |||
| Protein kinase C (nonspecified subtype) | Cancer | Diabetes | Leishmaniasis Epilepsy | |||
| Protein kinase C alpha type | P17252 | Cancer | Diabetes | |||
| Protein kinase C beta type (isoform 2) | P05771 | Cancer | Diabetes | |||
| Protein kinase C delta | Q05655 | Cancer Diabetes | ||||
| Protein kinase C epsilon | Q02156 | Cancer | Diabetes | |||
| Protein kinase C eta type | P24723 | Cancer | ||||
| Protein kinase C gamma type | P05129 | | Cancer Diabetes | |||
| Protein kinase C iota | P41743 | Cancer Diabetes | ||||
| Protein kinase C theta type (isoform 2) | Q04759 | | Cancer Diabetes | |||
| Protein kinase C zeta type (isoform 1) | Q05513 | Cancer | ||||
| Protein kinase C zeta type (isoform 2) | Q05513 | Cancer | ||||
| Protein Kinase D (PKD) (nonspecified subtype) | Cancer | |||||
| Protein lin-28 homolog A | Q9H9Z2 | Cancer | ||||
| Protein LYRIC | Q86UE4 | Cancer | ||||
| Protein Mdm4 (isoform 1) | O15151 | Cancer | Diabetes | |||
| Protein Mdm4 (isoform 2) | O15151 | | Cancer | Diabetes | ||
| Protein Mdm4 (isoform 3) | O15151 | | Cancer | Diabetes | ||
| Protein Mdm4 (isoform 4) | O15151 | | Cancer | Diabetes | ||
| Protein Mdm4 (isoform 5) | O15151 | | Cancer | Diabetes | ||
| Protein Mdm4 (isoform 6) | O15151 | | Cancer | Diabetes | ||
| Protein Mdm4 (isoform 7) | O15151 | | Cancer | Diabetes | ||
| Protein O-GlcNAcase | O60502 | Diabetes | Cancer | |||
| Protein patched homolog 1 (isoform 1a) | Q13635 | Cancer | Diabetes | |||
| Protein patched homolog 1 (isoform 1b) | Q13635 | Cancer | Diabetes | |||
| Protein patched homolog 1 (isoform 1c) | Q13635 | Cancer | Diabetes | |||
| Protein patched homolog 1 (isoform L) | Q13635 | Cancer | Diabetes | |||
| Protein Phosphatase (nonspecified subtype) | Cancer | |||||
| Protein phosphatase 1D | O15297 | Cancer | ||||
| Protein Phosphatase 2A | Cancer | Diabetes | ||||
| Protein Phosphatase 2B | Diabetes | Cancer | ||||
| Protein phosphatase Slingshot homolog 1 (isoform 1) | Q8WYL5 | Cancer | ||||
| Protein phosphatase Slingshot homolog 1 (isoform 3) | Q8WYL5 | Cancer | ||||
| Protein phosphatase Slingshot homolog 2 (isoform 1) | Q76I76 | Cancer | ||||
| Protein phosphatase Slingshot homolog 2 (isoform 2) | Q76I76 | Cancer | ||||
| Protein phosphatase Slingshot homolog 2 (isoform 3) | Q76I76 | Cancer | ||||
| Protein phosphatase-1 | Cancer Malaria | |||||
| Protein polybromo-1 | Q86U86 | | Cancer | |||
| Protein S100-A10 | P60903 | | Cancer | |||
| Protein S100-A4 | P26447 | | Cancer | |||
| Protein S100-A9 | P06702 | Cancer | ||||
| Protein S100-B | P04271 | Cancer | ||||
| Protein S100-P | P25815 | Cancer | ||||
| Protein Tyrosine Phosphatase (PTP) (nonspecified subtype) | Cancer Leishmaniasis | Diabetes | ||||
| Protein tyrosine phosphatase non-receptor type 11 (isoform 1) | Q06124 | Cancer | Diabetes | |||
| Protein Tyrosine Phosphatase Type IVA (PTP4A; PRL Phosphatase) (nonspecified subtype) | Cancer | |||||
| Protein tyrosine phosphatase type IVA, member 3 (isoform 1) | O75365 | Cancer | ||||
| Protein tyrosine phosphatase, non-receptor type 6 (isoform 1) | P29350 | Cancer | Diabetes Schistosomiasis | |||
| Protein tyrosine phosphatase, non-receptor type 6 (isoform 2) | P29350 | Cancer | Diabetes Schistosomiasis | |||
| Protein tyrosine phosphatase, non-receptor type 6 (isoform 3) | P29350 | Cancer | Diabetes Schistosomiasis | |||
| Protein tyrosine phosphatase, receptor type, F | P10586 | Cancer Diabetes | ||||
| Protein-arginine deiminase type-1 | Q9ULC6 | Cancer | ||||
| Protein-arginine deiminase type-2 | Q9Y2J8 | Cancer | ||||
| Protein-arginine deiminase type-3 | Q9ULW8 | Cancer | ||||
| Protein-arginine deiminase type-4 | Q9UM07 | | Cancer | |||
| Protein-cysteine N-palmitoyltransferase HHAT | Q5VTY9 | Cancer | ||||
| Protein-glutamine gamma-glutamyltransferase 2 (TGase-2) (isoform 1) | P21980 | Cancer | Malaria Tuberculosis | |||
| Protein-glutamine gamma-glutamyltransferase 2 (TGase-2) (isoform 2) | P21980 | Cancer | Malaria Tuberculosis | |||
| Protein-L-isoaspartate(D-aspartate) O-methyltransferase | P22061 | | Cancer Epilepsy | |||
| Protein-lysine 6-oxidase (isoform 1) | P28300 | Cancer | ||||
| Protein-lysine 6-oxidase (isoform 2) | P28300 | Cancer | ||||
| Protein-S-isoprenylcysteine O-methyltransferase | O60725 | Cancer | ||||
| Protein-serine O-palmitoleoyltransferase porcupine | Q9H237 | Cancer | ||||
| Protein-tyrosine kinase 2-beta (isoform 1) | Q14289 | Cancer | ||||
| Protein-tyrosine kinase 2-beta (isoform 4) | Q14289 | Cancer | ||||
| Protein-tyrosine kinase 6 (isoform 1) | Q13882 | | Cancer | |||
| Protein-tyrosine kinase Fyn (isoform 1) | P06241 | Cancer | Diabetes | |||
| Protein-tyrosine kinase Fyn (isoform 2) | P06241 | Cancer | Diabetes | |||
| Protein-tyrosine kinase Fyn (isoform 3) | P06241 | Cancer | Diabetes | |||
| Protein-tyrosine phosphatase, non-receptor type 22 (isoform 1) | Q9Y2R2 | Cancer | Diabetes | |||
| Protein-tyrosine phosphatase, non-receptor type 22 (isoform 2) | Q9Y2R2 | Cancer | Diabetes | |||
| Protein-tyrosine-phosphatase | P9WIA1 | | Cancer | Tuberculosis | ||
| Protein/nucleic acid deglycase DJ-1 | Q99497 | | Cancer Diabetes | |||
| Proteinase-activated receptor 1 | P25116 | | Cancer | Tuberculosis | ||
| Proteinase-activated receptor 2 (PAR-2) precursor | P55085 | Cancer | ||||
| Proteinase-activated receptor 4 | Q96RI0 | | Cancer | |||
| Prothrombin preproprotein | P00734 | | Diabetes | Cancer Leishmaniasis | ||
| Proto-oncogene c-Fos | P01100 | | Cancer | |||
| Proto-oncogene c-Rel | Q04864 | Cancer Diabetes | ||||
| Proto-oncogene Mas | P04201 | Cancer | ||||
| Proto-oncogene tyrosine-protein kinase receptor Ret (isoform 2) | P07949 | | Cancer | |||
| Proto-oncogene tyrosine-protein kinase receptor Ret (isoform 4) | P07949 | | Cancer | |||
| Proto-oncogene tyrosine-protein kinase ROS | P08922 | Cancer | ||||
| Proto-oncogene tyrosine-protein kinase Src | P12931 | Cancer | Diabetes | |||
| Proto-oncogene vav | P15498 | Cancer | ||||
| Proton-coupled folate transporter | Q96NT5 | Cancer | ||||
| PRPS2 variant 1 | Cancer | |||||
| PRPS2 variant 2 | Cancer | |||||
| PRV1 | Cancer | |||||
| PSMD10 variant 1 | Cancer | |||||
| PTEN (isoform 3) | P60484 | Cancer Diabetes | ||||
| PTEN (isoform PTEN) | P60484 | Cancer Diabetes | ||||
| PTEN (isoform PTEN-L) | P60484 | Cancer Diabetes | ||||
| PTEN variant 1 | Cancer | |||||
| PTEN variant 2 | Cancer | |||||
| PTGS2 | Cancer | |||||
| PTK2 variant 1 | Cancer | |||||
| PTK2 variant 2 | Cancer | |||||
| PTK2B variant 1 | Cancer | |||||
| PTK2B variant 2 | Cancer | |||||
| PTN | Cancer | |||||
| PTPN1 | Diabetes | Cancer | ||||
| PUM3 | Cancer | |||||
| Purine-nucleoside phosphorylase | P00491 | | Cancer | Schistosomiasis | ||
| Purinergic receptor P2Y11 | Q96G91 | Cancer Diabetes | ||||
| Puromycin-sensitive aminopeptidase | P55786 | Cancer | ||||
| Putative hydrolase RBBP9 | O75884 | Cancer | ||||
| Putative secreted protein-tyrosine phosphatase | O68720 | Cancer Diabetes | ||||
| PYCR1 variant 1 | Cancer | |||||
| PYCR1 variant 2 | Cancer | |||||
| Pygopus homolog 2 | Q9BRQ0 | Cancer | ||||
| Pyruvate Dehydrogenase Complex | Cancer | Diabetes | ||||
| Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial | P29803 | Cancer | Diabetes | |||
| Pyruvate dehydrogenase E1 component subunit beta, mitochondrial precursor (isoform 1) | P11177 | | Cancer | Diabetes | ||
| Pyruvate dehydrogenase kinase (nonspecified subtype) | Cancer Diabetes | Tuberculosis | ||||
| Pyruvate kinase | Q6GG09 | | Cancer | |||
| Pyruvate kinase PKLR (isoform 1) | P30613 | Cancer | ||||
| Pyruvate kinase PKLR (isoform 2) | P30613 | Cancer | ||||
| Pyruvate kinase PKM (isoform a) | P14618 | | Cancer | |||
| Pyruvate kinase PKM (isoform b) | P14618 | Cancer | ||||
| Pyruvate kinase PKM (isoform c) | P14618 | Cancer | ||||
| R-spondin-3 | Q9BXY4 | Cancer | ||||
| RAB23 variant 1 | Cancer | |||||
| RAC-alpha serine/threonine-protein kinase | P31749 | | Cancer | Diabetes | ||
| RAC-beta serine/threonine-protein kinase (isoform 1) | P31751 | | Cancer | Diabetes | ||
| RAC-beta serine/threonine-protein kinase (isoform 2) | P31751 | | Cancer | Diabetes | ||
| RAC-gamma serine/threonine-protein kinase (isoform 1) | Q9Y243 | Cancer | Diabetes | |||
| RAC-gamma serine/threonine-protein kinase (isoform 2) | Q9Y243 | Cancer | Diabetes | |||
| RAD51 variant 1 | Cancer | |||||
| RAD51 variant 2 | Cancer | |||||
| RAD51 variant 4 | Cancer | |||||
| RAD9A | Cancer | |||||
| Raf kinase (nonspecified subtype) | Cancer | |||||
| RAF proto-oncogene serine/threonine-protein kinase | P04049 | | Cancer | |||
| RAF1 | Cancer | |||||
| Rap guanine nucleotide exchange factor 4 (isoform 1) | Q8WZA2 | Cancer | ||||
| Rap guanine nucleotide exchange factor 4 (isoform 2) | Q8WZA2 | Cancer | ||||
| RAP guanine-nucleotide-exchange factor 3 | O95398 | Cancer | ||||
| Ras GTPase (nonspecified subtype) | Cancer | Diabetes | ||||
| Ras guanyl-releasing protein 3 (isoform 1) | Q8IV61 | Cancer | ||||
| Ras-related C3 botulinum toxin substrate 1 (isoform Rac1) | P63000 | | Cancer | |||
| Ras-related C3 botulinum toxin substrate 1 (isoform Rac1b) | P63000 | Cancer | ||||
| Ras-related GTP-binding protein D | Q9NQL2 | Cancer | ||||
| Ras-related protein Rab-25 | P57735 | Cancer | ||||
| Ras-related protein Rab-7a | P51149 | | Cancer | |||
| Ras-related protein Ral-A | P11233 | | Cancer | |||
| Ras-related protein Ral-B | P11234 | Cancer | ||||
| RBBP4 | Cancer | |||||
| RBM47 variant 1 | Cancer | |||||
| RBM47 variant 2 | Cancer | |||||
| Receptor tyrosine-protein kinase erbB-2 (isoform a) | P04626 | | Cancer | |||
| Receptor tyrosine-protein kinase erbB-2 (isoform b) | P04626 | | Cancer | |||
| Receptor tyrosine-protein kinase erbB-2 (isoform d) | P04626 | | Cancer | |||
| Receptor tyrosine-protein kinase erbB-3 (isoform 1) | P21860 | | Cancer | |||
| Receptor tyrosine-protein kinase erbB-4 (isoform JM-a/CVT-1) | Q15303 | | Cancer | |||
| Receptor tyrosine-protein kinase erbB-4 (isoform JM-a/CVT-2) | Q15303 | | Cancer | |||
| Receptor-interacting serine-threonine kinase 2 | O43353 | Cancer Diabetes | ||||
| Receptor-interacting serine/threonine-protein kinase 1 | Q13546 | Cancer | ||||
| Receptor-type tyrosine-protein kinase FLT3 | P36888 | | Cancer | Diabetes | ||
| Receptor-type tyrosine-protein phosphatase beta (isoform a) | P23467 | Cancer | ||||
| Receptor-type tyrosine-protein phosphatase C (isoform 1) | P08575 | Cancer | Diabetes | |||
| Receptor-type tyrosine-protein phosphatase C (isoform 2) | P08575 | | Cancer | Diabetes | ||
| Receptor-type tyrosine-protein phosphatase C (isoform 5) | P08575 | Cancer | Diabetes | |||
| Receptor-type tyrosine-protein phosphatase S precursor (isoform 1) | Q13332 | Cancer Diabetes | ||||
| RECK variant 1 | Cancer | |||||
| RECK variant 2 | Cancer | |||||
| RECQL variant 1 | Cancer | |||||
| REL | Cancer | |||||
| RELA variant 1 | Cancer | |||||
| RELA variant 2 | Cancer | |||||
| RELB | Cancer | |||||
| Renalase (isoform 1) | Q5VYX0 | Cancer | ||||
| Renalase (isoform 2) | Q5VYX0 | Cancer | ||||
| Renalase (isoform XI) | Q5VYX0 | Cancer | ||||
| Renin | P00797 | | Cancer Diabetes | |||
| Renin receptor | O75787 | Cancer | ||||
| Replication Protein A Complex (RPA) | Cancer | |||||
| Resistin | Q9HD89 | Cancer Diabetes | ||||
| Reticulon-4 (isoform 1) | Q9NQC3 | | Cancer | |||
| Reticulon-4 (isoform 2) | Q9NQC3 | | Cancer | |||
| Reticulon-4 (isoform 4) | Q9NQC3 | Cancer | ||||
| Retinal dehydrogenase 1 | P00352 | Cancer | ||||
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | O43924 | | Cancer | Diabetes | Epilepsy | |
| Retinoic acid receptor alpha (isoform 1) | P10276 | | Cancer | |||
| Retinoic acid receptor beta (isoform 1) | P10826 | | Cancer | |||
| Retinoic acid receptor beta (isoform 2) | P10826 | Cancer | ||||
| Retinoic acid receptor beta (isoform 3) | P10826 | Cancer | ||||
| Retinoic acid receptor gamma (isoform 1) | P13631 | | Cancer | |||
| Retinoic acid receptor RXR-alpha (isoform a) | P19793 | | Cancer | Diabetes | ||
| Retinoid acid receptor (nonspecified subtype) | Cancer | |||||
| Retinoid RXR receptor (nonspecified subtype) | Cancer | Diabetes | ||||
| Retinoid RXRbeta receptor | P28702 | Cancer Diabetes | ||||
| Retinoid RXRgamma receptor | P48443 | Diabetes | Cancer | |||
| Retinol dehydrogenase 10 | Q8IZV5 | Cancer | ||||
| REV1 variant 1 | Cancer | |||||
| REV3L | Cancer | |||||
| REV3L variant 2 | Cancer | |||||
| Reverse transcriptase (Telomerase) | Cancer | Diabetes Tuberculosis | ||||
| RHCG | Cancer | |||||
| Rho GTPase (nonspecified subtype) | Cancer | Diabetes | ||||
| Rho guanine nucleotide exchange factor (GEF) 12 (isoform 1) | Q9NZN5 | Cancer | ||||
| Rho guanine nucleotide exchange factor 12 (isoform 2) | Q9NZN5 | | Cancer | |||
| Rho guanine nucleotide exchange factor 4 (isoform a) | Q9NR80 | Cancer | ||||
| Rho guanine nucleotide exchange factor 4 (isoform b) | Q9NR80 | | Cancer | |||
| Rho kinase (ROCK) (nonspecified subtype) | Cancer Diabetes | |||||
| Rho-associated protein kinase 1 (ROCK1) | Q13464 | Cancer | ||||
| Rho-associated protein kinase 2 (isoform X1) | O75116 | Cancer | Malaria | |||
| Rho-associated protein kinase 2 (ROCK2) | O75116 | Cancer | Malaria | |||
| Rho-related GTP-binding protein RhoC | P08134 | | Cancer | |||
| RHOA | Cancer | |||||
| RHOC variant 1 | Cancer | |||||
| RHOC variant 2 | Cancer | |||||
| Ribonuclease P Complex | Cancer | |||||
| Ribonuclease P protein subunit p14 | O95059 | Cancer | ||||
| Ribonuclease P protein subunit p30 (isoform a) | P78346 | Cancer | ||||
| Ribonucleoside-diphosphate reductase | Cancer | |||||
| Ribonucleoside-diphosphate reductase large subunit | P23921 | Cancer | ||||
| Ribose-phosphate diphosphokinase 1 | P60891 | Cancer | ||||
| Ribose-phosphate pyrophosphokinase 2 (isoform 2) | P11908 | Cancer | ||||
| Ribosomal protein S6 kinase alpha-1 | Q15418 | Cancer Diabetes | ||||
| Ribosomal protein S6 kinase alpha-3 | P51812 | Cancer Diabetes | ||||
| Ribosomal protein S6 kinase alpha-4 (isoform 1) | O75676 | Cancer Diabetes | ||||
| Ribosomal protein S6 kinase alpha-4 (isoform 2) | O75676 | Cancer Diabetes | ||||
| Ribosomal protein S6 kinase alpha-6 | Q9UK32 | Cancer | ||||
| Ribosomal protein S6 kinase beta-1 | P23443 | Cancer | Diabetes | |||
| Ribosomal protein S6 kinase beta-1 (isoform e) | P23443 | | Cancer Diabetes | |||
| Ribosomal Protein S6 Kinase, 70kDa (p70S6K) (nonspecified subtype) | Cancer | Diabetes | ||||
| Ribosomal Protein S6 Kinase, 90kDa (nonspecified subtype) | Cancer | |||||
| Ribosyldihydronicotinamide dehydrogenase [quinone] | P16083 | | Cancer Diabetes Malaria | |||
| RIOK2 variant 1 | Cancer | |||||
| RIOK2 variant 2 | Cancer | |||||
| RNA polymerase (viral) | Cancer | |||||
| RNA-binding protein EWS (isoform 1) | Q01844 | Cancer | ||||
| RNA-binding protein EWS (isoform 2) | Q01844 | Cancer | ||||
| RNA-binding protein EWS (isoform 3) | Q01844 | Cancer | ||||
| RNA-binding protein EWS (isoform 4) | Q01844 | Cancer | ||||
| RNA-binding protein Musashi homolog 1 | O43347 | Cancer | ||||
| Roundabout homolog 1 (isoform 1) | Q9Y6N7 | Cancer | ||||
| Roundabout homolog 4, magic roundabout | Q8WZ75 | Cancer | ||||
| RPL21 | Cancer | |||||
| RPL31 variant 1 | Cancer | |||||
| RPL31 variant 2 | Cancer | |||||
| RPL39 | Cancer | |||||
| RPN2 variant 1 | Cancer | |||||
| RPRD1B | Cancer | |||||
| RPS6KA5 variant 1 | Cancer | |||||
| RPS6KB1 variant 1 | Cancer | |||||
| RRM1 | Cancer | |||||
| RRM2 variant 2 | Cancer | |||||
| RSL1D1 | Cancer | |||||
| Runt-related transcription factor 1 (isoform a) | Q01196 | | Cancer | Diabetes | ||
| Runt-related transcription factor 1 (isoform AML1a) | Q01196 | | Cancer | Diabetes | ||
| Runt-related transcription factor 1 (isoform b) | Q01196 | Cancer | Diabetes | |||
| Runt-related transcription factor 2 (isoform 1) | Q13950 | | Cancer | Diabetes | ||
| Runt-related transcription factor 2 (isoform 2) | Q13950 | Cancer | Diabetes | |||
| Runt-related transcription factor 2 (isoform 3) | Q13950 | Cancer | Diabetes | |||
| Runt-related transcription factor 2 (isoform X11) | Q13950 | | Cancer | Diabetes | ||
| Runt-related transcription factor 3 | Q13761 | Cancer | Diabetes | |||
| Runt-related transcription factor 3 (isoform 1) | Q13761 | Cancer | Diabetes | |||
| RUNX2 | Cancer | |||||
| RUNX2 variant 1 | Cancer | |||||
| RUNX2 variant 3 | Cancer | |||||
| RUNX2 variant X11 | Cancer | |||||
| RuvB-like 1 | Q9Y265 | | Cancer | |||
| RuvB-like 2 | Q9Y230 | Cancer | ||||
| Ryanodine receptor 2 | Q92736 | Cancer | ||||
| S-adenosylmethionine decarboxylase proenzyme (isoform 1) | P17707 | | Cancer | |||
| S-adenosylmethionine synthase isoform type-2 | P31153 | Cancer | ||||
| S-Methyl-5-thioadenosine phosphorylase | Q13126 | | Cancer | |||
| S-phase kinase-associated protein 2 (isoform 1) | Q13309 | | Cancer | |||
| S-phase kinase-associated protein 2 (isoform 2) | Q13309 | | Cancer | |||
| S-phase kinase-associated protein 2 (isoform 3) | Q13309 | | Cancer | |||
| S100 Calcium Binding Protein (nonspecified subtype) | Cancer | |||||
| Sal-like protein 4 | Q9UJQ4 | Cancer | ||||
| SALL4 | Cancer | |||||
| Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA) (nonspecified subtype) | Cancer | Diabetes | ||||
| SATB1 | Cancer | |||||
| Scavenger receptor class B member 1 (isoform 1) | Q8WTV0 | Cancer | ||||
| Scavenger receptor class B member 1 (isoform 2) | Q8WTV0 | Cancer | ||||
| Secreted frizzled-related protein 2 | Q96HF1 | Cancer | ||||
| Secretogranin-3 | Q8WXD2 | Cancer | ||||
| SEMA3C | Cancer | |||||
| SEMA3D | Cancer | |||||
| SEMA4C | Cancer | |||||
| Semaphorin-4D (isoform 1) | Q92854 | Cancer | ||||
| Semaphorin-4D (isoform 2) | Q92854 | | Cancer | |||
| SENP1 | Cancer | |||||
| Sentrin-specific protease 1 | Q9P0U3 | Cancer | ||||
| Sentrin-specific protease 2 | Q9HC62 | | Cancer | |||
| Sentrin-specific protease 5 | Q96HI0 | Cancer | ||||
| Sentrin-specific protease 7 (isoform 1) | Q9BQF6 | Cancer | ||||
| Sentrin-specific protease 7 (isoform 2) | Q9BQF6 | Cancer | ||||
| Serine hydroxymethyltransferase, cytosolic | P34896 | Cancer | ||||
| Serine hydroxymethyltransferase, mitochondrial (isoform 1) | P34897 | Cancer | ||||
| Serine palmitoyltransferase | Cancer Diabetes | |||||
| Serine protease (nonspecified subtype) | Cancer | Diabetes | ||||
| Serine protease hepsin | P05981 | Cancer | ||||
| Serine-protein kinase ATM (isoform 2) | Q13315 | Cancer | ||||
| Serine/Threonine Kinase (nonspecified subtype) | Cancer | Diabetes | ||||
| Serine/threonine kinase 17A | Q9UEE5 | Cancer | ||||
| Serine/threonine kinase 17B | O94768 | Cancer Diabetes | ||||
| Serine/threonine-protein kinase (PAK) (nonspecified subtype) | Cancer | |||||
| Serine/threonine-protein kinase 32C | Q86UX6 | Cancer | ||||
| Serine/threonine-protein kinase 33 (isoform 1) | Q9BYT3 | Cancer | ||||
| Serine/threonine-protein kinase 33 (isoform 2) | Q9BYT3 | Cancer | ||||
| Serine/threonine-protein kinase 4 | Q13043 | Cancer Diabetes | ||||
| Serine/threonine-protein kinase A-Raf (isoform 1) | P10398 | Cancer | ||||
| Serine/threonine-protein kinase ATR (isoform 1) | Q13535 | Cancer | ||||
| Serine/threonine-protein kinase ATR (isoform 2) | Q13535 | Cancer | ||||
| Serine/threonine-protein kinase B-raf (isoform 1) | P15056 | | Cancer | |||
| Serine/threonine-protein kinase B-raf (isoform 2) | P15056 | Cancer | ||||
| Serine/threonine-protein kinase Chk1 (isoform 1) | O14757 | | Cancer | Diabetes | ||
| Serine/threonine-protein kinase Chk2 (isoform 1) | O96017 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase Chk2 (isoform 3) | O96017 | | Cancer | Diabetes | ||
| Serine/threonine-protein kinase Chk2 (isoform 5) | O96017 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase D1 | Q15139 | Cancer | ||||
| Serine/threonine-protein kinase D2 (isoform 1) | Q9BZL6 | Cancer | ||||
| Serine/threonine-protein kinase D2 (isoform 3) | Q9BZL6 | Cancer | ||||
| Serine/threonine-protein kinase D3 | O94806 | Cancer | ||||
| Serine/threonine-protein kinase DCLK1 | O15075 | Cancer | ||||
| Serine/threonine-protein kinase greatwall (GWL) | Q96GX5 | Cancer | ||||
| Serine/threonine-protein kinase MRCK alpha (isoform B) | Q5VT25 | Cancer | ||||
| Serine/threonine-protein kinase MRCK beta | Q9Y5S2 | Cancer | ||||
| Serine/threonine-protein kinase mTOR | P42345 | | Cancer Epilepsy | Diabetes | ||
| Serine/threonine-protein kinase Nek1 | Q96PY6 | Cancer | ||||
| Serine/threonine-protein kinase Nek2 (isoform 1) | P51955 | | Cancer | |||
| Serine/threonine-protein kinase PAK 1 (isoform 1) | Q13153 | | Cancer | |||
| Serine/threonine-protein kinase PAK 1 (isoform 2) | Q13153 | | Cancer | |||
| Serine/threonine-protein kinase PAK 2 | Q13177 | Cancer | ||||
| Serine/threonine-protein kinase PAK 4 (isoform 1) | O96013 | | Cancer | |||
| Serine/threonine-protein kinase PAK 4 (isoform 2) | O96013 | | Cancer | |||
| Serine/threonine-protein kinase PAK 6 | Q9NQU5 | Cancer | ||||
| Serine/threonine-protein kinase PAK 7 | Q9P286 | Cancer | ||||
| Serine/threonine-protein kinase pim-1 (isoform 1) | P11309 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase pim-1 (isoform 44kDa) | P11309 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase pim-2 | Q9P1W9 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase pim-3 | Q86V86 | Cancer | Diabetes | |||
| Serine/Threonine-Protein Kinase PLK (nonspecified subtype) | Cancer | |||||
| Serine/threonine-protein kinase PLK1 | P53350 | | Cancer | Epilepsy | Diabetes | |
| Serine/threonine-protein kinase PLK2 | Q9NYY3 | Cancer | ||||
| Serine/threonine-protein kinase PLK3 | Q9H4B4 | Cancer | ||||
| Serine/threonine-protein kinase PLK4 | O00444 | Cancer | ||||
| Serine/threonine-protein kinase receptor R3 | P37023 | Cancer | ||||
| Serine/threonine-protein kinase RIO2 (isoform 1) | Q9BVS4 | Cancer | ||||
| Serine/threonine-protein kinase RIO2 (isoform 2) | Q9BVS4 | Cancer | ||||
| Serine/threonine-protein kinase Sgk1 (isoform 1) | O00141 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase Sgk1 (isoform 2) | O00141 | | Cancer | Diabetes | ||
| Serine/threonine-protein kinase Sgk1 (isoform 3) | O00141 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase Sgk1 (isoform 4) | O00141 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase Sgk2 | Q9HBY8 | Cancer Diabetes | ||||
| Serine/threonine-protein kinase Sgk3 | Q96BR1 | Cancer | ||||
| Serine/threonine-protein kinase SIK1 | P57059 | Cancer | ||||
| Serine/threonine-protein kinase SIK2 | Q9H0K1 | Cancer | Diabetes | |||
| Serine/threonine-protein kinase SIK3 | Q9Y2K2 | Cancer | ||||
| Serine/threonine-protein kinase TAO2 (isoform 1) | Q9UL54 | Cancer | ||||
| Serine/threonine-protein kinase TAO2 (isoform 3) | Q9UL54 | Cancer | ||||
| Serine/threonine-protein kinase TBK1 | Q9UHD2 | | Cancer Diabetes | |||
| Serine/threonine-protein kinase tousled-like 2 (isoform A) | Q86UE8 | Cancer | ||||
| Serine/threonine-protein kinase ULK1 | O75385 | Cancer | ||||
| Serine/threonine-protein kinase ULK2 | Q8IYT8 | Cancer | ||||
| Serine/threonine-protein kinase/endoribonuclease IRE1 | O75460 | Cancer Diabetes | ||||
| Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | P16298 | | Diabetes | Cancer | ||
| Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform | P48454 | Diabetes | Cancer | |||
| SERPINA1 variant 1 | Cancer | |||||
| SERPINA1 variant 2 | Cancer | |||||
| SERPINA1 variant 3 | Cancer | |||||
| SERPINH1 | Cancer | |||||
| Serum albumin | P02768 | | Cancer | |||
| SEZ6L2 variant 1 | Cancer | |||||
| SEZ6L2 variant 2 | Cancer | |||||
| SFRS protein kinase 1 | Q96SB4 | Cancer | ||||
| SHMT1 variant 1 | Cancer | |||||
| Short transient receptor potential channel 5 | Q9UL62 | Cancer | Epilepsy | |||
| Short transient receptor potential channel 6 | Q9Y210 | Cancer | Diabetes | |||
| Sialic acid-binding Ig-like lectin 15 | Q6ZMC9 | Cancer | ||||
| Sialic acid-binding Ig-like lectin 7 (isoform 1) | Q9Y286 | | Cancer | |||
| Sialic acid-binding Ig-like lectin 7 (isoform 3) | Q9Y286 | | Cancer | |||
| Sialidase-3 | Q9UQ49 | Cancer Diabetes | ||||
| Sialoadhesin | Q9BZZ2 | Cancer | ||||
| Sialyltransferase (nonspecified subtype) | Cancer | |||||
| Sigma non-opioid intracellular receptor 1 (isoform 1) | Q99720 | Cancer | Epilepsy | Leishmaniasis | ||
| Sigma non-opioid intracellular receptor 1 (isoform 2) | Q99720 | Cancer | Epilepsy | |||
| Sigma non-opioid intracellular receptor 1 (isoform 6) | Q99720 | Cancer | Epilepsy | |||
| sigma Receptor (nonspecified subtype) | Cancer | Epilepsy | ||||
| Signal peptide, CUB and EGF-like domain-containing protein 2 (isoform 1) | Q9NQ36 | Cancer | ||||
| Signal peptide, CUB and EGF-like domain-containing protein 2 (isoform 3) | Q9NQ36 | Cancer | ||||
| Signal transducer and activator of transcription 1-alpha/beta | P42224 | Cancer | ||||
| Signal transducer and activator of transcription 3 (isoform 1) | P40763 | | Cancer Diabetes | Schistosomiasis Tuberculosis | ||
| Signal transducer and activator of transcription 3 (isoform 2) | P40763 | | Cancer Diabetes | Schistosomiasis Tuberculosis | ||
| Signal transducer and activator of transcription 3 (isoform 3) | P40763 | | Cancer Diabetes | Schistosomiasis Tuberculosis | ||
| Signal transducer and activator of transcription 5B | P51692 | Cancer | ||||
| Signal transducer and activator of transcription 6 (isoform 1) | P42226 | Cancer | ||||
| Signal transducer and activator of transcription 6 (isoform 2) | P42226 | | Cancer | |||
| Signal transducer CD24 | P25063 | Cancer | ||||
| Signal-regulatory protein gamma (isoform 1) | Q9P1W8 | Cancer | ||||
| Signal-regulatory protein gamma (isoform 2) | Q9P1W8 | Cancer | ||||
| SKP2 variant 1 | Cancer | |||||
| SKP2 variant 2 | Cancer | |||||
| SKP2 variant 3 | Cancer | |||||
| SLC1A5 variant 1 | Cancer | |||||
| SLC1A5 variant 2 | Cancer | |||||
| SLC1A5 variant X1 | Cancer | |||||
| SLC25A5 | Cancer | |||||
| SLC38A7 | Cancer | |||||
| SLC7A5 | Cancer | |||||
| SLC9A3R1 | Cancer | |||||
| SLCO1B3 variant 1 | Cancer | |||||
| Small Conductance Calcium-Activated Potassium Channel (SK) (nonspecified subtype)S | Cancer Diabetes Epilepsy | |||||
| Small conductance calcium-activated potassium channel protein 2 (isoform a) | Q9H2S1 | Cancer Diabetes Epilepsy | ||||
| Small conductance calcium-activated potassium channel protein 3 (isoform a) | Q9UGI6 | Cancer Diabetes Epilepsy | ||||
| Small ubiquitin-related modifier 1 (isoform a) | P63165 | | Cancer | |||
| Smoothened homolog | Q99835 | | Cancer | Diabetes | ||
| SMYD3 variant 1 | Cancer | |||||
| SMYD3 variant 2 | Cancer | |||||
| SNTB2 | Cancer | |||||
| SOCS1 | Cancer | |||||
| Sodium channel (nonspecified subtype) | Cancer Epilepsy | Diabetes | Malaria | |||
| Sodium channel protein type 1 subunit alpha (isoform 1) | P35498 | Epilepsy | ||||
| Sodium channel protein type 1 subunit alpha (isoform 2) | P35498 | Epilepsy | ||||
| Sodium channel protein type 2 subunit alpha (Nav1.2) (isoform 1) | Q99250 | Epilepsy | ||||
| Sodium channel protein type 5 subunit alpha (Nav1.5) (isoform 1) | Q14524 | | Cancer Diabetes Epilepsy | |||
| Sodium channel protein type 5 subunit alpha (Nav1.5) (isoform 2) | Q14524 | | Cancer Diabetes Epilepsy | |||
| Sodium channel protein type 5 subunit alpha (Nav1.5) (isoform 3) | Q14524 | | Cancer Diabetes Epilepsy | |||
| Sodium channel protein type 5 subunit alpha (Nav1.5) (isoform 4) | Q14524 | | Cancer Diabetes Epilepsy | |||
| Sodium channel protein type 5 subunit alpha (Nav1.5) (isoform 6) | Q14524 | Cancer Diabetes Epilepsy | ||||
| Sodium channel protein type 9 subunit alpha (Nav1.7) | Q15858 | Cancer Epilepsy | Diabetes | |||
| Sodium- and chloride-dependent creatine transporter 1 | P48029 | Cancer | ||||
| Sodium- and chloride-dependent GABA transporter 1 | P30531 | Epilepsy | Cancer Malaria | |||
| Sodium-dependent dopamine transporter | Q01959 | Diabetes | Epilepsy | Cancer | ||
| Sodium-dependent noradrenaline transporter (isoform 1) | P23975 | Cancer Diabetes | Epilepsy | |||
| Sodium-dependent noradrenaline transporter (isoform 2) | P23975 | Cancer Diabetes | Epilepsy | |||
| Sodium-dependent Phosphate Transport Protein 2B | O95436 | Cancer | ||||
| Sodium-dependent serotonin transporter | P31645 | Diabetes | Epilepsy | Cancer | ||
| Sodium-Glucose Cotransporter (SGLT) (nonspecified subtype) | Diabetes | Cancer | ||||
| Sodium/glucose cotransporter 1 (SGLT-1) | P13866 | Diabetes | Cancer | |||
| Sodium/glucose cotransporter 2 (SGLT-2) | P31639 | Diabetes | Cancer | |||
| Sodium/hydrogen exchanger 1 (NHE-1) | P19634 | | Cancer Diabetes | |||
| Sodium/iodide cotransporter | Q92911 | Cancer | ||||
| Soluble epoxide hydrolase (SEH) | P34913 | | | Cancer | Diabetes | Epilepsy Tuberculosis |
| Soluble guanylyl cyclase | Cancer | Diabetes | ||||
| Solute carrier family 2, facilitated glucose transporter member 1 | P11166 | Cancer Diabetes | ||||
| Solute carrier family 2, facilitated glucose transporter member 3 | P11169 | Cancer | ||||
| Solute carrier family 2, facilitated glucose transporter member 4 | P14672 | Cancer | ||||
| Solute carrier family 2, facilitated glucose transporter member 5 (isoform 1) | P22732 | Cancer Diabetes | ||||
| Solute carrier family 2, facilitated glucose transporter member 8 (isoform 1) | Q9NY64 | Cancer | ||||
| Solute carrier family 22 member 12 (isoform 1) | Q96S37 | Diabetes | Cancer | |||
| Solute carrier family 22 member 12 (isoform 3) | Q96S37 | Diabetes | Cancer | |||
| Solute carrier family 28 member 3 | Q9HAS3 | Cancer | ||||
| Solute carrier family 29 member (nonspecified subtype) | Cancer | |||||
| Somatostatin preproprotein | P61278 | Cancer | Diabetes | |||
| Somatostatin receptor (nonspecified subtype) | Cancer | Diabetes | ||||
| Somatostatin receptor type 1 | P30872 | Cancer | Diabetes | |||
| Somatostatin receptor type 2 | P30874 | Cancer | Diabetes | |||
| Somatostatin receptor type 3 | P32745 | Cancer | Diabetes | Epilepsy | ||
| Somatostatin receptor type 4 | P31391 | Cancer | Diabetes | |||
| Somatostatin Receptor Type 5 Receptor | P35346 | Cancer | Diabetes | |||
| Somatotropin precursor (isoform 1) | P01241 | | Cancer | Diabetes | ||
| Sonic hedgehog protein | Q15465 | Cancer | ||||
| Sorbitol dehydrogenase | Q00796 | | Cancer | |||
| SOX4 | Cancer | |||||
| Sp1 transcription factor | P08047 | Cancer | ||||
| SPECC1L | Cancer | |||||
| Speckle-type POZ protein | O43791 | | Cancer | |||
| Spermidine synthase | P19623 | | Cancer | |||
| Sphingolipid delta(4)-desaturase DES1 | O15121 | Cancer | Diabetes | |||
| Sphingomyelin phosphodiesterase (isoform 1) | P17405 | Cancer | Diabetes | |||
| Sphingomyelin phosphodiesterase (isoform 2) | P17405 | Cancer | Diabetes | |||
| Sphingomyelin phosphodiesterase 2 | O60906 | Cancer Diabetes | ||||
| Sphingomyelin phosphodiesterase 3 | Q9NY59 | Cancer | ||||
| Sphingosine 1-phosphate receptor 1 | P21453 | | Cancer | Diabetes | ||
| Sphingosine 1-phosphate receptor 2 | O95136 | Cancer | Diabetes | |||
| Sphingosine 1-phosphate receptor 4 | O95977 | Cancer | ||||
| Sphingosine 1-phosphate receptor 5 | Q9H228 | Cancer Diabetes | ||||
| Sphingosine kinase (SPK; SphK) (nonspecified subtype) | Cancer | Diabetes | ||||
| Sphingosine kinase 1 (SPK1) (long isoform) | Q9NYA1 | Cancer | ||||
| Sphingosine kinase 2 (SPK2) | Q9NRA0 | Cancer | ||||
| Spindlin-1 | Q9Y657 | Cancer | ||||
| Splicing factor 3B protein complex | Cancer | |||||
| Splicing factor 3B subunit 1 (isoform 1) | O75533 | | Cancer | |||
| Splicing factor 45 | Q96I25 | Cancer | ||||
| SPP1 variant 1 | Cancer | |||||
| SPP1 variant 2 | Cancer | |||||
| SPP1 variant 3 | Cancer | |||||
| SPP1 variant 5 | Cancer | |||||
| SPRY2 | Cancer | |||||
| SPRY2 variant 3 | Cancer | |||||
| Squalene synthase (isoform 1) | P37268 | Cancer | Diabetes | |||
| Squalene synthase (isoform 2) | P37268 | | Cancer | Diabetes | ||
| SRSF3 variant 1 | Cancer | |||||
| ST6GAL1 variant 1 | Cancer | |||||
| STAT3 variant 1 | Cancer | |||||
| STAT3 variant 2 | Cancer | |||||
| STAT3 variant 3 | Cancer | |||||
| STAT5 (nonspecified subtype) | Cancer | |||||
| STAT6 variant 1 | Schistosomiasis | Cancer | ||||
| STAT6 variant 2 | Schistosomiasis | Cancer | ||||
| STAT6 variant 3 | Schistosomiasis | Cancer | ||||
| STAT6 variant 4 | Schistosomiasis | Cancer | ||||
| STAT6 variant 5 | Schistosomiasis | Cancer | ||||
| Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | Cancer | Diabetes | |||
| Steroid 5-alpha-Reductase (nonspecified subtype) | Cancer | Diabetes | ||||
| Steroid hormone receptor ERR1 (isoform 2) | P11474 | | Cancer Diabetes | |||
| Sterol 14-alpha demethylase | Q7Z1V1 | | Leishmaniasis | Cancer Malaria Tuberculosis | ||
| Sterol O-acyltransferase (ACAT) (nonspecified subtype) | Cancer | Diabetes | Epilepsy | |||
| Sterol O-acyltransferase 1 (ACAT-1) (isoform 1) | P35610 | Cancer | Diabetes | |||
| Sterol O-acyltransferase 1 (ACAT-1) (isoform 2) | P35610 | Cancer | Diabetes | |||
| Sterol O-acyltransferase 2 | O75908 | Cancer Diabetes | ||||
| Sterol Regulatory Element-Binding Protein (nonspecified subtype) | Cancer | Diabetes | ||||
| Steryl-sulfatase | P08842 | Cancer | Diabetes | |||
| Stimulator of interferon genes protein | Q86WV6 | Cancer | Diabetes | |||
| STMN1 variant 1 | Cancer | |||||
| STMN1 variant 2 | Cancer | |||||
| STMN1 variant 3 | Cancer | |||||
| STMN1 variant 4 | Cancer | |||||
| Stromal cell-derived factor 1 (isoform 1) | P48061 | | Cancer | |||
| Stromal cell-derived factor 1 (isoform 2) | P48061 | | Cancer | |||
| Stromal cell-derived factor 1 (isoform 4) | P48061 | | Cancer | |||
| Stromal cell-derived factor 1 precursor (isoform gamma) | P48061 | Cancer | ||||
| Stromelysin-1 (MMP-3) | P08254 | | | Cancer | Diabetes Tuberculosis | |
| Stromelysin-2 (MMP-10) | P09238 | Cancer | ||||
| Stromelysin-3 (MMP-11) | P24347 | Cancer | ||||
| Substance-K receptor | P21452 | Cancer | ||||
| Substance-P receptor (long isoform) | P25103 | | Cancer | Epilepsy | ||
| Substance-P receptor (short isoform) | P25103 | | Cancer | Epilepsy | ||
| Succinate Dehydrogenase Complex | Cancer | |||||
| Succinate receptor 1 | Q9BXA5 | Cancer | ||||
| SULF2 variant 1 | Cancer | |||||
| Sulfhydryl oxidase 1 (hQSOX) (isoform 1) | O00391 | Cancer Diabetes | ||||
| Sulfhydryl oxidase 1 (hQSOX) (isoform 2) | O00391 | | Cancer Diabetes | |||
| Sulfiredoxin-1 | Q9BYN0 | | Cancer | |||
| SULT2B1 variant 2 | Cancer | |||||
| SUMO activating enzyme complex | Cancer | |||||
| Superoxide dismutase (SOD) (nonspecified subtype) | Cancer | Diabetes | Leishmaniasis Malaria | |||
| Superoxide dismutase [Cu-Zn] | P00441 | | Cancer | |||
| Suppressor of cytokine signaling 3 | O14543 | Cancer | ||||
| Suppressor of tumorigenicity 14 protein | Q9Y5Y6 | | Cancer | |||
| Surface antigen (HBV) | Q89699 | Cancer | ||||
| Synaptic vesicular amine transporter | Q05940 | Cancer Diabetes | ||||
| Syndecan (nonspecified subtype) | Cancer | |||||
| Syndecan-1 | P18827 | Cancer | ||||
| Syntenin-1 | O00560 | | Cancer | |||
| T-cell antigen CD7 | P09564 | Cancer | ||||
| T-cell immunoglobulin and mucin domain containing 4 | Q96H15 | Cancer | ||||
| T-cell immunoreceptor with Ig and ITIM domains | Q495A1 | Cancer | ||||
| T-cell lymphoma invasion and metastasis 1 | Q13009 | Cancer | ||||
| T-cell surface glycoprotein CD1a | P06126 | | Cancer | |||
| T-cell surface glycoprotein CD3 epsilon chain | P07766 | | Cancer | |||
| T-cell surface glycoprotein CD4 (isoform 1) | P01730 | | Cancer | |||
| T-cell surface glycoprotein CD4 (isoform 2) | P01730 | Cancer | ||||
| T-cell surface glycoprotein CD5 | P06127 | Cancer | ||||
| T-cell surface glycoprotein CD8 alpha chain | P01732 | | Cancer | |||
| T-cell-specific surface glycoprotein CD28 (isoform 1) | P10747 | Cancer | ||||
| T-cell-specific surface glycoprotein CD28 (isoform 2) | P10747 | | Cancer | |||
| T-complex protein 1 subunit alpha | P17987 | Cancer | ||||
| T-lymphocyte activation antigen CD80 | P33681 | Diabetes | Cancer | |||
| T-lymphocyte activation antigen CD86 (isoform 1) | P42081 | Cancer Diabetes | ||||
| T-lymphocyte activation antigen CD86 (isoform 3) | P42081 | Cancer Diabetes | ||||
| T-lymphocyte activation antigen CD86 (isoform 4) | P42081 | | Cancer Diabetes | |||
| T-plasminogen activator (isoform 3) | P00750 | | Cancer | |||
| T-Type Calcium Channel | Cancer Epilepsy | Diabetes | ||||
| Tachykinin Receptor (nonspecified subtype) | Cancer | |||||
| Tankyrase (nonspecified subtype) | Cancer | |||||
| Tankyrase-1 | O95271 | Cancer | ||||
| Tankyrase-2 | Q9H2K2 | Cancer Diabetes | ||||
| TAR DNA-binding protein 43 | Q13148 | | Cancer | |||
| Tartrate-resistant acid phosphatase type 5 | P13686 | | Cancer | |||
| Tax1-binding protein 3 | O14907 | Cancer | ||||
| TAZ variant 1 | Cancer | |||||
| TAZ variant 2 | Cancer | |||||
| TCDD-inducible poly [ADP-ribose] polymerase (PARP-7) | Q7Z3E1 | Cancer | ||||
| TCRA | Cancer | |||||
| TDRG1 variant 1 | Cancer | |||||
| Telomerase reverse transcriptase (isoform 1) | O14746 | Cancer | Diabetes | |||
| Telomerase reverse transcriptase (isoform 2) | O14746 | Cancer | Diabetes Tuberculosis | |||
| Telomeric repeat binding factor 2, interacting protein 1 | Q9NYB0 | | Cancer | |||
| Telomeric repeat-binding factor 1 | P54274 | Cancer | ||||
| Telomeric repeat-binding factor 1 (isoform 2) | P54274 | | Cancer | |||
| Telomeric repeat-binding factor 2 | Q15554 | Cancer | ||||
| Tenascin | P24821 | Cancer | ||||
| Teneurin-4 | Q6N022 | Cancer | ||||
| TERC | Cancer | |||||
| TERT variant 1 | Cancer | Diabetes | ||||
| TERT variant 2 | Cancer | Diabetes | ||||
| Testis-specific serine/threonine-protein kinase 2 | Q96PF2 | Cancer | ||||
| Testosterone 17-beta-dehydrogenase 3 | P37058 | Cancer | Diabetes | |||
| TFIID Basal Transcription Factor Complex | Cancer | |||||
| TGF-beta receptor type-1 (isoform 1) | P36897 | | Cancer | Diabetes | ||
| TGF-beta receptor type-1 (isoform 2) | P36897 | | Cancer | Diabetes | ||
| TGF-beta receptor type-1 (isoform 3) | P36897 | | Cancer | Diabetes | ||
| TGF-beta receptor type-2 (isoform 1) | P37173 | | Cancer | |||
| TGF-beta receptor type-2 (isoform 2) | P37173 | | Cancer | |||
| TGFB1 | Cancer | |||||
| TGFB2 variant 1 | Cancer | |||||
| TGFB2 variant 2 | Cancer | |||||
| TGFBR2 variant 1 | Cancer | |||||
| TGFBR2 variant 2 | Cancer | |||||
| TGIF2 variant 2 | Cancer | |||||
| TH variant 1 | Cancer | |||||
| TH variant 2 | Cancer | |||||
| TH variant 3 | Cancer | |||||
| THBS1 | Cancer | |||||
| Thioredoxin | P10599 | | Cancer | Diabetes | Malaria Schistosomiasis | |
| Thioredoxin reductase 1, cytoplasmic (isoform 1) | Q16881 | | Cancer Diabetes | Leishmaniasis Malaria | ||
| Thioredoxin reductase 1, cytoplasmic (isoform 3) | Q16881 | | Cancer Diabetes | Leishmaniasis Malaria | ||
| Thioredoxin-disulfide reductase (TrxR) (nonspecified subtype) | Cancer | Diabetes | Malaria Schistosomiasis | |||
| Thomsen-Friedenreich Antigen (CD176) | Cancer | |||||
| Threonine aspartase 1 | Q9H6P5 | | Cancer | |||
| Threonine protease (nonspecified subtype) | Cancer | |||||
| Threonyl-tRNA synthetase | P26639 | Cancer Malaria | ||||
| Thromboxane A2 receptor (isoform alpha) | P21731 | Cancer | ||||
| Thromboxane A2 receptor (isoform beta) | P21731 | Cancer | ||||
| Thromboxane-A synthase (isoform 1) | P24557 | Cancer Diabetes | ||||
| Thromboxane-A synthase (isoform 3) | P24557 | Cancer Diabetes | ||||
| Thymidine kinase (HHV-1) | P03176 | | Cancer | |||
| Thymidine kinase 2, mitochondrial | O00142 | Cancer | ||||
| Thymidine kinase, cytosolic | P04183 | Cancer | ||||
| Thymidine phosphorylase (isoform 1) | P19971 | Cancer | ||||
| Thymidine phosphorylase (isoform 2) | P19971 | Cancer | ||||
| Thymidine phosphorylase (isoform 3) | P19971 | Cancer | ||||
| Thymidine phosphorylase (isoform 5) | P19971 | Cancer | ||||
| Thymidylate kinase | P23919 | | Cancer | |||
| Thymidylate synthase | P04818 | | Cancer | |||
| Thyroid hormone receptor (nonspecified subtype) | Cancer Diabetes | |||||
| Thyroid hormone receptor beta | P10828 | | Diabetes | Cancer | ||
| Thyrotropin receptor | P16473 | | Cancer | |||
| Tie Receptor (nonspecified subtype) | Cancer | |||||
| TIGIT | Cancer | |||||
| TIMP1 | Cancer Diabetes | |||||
| TIP41-like protein (isoform 1) | O75663 | Cancer | ||||
| Tissue alpha-L-fucosidase | P04066 | Cancer Diabetes | ||||
| Tissue factor (isoform 1) | P13726 | | Cancer | |||
| TK1 | Cancer | |||||
| TLR9 | Cancer | |||||
| TMEPAI variant 1 | Cancer | |||||
| TMSB4X | Cancer | |||||
| TNC | Cancer | |||||
| TNF | Cancer | Diabetes | ||||
| TNF receptor-associated factor 6 | Q9Y4K3 | Cancer Diabetes | ||||
| TNFAIP3 variant 1 | Cancer | |||||
| TNFAIP3 variant 2 | Cancer | |||||
| TNFAIP3 variant 3 | Cancer | |||||
| TNFRSF11A | Cancer | |||||
| TNFRSF11A variant 2 | Cancer | |||||
| TNFRSF4 | Cancer | |||||
| TNFSF4 variant 1 | Cancer | |||||
| TNFSF4 variant X4 | Cancer | |||||
| TNFSF9 | Cancer | |||||
| Toll-Like Receptor (nonspecified subtype) | Cancer | |||||
| Toll-like receptor 2 (isoform 1) | O60603 | Cancer Tuberculosis | Diabetes | |||
| Toll-like receptor 2 (isoform 3) | O60603 | | Cancer Tuberculosis | Diabetes | ||
| Toll-like receptor 2 (isoform X5) | O60603 | | Cancer Tuberculosis | Diabetes | ||
| Toll-like receptor 3 | O15455 | Cancer | Diabetes | |||
| Toll-like receptor 4 (isoform 1) | O00206 | | Cancer Diabetes | Epilepsy | ||
| Toll-like receptor 4 (isoform 3) | O00206 | | Cancer Diabetes | Epilepsy | ||
| Toll-like receptor 4 (isoform 4) | O00206 | | Cancer Diabetes | Epilepsy | ||
| Toll-like receptor 5 | O60602 | Cancer | ||||
| Toll-like receptor 6 | Q9Y2C9 | Cancer | ||||
| Toll-like receptor 7 | Q9NYK1 | Cancer | Leishmaniasis Malaria | Diabetes | ||
| Toll-like receptor 8 (isoform 1) | Q9NR97 | Cancer | Tuberculosis | Diabetes | ||
| Toll-like receptor 8 (isoform 2) | Q9NR97 | Cancer | Tuberculosis | Diabetes | ||
| Toll-like receptor 9 | Q9NR96 | Cancer | Malaria Tuberculosis | Diabetes | ||
| TP53 variant 1 | Cancer | Diabetes | ||||
| TP53 variant 2 | Cancer | Diabetes | ||||
| TP53 variant 3 | Cancer | Diabetes | ||||
| TP53 variant 4 | Cancer | Diabetes | ||||
| TP53 variant 5 | Cancer | Diabetes | ||||
| TP53 variant 6 | Cancer | Diabetes | ||||
| TP53 variant 7 | Cancer | Diabetes | ||||
| TP53 variant 8 | Cancer | Diabetes | ||||
| Trace amine associated receptor 1 (TAAR1) | Q96RJ0 | Cancer Diabetes Epilepsy | ||||
| TRADD | Cancer | |||||
| TRAF2 and NCK interacting kinase (isoform 1) | Q9UKE5 | Cancer | ||||
| Trans-acting T-cell-specific transcription factor GATA-3 (isoform 1) | P23771 | Cancer | Diabetes | |||
| Trans-acting T-cell-specific transcription factor GATA-3 (isoform 2) | P23771 | Cancer | Diabetes | |||
| Trans-acting T-cell-specific transcription factor GATA-3 (isoform X1) | P23771 | | Cancer | Diabetes | ||
| Transcription activator BRG1 (isoform 1) | P51532 | | Cancer | |||
| Transcription activator BRG1 (isoform 2) | P51532 | | Cancer | |||
| Transcription activator BRG1 (isoform 3) | P51532 | Cancer | ||||
| Transcription activator BRG1 (isoform 5) | P51532 | | Cancer | |||
| Transcription activator BRG1 (isoform 6) | P51532 | Cancer | ||||
| Transcription activator BRG1 (isoform 7) | P51532 | | Cancer | |||
| Transcription Factor AP-1 (nonspecified subtype) | Cancer | Malaria | Diabetes | |||
| Transcription factor jun-B | P17275 | Cancer | Diabetes | |||
| Transcription factor jun-D | P17535 | Cancer | Diabetes | |||
| Transcription factor p65 (isoform 1) | Q04206 | | Cancer | |||
| Transcription factor p65 (isoform 2) | Q04206 | | Cancer | |||
| Transcription factor RelB | Q01201 | Cancer | ||||
| Transcription factor SOX-18 | P35713 | Cancer | ||||
| Transcription Factor TCF (nonspecified subtype) | Cancer | Diabetes | ||||
| Transcription initiation factor TFIID subunit 1 (isoform 1) | P21675 | Cancer | ||||
| Transcription initiation factor TFIID subunit 1 (isoform 2) | P21675 | | Cancer | |||
| Transcriptional activator Myb (isoform 1) | P10242 | Cancer | ||||
| Transcriptional activator Myb (isoform 2) | P10242 | Cancer | ||||
| Transcriptional coactivator YAP1 (isoform 2) | P46937 | Cancer | ||||
| Transcriptional coactivator YAP1 (isoform 9) | P46937 | Cancer | ||||
| Transcriptional coactivator YAP1 (isofrom 1) | P46937 | | Cancer | |||
| Transcriptional Enhancer Factor (TEAD) (nonspecified subype) | Cancer | |||||
| Transcriptional intermediary factor 1-alpha (isoform a) | O15164 | Cancer | ||||
| Transcriptional regulator ERG (isoform 1) | P11308 | Cancer | ||||
| Transcriptional regulator ERG (isoform 2) | P11308 | | Cancer | |||
| Transcriptional regulator ERG (isoform 3) | P11308 | | Cancer | |||
| Transcriptional regulator ERG (isoform 4) | P11308 | Cancer | ||||
| Transcriptional regulator ERG (isoform 6) | P11308 | Cancer | ||||
| Transferrin receptor protein 1 | P02786 | | Cancer | |||
| Transforming growth factor (nonspecified subtype) | Cancer | |||||
| Transforming growth factor beta (nonspecified subtype) | Cancer | |||||
| Transforming growth factor beta 1 (TGF-beta1) | P01137 | | Cancer | |||
| Transforming growth factor beta 3 | P10600 | | Cancer | |||
| Transforming growth factor beta-2 precursor (isoform 1) | P61812 | | Cancer | |||
| Transforming growth factor beta-2 precursor (isoform 2) | P61812 | | Cancer | |||
| Transforming protein RhoA | P61586 | | Cancer | |||
| Transforming, acidic coiled-coil containing protein 3 | Q9Y6A5 | Cancer | ||||
| Transglutaminase (nonspecified subtype) | Cancer | |||||
| Transient receptor potential cation channel subfamily A member 1 (TRPA1) | O75762 | Cancer Diabetes Epilepsy | Leishmaniasis | |||
| Transient receptor potential cation channel subfamily M member 3 (isoform 9) | Q9HCF6 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 3 (isoform X8) | Q9HCF6 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 4 (isoform 1) | Q8TD43 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 4 (isoform 2) | Q8TD43 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 6 (isoform a) | Q9BX84 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 6 (isoform b) | Q9BX84 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 6 (isoform c) | Q9BX84 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 7 | Q96QT4 | Cancer | ||||
| Transient receptor potential cation channel subfamily M member 8 | Q7Z2W7 | Epilepsy | Cancer | |||
| Transient receptor potential cation channel subfamily V member 1 | Q8NER1 | Epilepsy | Cancer Diabetes | |||
| Transient receptor potential cation channel subfamily V member 3 (isoform 1) | Q8NET8 | Cancer | ||||
| Transient receptor potential cation channel subfamily V member 3 (isoform 2) | Q8NET8 | Cancer | ||||
| Transient receptor potential cation channel subfamily V member 6 | Q9H1D0 | Cancer | ||||
| Transient receptor potential cation channel, subfamily M, member 3 (isoform 1) | Q9HCF6 | Cancer | ||||
| Transient receptor potential cation channel, subfamily V member 2 | Q9Y5S1 | Cancer Epilepsy | ||||
| Transitional endoplasmic reticulum ATPase | P55072 | Cancer | ||||
| Transketolase (isoform 1) | P29401 | Cancer | ||||
| Transketolase (isoform 2) | P29401 | Cancer | ||||
| Translocator protein | P30536 | | Cancer Epilepsy Tuberculosis | |||
| Transmembrane 4 L6 family member 1 | P30408 | Cancer | ||||
| Transmembrane 4 L6 family member 5 | O14894 | Cancer | ||||
| Transmembrane and coiled-coil domains protein 3 | Q9ULS5 | Cancer | ||||
| Transmembrane protease serine 2 (isoform 1) | O15393 | Cancer | ||||
| Transmembrane protease, serine 2 | O15393 | Cancer | ||||
| Transmembrane protein 97 (Sigma-2 receptor) | Q5BJF2 | Cancer | ||||
| Transmembrane protein PVRIG | Q6DKI7 | Cancer | ||||
| TRBV3-1 | Cancer | |||||
| TRIB1 | Cancer | |||||
| Trifunctional purine biosynthetic protein adenosine-3 (isoform 1) | P22102 | | Cancer | |||
| Triggering receptor expressed on myeloid cells 1 | Q9NP99 | | Cancer | |||
| Triggering receptor expressed on myeloid cells 2 (isoform 1) | Q9NZC2 | Cancer | ||||
| Triggering receptor expressed on myeloid cells 2 (isoform 2) | Q9NZC2 | Cancer | ||||
| TRIM25 | Cancer | |||||
| TRIM28 | Cancer | |||||
| Tripeptidyl-peptidase II | P29144 | Cancer | ||||
| Triple functional domain protein | O75962 | | Cancer | |||
| Trophoblast glycoprotein | Q13641 | | Cancer | |||
| Tropomyosin-3 (isoform 1) | P06753 | Cancer | ||||
| Trypanothione reductase (Leishmania infantum) | A4HSF7 | | Cancer Leishmaniasis | |||
| Trypanothione reductase (trypanosomal) | Leishmaniasis Malaria | |||||
| Trypsin (nonspecified subtype) | Cancer | Diabetes | ||||
| Trypsin-2 | P07478 | Cancer | ||||
| Trypsin-3 (isoform 2) | P35030 | | Cancer | |||
| Tryptase (nonspecified subtype) | Cancer | |||||
| Tryptophan 2,3-dioxygenase | P48775 | Cancer | Malaria | |||
| Tryptophan 5-hydroxylase 1 | P17752 | | Cancer | Diabetes | ||
| Tryptophan 5-hydroxylase 2 | Q8IWU9 | Cancer | Diabetes | |||
| Tryptophan 5-Monooxygenase (nonspecified subtype) | Cancer | |||||
| Tubulin | Cancer | Diabetes | Leishmaniasis Malaria | |||
| Tumor necrosis factor (TNF-alpha) | P01375 | | Cancer Diabetes | Leishmaniasis Malaria | Epilepsy Schistosomiasis | |
| Tumor necrosis factor ligand superfamily member 10 (TRAIL) | P50591 | | Cancer | |||
| Tumor necrosis factor ligand superfamily member 11 (isoform 1) | O14788 | Cancer | Diabetes | |||
| Tumor necrosis factor ligand superfamily member 11 (isoform 2) | O14788 | Cancer | Diabetes | |||
| Tumor necrosis factor ligand superfamily member 12 (isoform 1) | O43508 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 13 (isoform alpha) | O75888 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 13 (isoform beta) | O75888 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 13 (isoform delta) | O75888 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 13 (isoform eta) | O75888 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 13 (isoform gamma) | O75888 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 13 (isoform zeta) | O75888 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 13B (isoform 1) | Q9Y275 | | Diabetes | |||
| Tumor necrosis factor ligand superfamily member 15 (isoform 1) | O95150 | Cancer Diabetes | ||||
| Tumor necrosis factor ligand superfamily member 15 (isoform 2) | O95150 | Cancer Diabetes | ||||
| Tumor necrosis factor ligand superfamily member 4 (isoform 1) | P23510 | Cancer | Diabetes | |||
| Tumor necrosis factor ligand superfamily member 4 (isoform X4) | P23510 | Cancer | Diabetes | |||
| Tumor necrosis factor ligand superfamily member 6 (isoform 1) | P48023 | Cancer | ||||
| Tumor necrosis factor ligand superfamily member 6 (isoform 2) | P48023 | Cancer | ||||
| Tumor Necrosis Factor Receptor Superfamily Member 10 (TRAIL-R) (nonspecified subtype) | Cancer | |||||
| Tumor necrosis factor receptor superfamily member 10A (TRAIL-R1) | O00220 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 10B (TRAIL-R2) | O14763 | | Cancer | |||
| Tumor necrosis factor receptor superfamily member 14 | Q92956 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 16 precursor | P08138 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 17 | Q02223 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 18 (isoform 1) | Q9Y5U5 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 18 (isoform 2) | Q9Y5U5 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 1A (isoform 1) | P19438 | | Cancer | |||
| Tumor necrosis factor receptor superfamily member 1B | P20333 | | Cancer | |||
| Tumor necrosis factor receptor superfamily member 25 (DR3) | Q93038 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 4 (OX40) | P43489 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 5 (isoform 1) | P25942 | | Cancer | Diabetes | ||
| Tumor necrosis factor receptor superfamily member 6 (isoform 1) | P25445 | | Cancer | |||
| Tumor necrosis factor receptor superfamily member 6 (isoform 2) | P25445 | | Cancer | |||
| Tumor necrosis factor receptor superfamily member 6 (isoform 3) | P25445 | | Cancer | |||
| Tumor necrosis factor receptor superfamily member 6 (isoform X3) | P25445 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 8 (isoform 1) | P28908 | Cancer | ||||
| Tumor necrosis factor receptor superfamily member 9 | Q07011 | Cancer | ||||
| Tumor-associated calcium signal transducer 2 (TROP-2) | P09758 | Cancer | ||||
| Tumor-Associated Glycoprotein 72 (TAG-72) | Cancer | |||||
| TXN variant 1 | Cancer | |||||
| TYMS | Cancer | |||||
| Type I transmembrane protein Fn14 | Q9NP84 | Cancer | Diabetes | |||
| Type-1 angiotensin II receptor (isoform 1) | P30556 | Cancer Diabetes | ||||
| Type-1 angiotensin II receptor (isoform 2) | P30556 | Cancer Diabetes | ||||
| Type-2 Angiotensin II receptor | P50052 | Cancer | Diabetes | |||
| TYRO3 protein tyrosine kinase | Q06418 | Cancer | ||||
| Tyrosinase | P14679 | | Cancer | Diabetes Schistosomiasis Tuberculosis | ||
| Tyrosinase-related protein 1 | P17643 | Cancer | ||||
| Tyrosine 3-monooxygenase (isoform a) | P07101 | Epilepsy | ||||
| Tyrosine 3-monooxygenase (isoform b) | P07101 | Epilepsy | ||||
| Tyrosine 3-monooxygenase (isoform c) | P07101 | Epilepsy | ||||
| Tyrosine Kinase (nonspecified subtype) | Cancer | Diabetes Malaria | ||||
| Tyrosine-Protein Kinase ABL (nonspecified subtype) | Cancer | Diabetes | ||||
| Tyrosine-protein kinase ABL1 (isoform a) | P00519 | Cancer | Diabetes | Malaria | ||
| Tyrosine-protein kinase ABL1 (isoform b) | P00519 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase Blk | P51451 | Cancer | ||||
| Tyrosine-protein kinase BTK (isoform 1) | Q06187 | | Cancer Diabetes | |||
| Tyrosine-protein kinase BTK (isoform 3) | Q06187 | Cancer Diabetes | ||||
| Tyrosine-protein kinase CSK | P41240 | | Cancer | |||
| Tyrosine-protein kinase Fer | P16591 | Cancer | ||||
| Tyrosine-protein kinase Fgr | P09769 | Cancer | ||||
| Tyrosine-protein kinase HCK | P08631 | | Cancer | |||
| Tyrosine-protein kinase ITK/TSK | Q08881 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase JAK1 (isoform 1) | P23458 | Cancer | Diabetes | |||
| Tyrosine-protein kinase JAK1 (isoform 4) | P23458 | Cancer | Diabetes | |||
| Tyrosine-protein kinase JAK2 (isoform 1) | O60674 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase JAK2 (isoform 2) | O60674 | Cancer | Diabetes | |||
| Tyrosine-protein kinase JAK3 | P52333 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase Lck | P06239 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase Lyn (isoform 1) | P07948 | | Cancer Diabetes | |||
| Tyrosine-protein kinase Lyn (isoform 2) | P07948 | | Cancer Diabetes | |||
| Tyrosine-protein kinase receptor Tie-1 | P35590 | Cancer | Diabetes | |||
| Tyrosine-protein kinase receptor UFO (AXL) (isoform 1) | P30530 | | Cancer | |||
| Tyrosine-protein kinase receptor UFO (AXL) (isoform 2) | P30530 | | Cancer | |||
| Tyrosine-protein kinase SYK (isoform 1) | P43405 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase SYK (isoform 2) | P43405 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase SYK (isoform 3) | P43405 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase SYK (isoform 4) | P43405 | | Cancer | Diabetes | ||
| Tyrosine-protein kinase Tec | P42680 | Cancer | ||||
| Tyrosine-protein kinase transmembrane receptor ROR2 | Q01974 | Cancer | ||||
| Tyrosine-protein kinase Yes | P07947 | Cancer | ||||
| Tyrosine-protein kinase ZAP-70 (isoform 1) | P43403 | | Cancer Diabetes | |||
| Tyrosine-protein kinase ZAP-70 (isoform X1) | P43403 | | Cancer Diabetes | |||
| Tyrosine-Protein Kinases Src (nonspecified subtype) | Cancer | Diabetes | ||||
| Tyrosine-protein phosphatase non-receptor type 1 | P18031 | | | Cancer | Diabetes | Leishmaniasis Tuberculosis |
| Tyrosine-protein phosphatase non-receptor type 11 (isoform 3) | Q06124 | Cancer | Diabetes | |||
| Tyrosine-protein phosphatase non-receptor type 13 (isoform 4) | Q12923 | | Cancer | |||
| Tyrosine-protein phosphatase non-receptor type 2 (isoform 1) | P17706 | Cancer Diabetes | ||||
| Tyrosine-protein phosphatase non-receptor type 22 (isoform 3) | Q9Y2R2 | | Cancer | Diabetes | ||
| Tyrosine-protein phosphatase non-receptor type 5 | P54829 | | Epilepsy | Cancer | ||
| Tyrosine-protein phosphatase non-receptor type 9 | P43378 | Cancer Diabetes | ||||
| Tyrosine-protein phosphatase non-receptor type substrate 1 (isoform 1) | P78324 | Cancer | Diabetes | |||
| Tyrosine-protein phosphatase non-receptor type substrate 1 (isoform 2) | P78324 | | Cancer | Diabetes | ||
| Tyrosine-protein phosphatase non-receptor type substrate 1 (isoform 4) | P78324 | Cancer | Diabetes | |||
| Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | | Cancer | |||
| Tyrosyl-DNA phosphodiesterase 2 (TDP2) | O95551 | Cancer | ||||
| U-plasminogen activator (isoform 1) | P00749 | | Cancer | Diabetes | ||
| U-plasminogen activator (isoform 2) | P00749 | | Cancer | Diabetes | ||
| UBC | Cancer | |||||
| UBD | Cancer | |||||
| UBE2I variant 1 | Cancer | |||||
| UBE2T | Cancer | |||||
| Ubiquitin carboxyl-terminal hydrolase 10 (isoform 2) | Q14694 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 14 (isoform a) | P54578 | | Cancer | |||
| Ubiquitin carboxyl-terminal hydrolase 19 (isoform 1) | O94966 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 2 (isoform a) | O75604 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 25 | Q9UHP3 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 28 | Q96RU2 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 30 (isoform 1) | Q70CQ3 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 30 (isoform 2) | Q70CQ3 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 47 | Q96K76 | Cancer | ||||
| Ubiquitin carboxyl-terminal hydrolase 7 (isoform 1) | Q93009 | Cancer | Diabetes Leishmaniasis Malaria | |||
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | P09936 | | Cancer | |||
| Ubiquitin carboxyl-terminal hydrolase L5 | Q9Y5K5 | Cancer | ||||
| Ubiquitin-conjugating enzyme E2 B | P63146 | | Cancer | |||
| Ubiquitin-conjugating enzyme E2 D3 (isoform 1) | P61077 | | Cancer | |||
| Ubiquitin-conjugating enzyme E2 D3 (isoform 3) | P61077 | Cancer | ||||
| Ubiquitin-conjugating enzyme E2 N | P61088 | | Cancer Diabetes | |||
| Ubiquitin-conjugating enzyme E2 R1 | P49427 | | Cancer | |||
| Ubiquitin-like domain-containing CTD phosphatase 1 | Q8WVY7 | | Cancer | |||
| Ubiquitin-like modifier-activating enzyme 5 (isoform 1) | Q9GZZ9 | | Cancer | |||
| Ubiquitin-like modifier-activating enzyme 5 (isoform 2) | Q9GZZ9 | Cancer | ||||
| Ubiquitin-like modifier-activating enzyme ATG7 (isoform 1) | O95352 | Cancer | ||||
| Ubiquitin-like modifier-activating enzyme ATG7 (isoform 2) | O95352 | Cancer | ||||
| UCHL1 | Cancer | |||||
| UDP-N-acetylhexosamine pyrophosphorylase | Q16222 | | Cancer | |||
| UMP kinase | Cancer | |||||
| Unconventional myosin-Va (isoform 1) | Q9Y4I1 | Cancer | ||||
| Undecaprenyl Pyrophosphate Synthase (UPPS) | Cancer | |||||
| Uridine 5'-monophosphate synthase | P11172 | | Malaria | Cancer | ||
| Uridine phosphorylase (nonspecified subtype) | Cancer | |||||
| Urokinase plasminogen activator surface receptor (isoform 1) | Q03405 | | Cancer | |||
| Urokinase plasminogen activator surface receptor (isoform 2) | Q03405 | | Cancer | |||
| Uroporphyrinogen decarboxylase | P06132 | | Cancer | |||
| Urotensin-2 receptor | Q9UKP6 | Cancer | Diabetes | |||
| USP22 | Cancer | |||||
| V-set and immunoglobulin domain-containing protein 8 | P0DPA2 | Cancer | ||||
| V-set domain-containing T-cell activation inhibitor 1 (isoform 1) | Q7Z7D3 | Cancer | ||||
| V-set domain-containing T-cell activation inhibitor 1 (isoform 2) | Q7Z7D3 | Cancer | ||||
| V-type immunoglobulin domain-containing suppressor of T-cell activation (VISTA) | Q9H7M9 | Cancer | ||||
| Vacuolar protein sorting-associated protein 4B | O75351 | | Cancer | |||
| Vascular cell adhesion protein 1 | P19320 | | Cancer | |||
| Vascular endothelial growth factor receptor (VEGFR) (nonspecified subtype) | Cancer | Epilepsy | Diabetes | |||
| Vascular endothelial growth factor receptor 1 (isoform 1) | P17948 | | Cancer | Diabetes | ||
| Vascular endothelial growth factor receptor 1 (isoform 2) | P17948 | | Cancer | Diabetes | ||
| Vascular endothelial growth factor receptor 1 (isoform 3) | P17948 | | Cancer | Diabetes | ||
| Vascular endothelial growth factor receptor 2 | P35968 | Cancer | Diabetes | |||
| Vascular endothelial growth factor receptor 3 (isoform 1) | P35916 | Cancer | ||||
| Vascular endothelial growth factor receptor 3 (isoform 2) | P35916 | Cancer | ||||
| Vascular endothelial growth factors (VEGF) (nonspecified subtype) | Cancer Diabetes | Malaria | ||||
| Vasoactive intestinal polypeptide receptor (VIP-R) (nonspecified subtype) | Cancer | |||||
| Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) | P32241 | Cancer | Diabetes | |||
| Vasoactive intestinal polypeptide receptor 2 (VIP-R-2) | P41587 | Cancer | ||||
| Vasopressin V1a receptor | P37288 | Cancer Diabetes | ||||
| Vasopressin V2 receptor | P30518 | Diabetes | Cancer | |||
| VCAM1 variant 1 | Cancer Diabetes | Malaria | ||||
| VCAM1 variant 2 | Cancer Diabetes | Malaria | ||||
| VDAC1 | Cancer | |||||
| VEGFA | Cancer | Diabetes | ||||
| VEGFA variant 1 | Cancer | Diabetes | ||||
| VEGFA variant 2 | Cancer | Diabetes | ||||
| VEGFA variant 4 | Cancer | Diabetes | ||||
| VEGFA variant 5 | Cancer | Diabetes | ||||
| VEGFA variant 6 | Cancer | Diabetes | ||||
| VEGFA variant 7 | Cancer | Diabetes | ||||
| VEGFA variant 9 | Cancer | Diabetes | ||||
| VEGFB | Cancer | |||||
| VEGFC | Cancer | |||||
| Very-long-chain acyl-CoA synthetase | O14975 | Cancer | Diabetes | |||
| Villin 2 | P15311 | Cancer | ||||
| Vimentin | P08670 | | Cancer | |||
| VIP peptides (isoform 1) | P01282 | Cancer | ||||
| Vitamin D receptor (VDR) (isoform 1) | P11473 | | Cancer | Diabetes | ||
| Vitamin D3 receptor (VDR) (isoform 2) | P11473 | | Cancer | Diabetes | ||
| Vitamin D3 receptor (VDR) (isoform 3) | P11473 | | Cancer | Diabetes | ||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 1) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 10) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 11) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 13) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 14) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 15) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 16) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 17) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 18) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 19) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 2) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 20) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 21) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 23) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 3) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 4) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 5) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 6) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 7) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 8) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform 9) | Q13936 | Cancer | ||||
| Voltage-dependent L-type calcium channel subunit alpha-1C (isoform X28) | Q13936 | | Cancer | |||
| Voltage-dependent L-type calcium channel subunit alpha-1C (soform 12) | Q13936 | Cancer | ||||
| Voltage-dependent N-type calcium channel subunit alpha-1B (isoform 1) | Q00975 | Epilepsy | Cancer | |||
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A (isoform 1) | O00555 | Cancer | ||||
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A (isoform 2) | O00555 | Cancer | ||||
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A (isoform 3) | O00555 | Cancer | ||||
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A (isoform 4) | O00555 | Cancer | ||||
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A (isoform 5) | O00555 | Cancer | ||||
| Voltage-dependent T-type calcium channel subunit alpha-1G (isoform 1) | O43497 | Cancer | Epilepsy | |||
| Voltage-dependent T-type calcium channel subunit alpha-1H (isoform 1) | O95180 | Epilepsy | Cancer | |||
| Voltage-dependent T-type calcium channel subunit alpha-1H (isoform 2) | O95180 | Epilepsy | Cancer | |||
| Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | Cancer Diabetes | Leishmaniasis Epilepsy | ||||
| Voltage-gated K(V) channel (nonspecified subtype) | Cancer | Epilepsy | ||||
| Voltage-gated potassium channel beta-2 subunit | Q13303 | Cancer | Epilepsy | |||
| Voltage-gated potassium channel beta-2 subunit (isoform 2) | Q13303 | Cancer | Epilepsy | |||
| Voltage-Gated Sodium Channel Complex | Cancer Diabetes Epilepsy | |||||
| Von Hippel-Lindau disease tumor suppressor (isoform 2) | P40337 | Cancer | ||||
| von Hippel-Lindau tumor suppressor (isoform 1) | P40337 | | Cancer | |||
| VTN | Cancer | |||||
| WD repeat-containing protein 5 (isoform 1) | P61964 | Cancer | ||||
| WD repeat-containing protein 5 (isoform 2) | P61964 | | Cancer | |||
| WEE1 variant 1 | Cancer | |||||
| WEE1 variant 2 | Cancer | |||||
| Wee1-like protein kinase (isoform 1) | P30291 | | Cancer | |||
| Wee1-like protein kinase (isoform 2) | P30291 | | Cancer | |||
| Wee1-like protein kinase 2 | P0C1S8 | Cancer | ||||
| Wilms tumor protein (isoform A) | P19544 | Cancer | ||||
| Wilms tumor protein (isoform B) | P19544 | Cancer | ||||
| Wilms tumor protein (isoform D) | P19544 | Cancer | ||||
| Wilms tumor protein (isoform E) | P19544 | Cancer | ||||
| Wilms tumor protein (isoform F) | P19544 | Cancer | ||||
| WNT1 | Cancer | |||||
| WT1 variant A | Cancer | |||||
| WT1 variant B | Cancer | |||||
| WT1 variant D | Cancer | |||||
| WT1 variant E | Cancer | |||||
| WT1 variant F | Cancer | |||||
| WWP1 | Cancer | |||||
| X-box-binding protein 1 (isoform 1) | P17861 | Cancer | Diabetes | |||
| X-box-binding protein 1 (isoform 2) | P17861 | Cancer | Diabetes | |||
| X-Chromosome-Linked Inhibitor of Apoptosis Protein (XIAP) | P98170 | | Cancer | |||
| Xanthine oxidase | P47989 | | Cancer | Diabetes | Tuberculosis | |
| XBP1 variant 1 | Cancer | |||||
| XBP1 variant 2 | Cancer | |||||
| Xeroderma pigmentosum, complementation group A | P23025 | Cancer | ||||
| XIAP | Cancer | |||||
| YEATS4 | Cancer | |||||
| ZBTB7A | Cancer | |||||
| ZCCHC13 | Cancer | |||||
| ZIC5 | Cancer | |||||
| Zinc transporter ZIP6 | Q13433 | Cancer | ||||
| ZKSCAN3 variant 2 | Cancer | |||||
| ZNF667 variant 1 | Cancer | |||||
| ZRANB1 | Cancer | |||||
| Zymogen granule protein 16 homolog B precursor | Q96DA0 | Cancer | ||||
| 2-Acylglycerol O-acyltransferase 2 | Q3SYC2 | Diabetes | ||||
| 2-Acylglycerol O-acyltransferase 3 | Q86VF5 | Diabetes | ||||
| 7-alpha-Hydroxycholest-4-en-3-one 12-alpha-hydroxylase (CYP8B1) | Q9UNU6 | Diabetes | ||||
| [3-Methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (isoform 1) | O14874 | Diabetes | ||||
| [3-Methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (isoform 2) | O14874 | Diabetes | ||||
| [3-Methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (isoform 3) | O14874 | Diabetes | ||||
| A-Kinase Anchor Proteins (nonspecified subtype) | Diabetes | |||||
| Adenylate cyclase type 8 | P40145 | Diabetes | ||||
| Adhesion G protein-coupled receptor F5 (isoform 1) | Q8IZF2 | Diabetes | ||||
| Adhesion G protein-coupled receptor F5 (isoform 2) | Q8IZF2 | Diabetes | ||||
| ADIPOR2 | Diabetes | |||||
| Alpha-galactosidase A precursor | P06280 | | Diabetes | |||
| alpha2B-Adrenoceptor | P18089 | Diabetes | ||||
| alpha2C-Adrenoceptor | P18825 | Diabetes | ||||
| AMP Deaminase (nonspecified subtype) | Diabetes | |||||
| AMP-activated protein kinase alpha2beta2gamma2 | Diabetes | |||||
| Amylin receptor | Diabetes | |||||
| Angiotensin-converting enzyme 2 | Q9BYF1 | | Diabetes | |||
| ANGPTL3 | Diabetes | |||||
| AOC3 | Diabetes | |||||
| Apoptotic protease-activating factor 1 (isoform c) | O14727 | | Diabetes | |||
| Aquaporin-9 | O43315 | Diabetes | ||||
| ATP-binding cassette sub-family C member 8 (ABCC8) (isoform 1) | Q09428 | Diabetes | ||||
| ATP-binding cassette sub-family C member 8 (ABCC8) (isoform 2) | Q09428 | Diabetes | ||||
| ATP-binding cassette sub-family C member 9 (isoform SUR2B) | O60706 | Diabetes | ||||
| ATP-sensitive inward rectifier potassium channel 11 (isoform 1) | Q14654 | Diabetes | ||||
| ATP-sensitive inward rectifier potassium channel 11 (isoform 2) | Q14654 | Diabetes | ||||
| Atrial Natriuretic Peptide Receptor 1 | P16066 | Diabetes | ||||
| BCL2L11 variant 1 | Diabetes | |||||
| BCL2L11 variant 9 | Diabetes | |||||
| Beta-Ala-His dipeptidase | Q96KN2 | Diabetes | ||||
| Beta-klotho | Q86Z14 | Diabetes | ||||
| Beta-secretase 1 | P56817 | | Diabetes Epilepsy | |||
| Beta-secretase 1 (isoform C) | P56817 | Epilepsy | ||||
| C-X-C motif chemokine 10 | P02778 | | Diabetes | |||
| C3a anaphylatoxin chemotactic receptor | Q16581 | Diabetes | ||||
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Q14123 | Diabetes | ||||
| Carnitine Palmitoyltransferase II (nonspecified subtype) | Diabetes | |||||
| Caspase-4 (isoform alpha) | P49662 | Diabetes | ||||
| Caspase-5 | P51878 | Diabetes | ||||
| CD40 variant 1 | Diabetes | |||||
| CD7 | Diabetes | |||||
| CD80 | Diabetes | |||||
| CD86 variant 1 | Diabetes | |||||
| CD86 variant 3 | Diabetes | |||||
| CD86 variant 4 | Diabetes | |||||
| CDGSH iron-sulfur domain-containing protein 1 | Q9NZ45 | | Diabetes | |||
| Chemokine-like receptor 1 (isoform 1) | Q99788 | Diabetes | ||||
| Chemokine-like receptor 1 (isoform 2) | Q99788 | Diabetes | ||||
| Cholesterol 7-alpha-monooxygenase | P22680 | Diabetes | ||||
| Chromogranin-A | P10645 | Diabetes | ||||
| CIDEC variant 1 | Diabetes | |||||
| COL1A1 | Diabetes | |||||
| Corticotropin-releasing factor receptor 2 (isoform 1) | Q13324 | | Diabetes | |||
| Corticotropin-releasing factor receptor 2 (isoform 2) | Q13324 | | Diabetes | |||
| Corticotropin-releasing factor receptor 2 (isoform 3) | Q13324 | Diabetes | ||||
| Cryptochrome (nonspecified subtype) | Diabetes | |||||
| CX3CL1 | Diabetes | |||||
| Cyclic AMP-dependent transcription factor ATF-3 (isoform 1) | P18847 | Diabetes | ||||
| D-amino-acid oxidase | P14920 | | Diabetes | |||
| DGAT2 | Diabetes | |||||
| DNA-3-methyladenine glycosylase (isoform b) | P29372 | | Diabetes | |||
| DNA-3-methyladenine glycosylase II | P29372 | | Diabetes | |||
| Dopamine beta-monooxygenase | P09172 | Diabetes | ||||
| DPP4 | Diabetes | |||||
| Elongation of very long chain fatty acids protein 6 | Q9H5J4 | Diabetes | ||||
| Endothelial lipase (EDL) | Q9Y5X9 | Diabetes | Tuberculosis | |||
| Enteropeptidase | P98073 | Diabetes | ||||
| Fatty Acid Binding Protein (nonspecified subtype) | Diabetes | |||||
| Fatty acid-binding protein, heart | P05413 | | Diabetes | |||
| Fatty acid-binding protein, intestinal | P12104 | | Diabetes | |||
| Follistatin-related protein 3 | O95633 | Diabetes | ||||
| Forkhead box protein O1 | Q12778 | | Diabetes | |||
| Fructose-1,6-bisphosphatase 1 | P09467 | | Diabetes | Epilepsy | ||
| G protein-activated inward rectifier potassium channel 2 | P48051 | Epilepsy | Diabetes | |||
| G protein-coupled receptor 41 | O14843 | Diabetes | ||||
| Galanin receptor type 2 | O43603 | Epilepsy | ||||
| Gamma-butyrobetaine dioxygenase | O75936 | | Diabetes | |||
| Gastric inhibitory polypeptide | P09681 | Diabetes | ||||
| Gastric triacylglycerol lipase | P07098 | Diabetes | ||||
| GCGR | Diabetes | |||||
| Ghrelin O-acyltransferase | Q96T53 | Diabetes | ||||
| Glucagon | P01275 | Diabetes | ||||
| Glucagon receptor (GL-R) | P47871 | Diabetes | ||||
| Glucagon-like peptide receptor (GLP-R) (nonspecified subtype) | Diabetes | |||||
| Glucokinase (isoform 1) | P35557 | | Diabetes | |||
| Glucokinase regulatory protein | Q14397 | Diabetes | ||||
| Glutamate decarboxylase 2 | Q05329 | | Diabetes | |||
| Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (isoform 2) | Q06210 | | Diabetes | |||
| Glycogen phosphorylase, brain form | P11216 | Diabetes | ||||
| Glycogen synthase (nonspecified subtype) | Diabetes | |||||
| GPR139 | Q6DWJ6 | Diabetes | ||||
| Haptoglobin preproprotein (isoform 1) | P00738 | Diabetes | ||||
| Hepatic triacylglycerol lipase precursor | P11150 | Diabetes Tuberculosis | ||||
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | O60658 | Diabetes | ||||
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (isoform 1) | O95263 | Diabetes | ||||
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (isoform 3) | O95263 | Diabetes | ||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (isoform 1) | O76083 | | Diabetes Epilepsy | |||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (isoform 2) | O76083 | | Diabetes Epilepsy | |||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (isoform 3) | O76083 | | Diabetes Epilepsy | |||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (isoform 4) | O76083 | | Diabetes Epilepsy | |||
| HK2 | Diabetes | |||||
| Hormone-sensitive lipase | Q05469 | | Diabetes | Tuberculosis | ||
| Hydroxycarboxylic acid receptor 1 | Q9BXC0 | Diabetes | ||||
| Hydroxycarboxylic acid receptor 3 | P49019 | Diabetes | ||||
| IL-21 receptor | Diabetes | |||||
| Ileal Sodium/Bile acid Cotransporter | Q12908 | Diabetes | ||||
| Imidazoline I2 receptor (I2) | Diabetes | |||||
| Imidazoline receptor (nonspecified subtype) | Diabetes | |||||
| Inositol hexakisphosphate kinase 1 (isoform 1) | Q92551 | Diabetes | ||||
| Insulin-degrading enzyme | P14735 | Diabetes | ||||
| Interleukin-18 (isoform 1) | Q14116 | | Diabetes | |||
| Interleukin-18 (isoform 2) | Q14116 | | Diabetes | |||
| Islet amyloid polypeptide | P10997 | | Diabetes | |||
| Ketohexokinase (isoform b) | P50053 | | Diabetes | |||
| LanC-like protein 2 | Q9NS86 | Diabetes | ||||
| Lanosterol 14-alpha demethylase | Q16850 | | Diabetes | |||
| Leukotriene B4 receptor 1 (LTB4-R1) | Q15722 | Diabetes | ||||
| Long-chain fatty acid transport protein 1 | Q6PCB7 | Diabetes | ||||
| Major histocompatibility complex, class II, DR beta 4 | P13762 | Diabetes | ||||
| Mannan-binding lectin serine protease 2 (isoform 1) | O00187 | Diabetes | ||||
| Mannan-binding lectin serine protease 2 (isoform 2) | O00187 | Diabetes | ||||
| Mas-related G-protein coupled receptor MRG | P35410 | Diabetes | ||||
| Melanin-concentrating hormone (MCH) receptor (nonspecified subtype) | Diabetes Epilepsy | |||||
| Melanocortin receptor 3 (MC3-R) | P41968 | Diabetes | ||||
| Melanocortin receptor 5 | P33032 | Diabetes | ||||
| Memapsin 1 | Q9Y5Z0 | Diabetes | ||||
| Microsomal triglyceride transfer protein large subunit precursor | P55157 | Diabetes | ||||
| MIR133A1 | Diabetes | |||||
| MIR133A2 | Diabetes | |||||
| MIR133B | Diabetes | |||||
| Mitochondrial brown fat uncoupling protein 1 | P25874 | Diabetes | ||||
| Mitogen-activated protein kinase 10 (isoform 2) | P53779 | | Diabetes Epilepsy | |||
| MOGAT1 | Diabetes | |||||
| N-terminal kinase-like protein (isoform A) | Q96KG9 | Diabetes | ||||
| Na+/Ca2+ Exchanger (NCX) (nonspecified subtype) | Diabetes | |||||
| Neuromedin U receptor 1 | Q9HB89 | Diabetes | ||||
| Neuromedin U receptor 2 | Q9GZQ4 | Diabetes | ||||
| Neuropeptide Y receptor (NPY-R) (nonspecified subtype) | Diabetes | |||||
| Neuropeptide Y receptor type 5 (NPY5-R) | Q15761 | Diabetes Epilepsy | ||||
| Niemann-Pick C1-like protein 1 (isoform 1) | Q9UHC9 | Diabetes | ||||
| Niemann-Pick C1-like protein 1 (isoform 2) | Q9UHC9 | Diabetes | ||||
| Niemann-Pick C1-like protein 1 (isoform 3) | Q9UHC9 | Diabetes | ||||
| Nischarin (isoform 1) | Q9Y2I1 | Diabetes Epilepsy | ||||
| NNMT | Diabetes | |||||
| NR3C1 variant 1 | Diabetes | |||||
| NR3C1 variant 2 | Diabetes | |||||
| NR3C1 variant 3 | Diabetes | |||||
| NR3C1 variant 5 | Diabetes | |||||
| NR3C1 variant 6 | Diabetes | |||||
| NR3C1 variant 7 | Diabetes | |||||
| NR3C1 variant 8 | Diabetes | |||||
| NR3C1 variant X3 | Diabetes | |||||
| Orexin receptor (nonspecified subtype) | Diabetes Epilepsy | |||||
| Oxytocin-neurophysin 1 preproprotein | P01178 | Diabetes | ||||
| P2RY12 variant 1 | Diabetes | |||||
| P2RY12 variant 2 | Diabetes | |||||
| P2Y purinoceptor (nonspecified subtype) | Diabetes | |||||
| P2Y purinoceptor 1 | P47900 | Diabetes | ||||
| P2Y purinoceptor 14 (P2Y14) | Q15391 | Diabetes | ||||
| P2Y purinoceptor 6 | Q15077 | Diabetes | ||||
| Pantothenate kinase 1 (isoform alpha) | Q8TE04 | Diabetes | ||||
| Pantothenate kinase 2, mitochondrial (isoform 1) | Q9BZ23 | Diabetes Tuberculosis | ||||
| Pantothenate kinase 3 | Q9H999 | | Diabetes | |||
| PHKA1 variant 1 | Diabetes | |||||
| PHKA1 variant 2 | Diabetes | |||||
| Phosphatidylcholine:ceramide cholinephosphotransferase 2 | Q8NHU3 | Diabetes | ||||
| Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | O15357 | Diabetes | ||||
| Phosphoenolpyruvate carboxykinase [GTP], mitochondrial | Q16822 | Diabetes | ||||
| Phosphoenolpyruvate carboxykinase, cytosolic [GTP] | P35558 | | Diabetes | |||
| Presenilins-associated rhomboid-like protein, mitochondrial preproprotein (isoform 1) | Q9H300 | Diabetes | ||||
| Presenilins-associated rhomboid-like protein, mitochondrial preproprotein (isoform 2) | Q9H300 | Diabetes | ||||
| Probable G-protein coupled receptor 142 | Q7Z601 | Diabetes | ||||
| Probable G-protein coupled receptor 88 (GPR88) | Q9GZN0 | Diabetes | ||||
| Relaxin-3 receptor 2 | Q8TDU9 | Diabetes | ||||
| Retinol-binding protein 4 | P02753 | | Diabetes | |||
| Ribosomal protein S6 kinase alpha-2 (isoform a) | Q15349 | Diabetes | ||||
| Ribosomal protein S6 kinase alpha-5 | O75582 | Diabetes | ||||
| Sclerostin | Q9BQB4 | Diabetes | ||||
| Selenoprotein S (isoform 1) | Q9BQE4 | Diabetes | ||||
| Selenoprotein S (isoform 2) | Q9BQE4 | Diabetes | ||||
| SH3-containing GRB2-like protein 3-interacting protein 1 | Q9BQI5 | Diabetes | ||||
| SLC5A2 | Diabetes | |||||
| Sn1-specific diacylglycerol lipase alpha | Q9Y4D2 | Diabetes | ||||
| Sn1-specific diacylglycerol lipase beta (isoform 1) | Q8NCG7 | Diabetes | ||||
| Sn1-specific diacylglycerol lipase beta (isoform 2) | Q8NCG7 | Diabetes | ||||
| SOD1 | Diabetes | |||||
| Sodium/glucose cotransporter 3 (SGLT-3) | Q9NY91 | Diabetes | ||||
| Solute carrier family 13 member 5 (isoform a) | Q86YT5 | Diabetes | ||||
| Solute carrier family 13 member 5 (isoform b) | Q86YT5 | Diabetes | ||||
| Sortilin | Q99523 | Diabetes | ||||
| Sphingosine 1-phosphate receptor 3 | Q99500 | Diabetes | ||||
| Steroid hormone receptor ERR2 | O95718 | Diabetes | ||||
| Taste receptor type 1 member 2 | Q8TE23 | Diabetes | ||||
| Taste Receptor Type 1 Member 3 | Q7RTX0 | Diabetes | ||||
| Thioredoxin-interacting protein (isoform 1) | Q9H3M7 | Diabetes | ||||
| TLR4/MD-2 complex | Diabetes | |||||
| alpha-6 beta-2 Nicotinic receptor | Epilepsy | |||||
| Amyloid beta A4 protein (isoform d) | P05067 | | Epilepsy | |||
| Aquaporin-4 (isoform a) | P55087 | Epilepsy | ||||
| Aquaporin-4 (isoform b) | P55087 | Epilepsy | ||||
| Calcium channel, voltage-dependent, alpha-2/delta-2 (isoform a) | Q9NY47 | Epilepsy | ||||
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (isoform 1) | P54750 | Epilepsy | ||||
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (isoform 2) | P54750 | Epilepsy | ||||
| Cholesterol 24-hydroxylase | Q9Y6A2 | Epilepsy | ||||
| Corticotropin-releasing factor receptor 1 (isoform 1) | P34998 | | Epilepsy | |||
| Corticotropin-releasing factor receptor 1 (isoform 2) | P34998 | Epilepsy | ||||
| Corticotropin-releasing factor receptor 1 (isoform 5) | P34998 | | Epilepsy | |||
| Corticotropin-releasing factor receptor 1 (isoform 6) | P34998 | | Epilepsy | |||
| D(1B) dopamine receptor | P21918 | Epilepsy | ||||
| Disks large homolog 4 | P78352 | Epilepsy | ||||
| Excitatory amino acid transporter 3 | P43005 | Epilepsy | ||||
| Excitatory amino acid transporter 4 | P48664 | Epilepsy | ||||
| Galanin | P22466 | Epilepsy | ||||
| Galanin receptor (nonspecified subtype) | Epilepsy | |||||
| Gamma-aminobutyric acid (GABA) A receptor subunit alpha-3 | P34903 | Epilepsy | ||||
| Gamma-aminobutyric acid A receptor subunit alpha-2 | P47869 | Epilepsy | ||||
| Gamma-aminobutyric acid receptor subunit alpha-4 | P48169 | Epilepsy | ||||
| Gamma-aminobutyric acid receptor subunit alpha-5 | P31644 | | Epilepsy | |||
| Gamma-aminobutyric acid receptor subunit beta-1 | P18505 | Epilepsy | ||||
| Gamma-aminobutyric acid receptor subunit beta-1 (isoform X1) | P18505 | Epilepsy | ||||
| Gamma-aminobutyric acid receptor subunit delta | O14764 | Epilepsy | ||||
| Gap junction beta-2 protein | P29033 | Epilepsy | ||||
| Glutamate receptor 2 (isoform 1) | P42262 | | Epilepsy | |||
| Glutamate receptor ionotropic, kainate 1 (isoform 1) | P39086 | | Epilepsy | |||
| Glutamate receptor ionotropic, kainate 1 (isoform 2) | P39086 | | Epilepsy | |||
| Glutamate receptor ionotropic, kainate 1 (isoform 3) | P39086 | | Epilepsy | |||
| Glutamate receptor ionotropic, kainate 2 (isoform 1) | Q13002 | Epilepsy | ||||
| Glutamate receptor ionotropic, kainate 2 (isoform 3) | Q13002 | Epilepsy | ||||
| Glutamate receptor ionotropic, kainate 3 | Q13003 | Epilepsy | ||||
| Glutamate receptor ionotropic, NMDA 2C | Q14957 | Epilepsy | ||||
| Glutamate receptor ionotropic, NMDA 2D | O15399 | Epilepsy | ||||
| Kynurenine 3-monooxygenase | O15229 | Epilepsy | ||||
| Metabotropic glutamate receptor 7 (isoform a) | Q14831 | Epilepsy | ||||
| Metabotropic glutamate receptor 7 (isoform b) | Q14831 | Epilepsy | ||||
| MIR324 | Epilepsy | |||||
| P2X purinoceptor 3 | P56373 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily A member 1 | Q09470 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily C member 1 (isoform 1) | P48547 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily C member 1 (isoform 2) | P48547 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily KQT member 2 (isoform 1) | O43526 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily KQT member 2 (isoform 3) | O43526 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily KQT member 2 (isoform 4) | O43526 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily KQT member 4 | P56696 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily KQT member 5 (isoform 1) | Q9NR82 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily KQT member 5 (isoform 2) | Q9NR82 | Epilepsy | ||||
| Potassium voltage-gated channel subfamily KQT member 5 (isoform 4) | Q9NR82 | Epilepsy | ||||
| Potassium/Sodium Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel (nonspecified subtype) | Epilepsy | |||||
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | O60741 | Epilepsy | ||||
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | Q9UL51 | Epilepsy | ||||
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 | Q9P1Z3 | Epilepsy | ||||
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Q9Y3Q4 | Epilepsy | ||||
| Serine racemase | Q9GZT4 | Epilepsy | ||||
| Serum paraoxonase/arylesterase 1 | P27169 | Epilepsy | ||||
| Small conductance calcium-activated potassium channel protein 1 | Q92952 | Epilepsy | ||||
| Sodium channel protein type 10 subunit alpha (Nav1.8) (isoform 1) | Q9Y5Y9 | Epilepsy | ||||
| Sodium channel protein type 10 subunit alpha (Nav1.8) (isoform 2) | Q9Y5Y9 | Epilepsy | ||||
| Sodium channel protein type 2 subunit alpha (Nav1.2) (isoform 2) | Q99250 | Epilepsy | ||||
| Sodium channel protein type 3 subunit alpha (Nav1.3 (isoform 2) | Q9NY46 | Epilepsy | ||||
| Sodium channel protein type 3 subunit alpha (Nav1.3) (alternative isoform) | Q9NY46 | Epilepsy | ||||
| Sodium channel protein type 3 subunit alpha (Nav1.3) (isoform 1) | Q9NY46 | Epilepsy | ||||
| Sodium channel protein type 3 subunit alpha (Nav1.3) (isoform 3) | Q9NY46 | Epilepsy | ||||
| Sodium channel protein type 4 subunit alpha (Nav1.4) | P35499 | Epilepsy | ||||
| Sodium channel protein type 8 subunit alpha (Nav1.6) (isoform 1) | Q9UQD0 | Epilepsy | ||||
| Sodium- and chloride-dependent betaine transporter | P48065 | Epilepsy | ||||
| Sodium- and chloride-dependent GABA transporter 2 (isoform 1) | Q9NSD5 | Epilepsy | ||||
| Sodium- and chloride-dependent GABA transporter 3 | P48066 | Epilepsy | ||||
| Sodium- and chloride-dependent glycine transporter 1 (isoform 2) | P48067 | Epilepsy | ||||
| Sodium- and chloride-dependent glycine transporter 2 | Q9Y345 | Malaria Epilepsy | ||||
| Solute carrier family 12 member 5 (isoform 2) | Q9H2X9 | Epilepsy | ||||
| Synaptic vesicle glycoprotein 2A (isoform 1) | Q7L0J3 | Epilepsy | ||||
| Synaptic vesicle glycoprotein 2A (isoform 2) | Q7L0J3 | Epilepsy | ||||
| Synaptic vesicle glycoprotein 2C (isoform 1) | Q496J9 | Epilepsy | ||||
| Synaptic vesicle glycoprotein 2C (isoform 2) | Q496J9 | Epilepsy | ||||
| Thyrotropin-releasing hormone receptor | P34981 | Epilepsy | ||||
| Transthyretin | P02766 | | Epilepsy | |||
| Uracil nucleotide/cysteinyl leukotriene receptor | Q13304 | Epilepsy | Diabetes | |||
| Vasopressin V1b receptor | P47901 | Diabetes Epilepsy | ||||
| Voltage-dependent calcium channel alpha-2/delta-1 subunit | P54289 | Epilepsy | ||||
| Voltage-dependent calcium channel gamma-8 subunit | Q8WXS5 | Epilepsy | ||||
| Voltage-dependent R-type calcium channel subunit alpha-1E (isoform 3) | Q15878 | Epilepsy | ||||
| 1,4-Dihydroxy-2-naphthoyl-CoA synthase | P9WNP5 | | Tuberculosis | |||
| 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (Plasmodium falciparum) | Q8IKG4 | | Malaria | Tuberculosis | ||
| 16S Ribosomal protein (bacterial) | Tuberculosis | |||||
| 2-C-Methyl-D-Erythritol 2,4-Cyclodiphosphate Synthase (MECDP-synthase) (bacterial) | Malaria Tuberculosis | |||||
| 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (Escherichia coli) | Q46893 | | Malaria Tuberculosis | |||
| 2-Succinylbenzoate--CoA ligase (menE) | Tuberculosis | |||||
| 3-beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase | P9WQP7 | Tuberculosis | ||||
| 3-Dehydroquinate Dehydratase II (DHQ2) (bacterial) | Tuberculosis | |||||
| 3-Oxoacyl-[acyl-carrier-protein] synthase 1 | P9WQD9 | | Tuberculosis | |||
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | P0A6R0 | | Tuberculosis | |||
| 30S Ribosomal protein | Tuberculosis | |||||
| 50S Ribosomal protein | Malaria Tuberculosis | |||||
| AbaR (bacterial) | Tuberculosis | |||||
| Acetolactate synthase isozyme 2 large subunit | P00892 | Tuberculosis | ||||
| Acetolactate synthase large subunit IlvB | P9WG41 | Tuberculosis | ||||
| Acyl-CoA synthetase (Mycobacterium tuberculosis) (nonspecified subtype) | Tuberculosis | |||||
| Adenosine kinase | P9WID5 | | Tuberculosis | |||
| Adenosylmethionine-8-amino-7-oxononanoate aminotransferase | P9WQ81 | | Tuberculosis | |||
| Adenylate cyclase | P9WQ35 | Tuberculosis | ||||
| Alanine Racemase | Tuberculosis | |||||
| Alpha-crystallin (Mycobacterium tuberculosis) | P9WMK1 | Tuberculosis | ||||
| Alpha-L-Rhamnosidase | Tuberculosis | |||||
| ATP Synthase (M. tuberculosis) | Tuberculosis | |||||
| ATP-Dependent caseinolytic protease P1 and P2 (ClpP1P2) | Tuberculosis | |||||
| ATP-dependent Clp protease ATP-binding subunit ClpC1 | P9WPC9 | | Tuberculosis | |||
| ATP-Dependent Clp Protease ClpP1P2 | Tuberculosis | |||||
| Autolysin (Streptococcus pneumoniae) | P06653 | | Tuberculosis | |||
| beta-Carbonic anhydrase 1 | P9WPJ7 | | Tuberculosis | |||
| Beta-lactamase (nonspecified subtype) | Malaria | Tuberculosis | ||||
| Bifunctional protein GlmU | Tuberculosis | |||||
| Bifunctional salicyl-AMP ligase/salicyl-S-ArCP synthetase | P71716 | Tuberculosis | ||||
| CD209 antigen | Q9NNX6 | | Tuberculosis | |||
| Cell division protein FtsZ (bacterial) | Tuberculosis | |||||
| Cell division protein FtsZ (Mycobacterium tuberculosis) | P9WN95 | | Tuberculosis | |||
| Cyclopropane mycolic acid synthase (nonspecified subtype) | Tuberculosis | |||||
| Cytochrome bc1 complex cytochrome b subunit | P9WP37 | Tuberculosis | ||||
| Diacylglycerol acyltransferase/mycolyltransferase Ag85C | P9WQN9 | Tuberculosis | ||||
| Dihydrofolate reductase (DHFR) (bacterial) | Tuberculosis | |||||
| Dihydrofolate reductase (Mycobacterium tuberculosis) | P9WNX1 | | Tuberculosis | |||
| Dihydroorotate dehydrogenase (Plasmodium falciparum) | Q08210 | | Malaria | Tuberculosis | ||
| DNA gyrase (bacterial) | Tuberculosis | |||||
| DNA gyrase (type II topoisomerase), subunit A (Escherichia coli) | P0AES4 | Tuberculosis | ||||
| DNA gyrase subunit A (Mycobacterium smegmatis) | P48354 | Tuberculosis | ||||
| DNA gyrase subunit A (Mycobacterium tuberculosis) | Q07702 | | Tuberculosis | |||
| DNA gyrase subunit B (bacterial) | Tuberculosis | |||||
| DNA gyrase subunit B (Escherichia coli) | P0AES6 | | Tuberculosis | |||
| DNA gyrase subunit B (Mycobacterium tuberculosis) | P9WG45 | | Tuberculosis | |||
| DNA Polymerase III | Tuberculosis | |||||
| DNA Topoisomerase (bacterial) (nonspecified subtype) | Tuberculosis | |||||
| DNA topoisomerase 1 (Escherichia coli) | B7N487 | Tuberculosis | ||||
| DNA topoisomerase 1 (Mycobacterium tuberculosis) | P9WG49 | Tuberculosis | ||||
| DNA topoisomerase IV (bacterial) | Tuberculosis | |||||
| DNA-binding protein HU homolog (Mycobacterium tuberculosis) | P9WMK7 | | Tuberculosis | |||
| dTDP-4-dehydrorhamnose reductase (bacterial) | Tuberculosis | |||||
| Endopeptidase, peptidase family M13 (Mycobacterium tuberculosis) | O53649 | Tuberculosis | ||||
| Enoyl-[acyl-carrier-protein] reductase (NADH) | P9WGR0 | | Tuberculosis | Malaria | ||
| F0F1 ATP synthase (Mycobacterium spp.) | Tuberculosis | |||||
| F1F0 ATP Synthase (Mycobacterium) | Tuberculosis | |||||
| FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase | P9WJF1 | Tuberculosis | ||||
| Fatty acid synthase (bacterial) | Tuberculosis | Leishmaniasis | ||||
| Glutamate Racemase (bacterial) | Tuberculosis | |||||
| Glutamine synthetase | P15104 | | Tuberculosis | |||
| HTH-type transcriptional regulator EthR | P9WMC1 | | Tuberculosis | |||
| Inosine-5'-monophosphate dehydrogenase (Francisella tularensis) | Q5NFC2 | Tuberculosis | ||||
| Inosine-5'-monophosphate dehydrogenase (Mycobacterium tuberculosis) | P9WKI7 | Tuberculosis | ||||
| Isocitrate lyase (Mycobacterium tuberculosis) | P9WKK7 | | Tuberculosis | |||
| Ketol-acid Reductoisomerase (NADP(+)) | Tuberculosis | |||||
| L,D-transpeptidase 2 | I6Y9J2 | | Tuberculosis | |||
| L-alanine dehydrogenase | P9WQB1 | | Tuberculosis | |||
| L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | Q9NRN7 | | Tuberculosis | |||
| L-lysine-epsilon aminotransferase | P9WQ77 | | Tuberculosis | |||
| Leucine--tRNA ligase | P9WFV1 | | Tuberculosis | Malaria | ||
| Leucyl-tRNA Synthetase LeuRS (cryptosporidial) | Malaria Tuberculosis | |||||
| Long-chain-fatty-acid--AMP ligase FadD32 | O53580 | Tuberculosis | ||||
| Lutropin-choriogonadotropic hormone receptor | P22888 | Malaria Tuberculosis | ||||
| Metallo-beta-Lactamase (NDM-1) | Tuberculosis | |||||
| Methionine aminopeptidase 1 (Mycobacterium tuberculosis) | P9WK21 | Tuberculosis | ||||
| Methionine aminopeptidase 2 (Mycobacterium tuberculosis) | P9WK19 | | Tuberculosis | |||
| Mycocyclosin synthase | P9WPP7 | | Tuberculosis | |||
| NADH dehydrogenase (Mycobacterium tuberculosis) | A0A089QMS6 | Tuberculosis | ||||
| NADH-dependent fumarate reductase, putative (Trypanosoma cruzi) | Q4CYX1 | Tuberculosis | ||||
| O-Acetylserine sulfhydrylase | P9WP55 | | Tuberculosis | |||
| O-phosphoserine sulfhydrylase | P9WP53 | | Tuberculosis | |||
| Pantothenate synthetase | P9WIL5 | Tuberculosis | ||||
| Phospho-N-Acetylmuramoyl-Pentapeptide-Transferase (Mra Y Transferase) (bacterial) | Tuberculosis | |||||
| Phospho-N-acetylmuramoyl-pentappeptidetransferase | P9WMW7 | Tuberculosis | ||||
| Phosphoadenosine phosphosulfate reductase | P65668 | Tuberculosis | ||||
| Phosphotyrosine protein phosphatase PtpB | A0A0T9ME74 | Tuberculosis | ||||
| Polyketide synthase Pks13 | I6X8D2 | Tuberculosis | ||||
| RNA polymerase (bacterial) | Tuberculosis | |||||
| S-sulfocysteine synthase | Q79FV4 | Tuberculosis | ||||
| Salicylate synthase MbtI | Q7D785 | Tuberculosis | ||||
| Serine/threonine-protein kinase PknA | P9WI83 | | Tuberculosis | |||
| Serine/threonine-protein kinase PknB | P9WI80 | | Tuberculosis | |||
| Shikimate kinase (Mycobacterium tuberculosis) | I6XEJ5 | Tuberculosis | ||||
| Signal Peptidase IB (SpsB) | Tuberculosis | |||||
| TetR family transcriptional regulator | A0A0T9K301 | Tuberculosis | ||||
| Thymidylate kinase (TMPK) (bacterial) | Tuberculosis | |||||
| Thymidylate kinase (TMPK) (M. Tuberculosis) | P9WKE1 | | Tuberculosis | |||
| Thymidylate synthase ThyX | P9WG57 | Tuberculosis | ||||
| TNFAIP1 | Tuberculosis | |||||
| Trehalose monomycolate exporter MmpL3 (Mycobacterial) | Tuberculosis | |||||
| Triacylglycerol Lipase (TG Lipase) (nonspecified subtype) | Diabetes Tuberculosis | |||||
| Tryptophan Synthase | Tuberculosis | |||||
| Type II NADH dehydrogenase | Malaria | Tuberculosis | ||||
| Tyrosyl-tRNA synthetase (bacterial) | Tuberculosis | |||||
| UDP-galactopyranose mutase | P9WIQ1 | | Tuberculosis | |||
| Undecaprenyl-phosphate alpha-N-Acetylglucosaminyl 1-Phosphate Transferase (wecA) | Tuberculosis | |||||
| Arginase | E9B627 | Leishmaniasis | ||||
| Beta-hydroxyacyl-ACP dehydratase precursor | Q8I6T4 | Leishmaniasis Malaria | ||||
| Carbonic anhydrase (Vibrio cholerae) | Q9KMP6 | Leishmaniasis | ||||
| Casein kinase 1 (isoform 2) | Q9NHE1 | Leishmaniasis | ||||
| Cdc2-related kinase 3 | O15851 | Leishmaniasis | ||||
| Cysteine proteinase B | P36400 | Leishmaniasis | ||||
| DNA topoisomerase (Leishmania donovani) | E9BU44 | Leishmaniasis | ||||
| Enoyl-acyl carrier reductase | Q9BH77 | | Leishmaniasis Malaria | |||
| Glyceraldehyde-3-phosphate dehydrogenase (Trypanosoma brucei) | Q38AR9 | Leishmaniasis | ||||
| Methionine aminopeptidase (Plasmodium falciparum) | Q8IJP2 | Leishmaniasis Malaria | ||||
| N-Myristoyltransferase (protozoal) | Malaria | Leishmaniasis | ||||
| N-Myristoyltransferase 1 (NMT1) (protozoal) | Leishmaniasis Malaria | |||||
| Ornithine decarboxylase, putative | E9BAY5 | Leishmaniasis | ||||
| Peroxisomal membrane protein PEX14 | O75381 | | Leishmaniasis | |||
| Peroxisomal targeting signal 1 receptor (isoform 1) | P50542 | | Leishmaniasis | |||
| Peroxisomal targeting signal 1 receptor (isoform 8) | P50542 | | Leishmaniasis | |||
| Phosphotransferase (Leishmania major) | Q4VT70 | Leishmaniasis | ||||
| Proteasome | Leishmaniasis | |||||
| Pteridine reductase 1 | Q01782 | Leishmaniasis | ||||
| Pteridine reductase 1 (protozoal) | Leishmaniasis | |||||
| Purine nucleosidase (trypanosomal) | Leishmaniasis | |||||
| Putative cathepsin L-like protease | E9AMH7 | Leishmaniasis | ||||
| Quinolone resistance protein | P0A0J7 | Leishmaniasis Malaria | ||||
| Serine Protease (protozoal) | Leishmaniasis | Malaria | ||||
| Sterol 24-C-Methyltransferase (Bacterial) | Leishmaniasis | |||||
| Sterol 24-C-Methyltransferase (Fungal) | Leishmaniasis | |||||
| Trypanothione Reductase (Leishmanial) | Leishmaniasis | |||||
| Trypanothione reductase (Trypanosoma cruzi) | P28593 | | Leishmaniasis Malaria | |||
| 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (Escherichia coli) | P45568 | | Malaria | |||
| 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (Mycobacterium smegmatis) | A0QVH7 | Malaria | ||||
| 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (Mycobacterium tuberculosis) | P9WNS1 | Malaria,Tuberculosis | ||||
| 2-C-Methyl-D-erythritol 4-phosphate cytidylyltransferase (CDP-ME synthase) (bacterial) | Malaria | |||||
| 2-C-Methyl-D-erythritol 4-phosphate cytidylyltransferase, putative | Q8I273 | Malaria | ||||
| Adenosine deaminase, putative | Q8IJA9 | Malaria | ||||
| Aminopeptidase N (Escherichia coli) | P04825 | Malaria | ||||
| ATP-dependent Clp protease proteolytic subunit (Plasmodium falciparum) | Q8IL98 | Malaria | ||||
| Bifunctional dihydrofolate reductase-thymidylate synthase | Q8I1R6 | Malaria | ||||
| Bifunctional dihydrofolate reductase-thymidylate synthase 1 (Plasmodium vivax) | A5K620 | Malaria | ||||
| Bifunctional glucose-6-phosphate 1-dehydrogenase/6-phosphogluconolactonase (Plasmodium falciparum) | Q8IKU0 | Malaria | ||||
| Botulinum neurotoxin type A | A5HZZ9 | Malaria | ||||
| Calcium-dependent protein kinase 1 | P62344 | Malaria | ||||
| Calcium-Dependent Protein Kinase 1 (cryptosporidial) | Malaria | |||||
| Calcium-dependent protein kinase 4 | Q8IBS5 | Malaria | ||||
| Calcium-transporting ATPase | Q76NN8 | Malaria | ||||
| Carbonic anhydrase (bacterial) | Malaria | |||||
| Carbonic Anhydrase (protozoal) | Malaria | |||||
| cGMP-dependent protein kinase | Q8I719 | | Malaria | |||
| Chloroquine resistance transporter | Q8IBZ9 | Malaria | ||||
| Cruzipain, putative | Q4DW02 | Malaria | ||||
| Cytochrome b (Plasmodium falciparum) | Q02768 | Malaria | ||||
| Cytochrome b (Toxoplasma gondii) | O20672 | Malaria | ||||
| DNA Gyrase (protozoal) | Malaria | |||||
| Elongation factor 2 (Plasmodium falciparum) | Q8IKW5 | Malaria | ||||
| Endothelial protein C receptor | Q9UNN8 | | Malaria | |||
| Endothelial protein C receptor (isoform X1) | Q9UNN8 | | Malaria | |||
| Endothiapepsin (nonspecified subtype) | Malaria | |||||
| Enoyl-(Acyl Carrier Protein) Reductase (FabI) (protozoal) | Malaria | |||||
| Falcilysin | Q76NL8 | Malaria | ||||
| Falcipain-2A | Q8I6U4 | | Malaria | |||
| Falcipain-3 | Q8IIL0 | Malaria | ||||
| Farnesyl diphosphate synthase | Q197X6 | Malaria | ||||
| Farnesyl pyrophosphate synthase (Trypanosoma brucei) | Q57WF1 | Malaria | ||||
| FK506-binding protein (FKBP)-type peptidyl-propyl isomerase (Plasmodium falciparum) | Q8I4V8 | | Malaria | |||
| Geranylgeranyl Pyrophosphate Synthase | A0A1C6YD02 B3L593 Q8II79 | Malaria | ||||
| Glyceraldehyde-3-phosphate dehydrogenase (Plasmodium falciparum) | Q8IKK7 | Malaria | ||||
| Glycylpeptide N-tetradecanoyltransferase (Plasmodium falciparum) | Q8ILW6 | Malaria | ||||
| Glycylpeptide N-tetradecanoyltransferase (Plasmodium vivax) | A5K1A2 | | Malaria | |||
| Hexokinase (Plasmodium falciparum) | C6KT76 | Malaria | ||||
| Hypoxanthine-guanine phosphoribosyltransferase (Plasmodium falciparum) | P20035 | | Malaria | |||
| Kinesin-5, putative | A0A060RSU4 | Malaria | ||||
| Leucine--tRNA ligase, putative | C6KT64 | | Malaria | |||
| Leucyl-tRNA synthetase | S8GI40 | Malaria | ||||
| m-Calpain (calpain 2) | Malaria | |||||
| Merozoite surface protein 1 | P04933 | Malaria | ||||
| Merozoite surface protein 3 | Q8IJ55 | Malaria | ||||
| Methionine aminopeptidase (bacterial) | Malaria | |||||
| N-Myristoyltransferase 2 (NMT2) (protozoal) | Malaria | |||||
| Non-SERCA-type Ca2+-transporting P-ATPase, putative | A0A1C3KWV7 | Malaria | ||||
| Pannexin-1 | Q96RD7 | Malaria | ||||
| Peptidyl-prolyl cis-trans isomerase FKBP1B (isoform a) | P68106 | Malaria | ||||
| Phenylalanyl-tRNA synthetase (bacterial) | Malaria | |||||
| Phenylalanyl-tRNA synthetase (fungal) | Malaria | |||||
| Phosphatidylinositol 4-kinase (Cryptosporidium parvum) | Q5CVD3 | Malaria | ||||
| Phosphatidylinositol 4-kinase (Plasmodium falciparum) | Q8I406 | Malaria | ||||
| Phosphotransferase (Trypanosoma brucei) | Q385M0 | Malaria | ||||
| Plasmepsin (nonspecified subtype) | Malaria | |||||
| Plasmepsin I | Q7KQM4 | Malaria | ||||
| Plasmepsin II | Q8I6V3 | Malaria | ||||
| Plasmepsin IV | Q8IM16 | Malaria | ||||
| Plasmepsin IX | Q8ILG2 | Malaria | ||||
| Plasmepsin V | Q8I6Z5 | Malaria | ||||
| Plasmepsin X | Q8IAS0 | Malaria | ||||
| Proteasome subunit beta type (Plasmodium falciparum) | Q8IJT1 | Malaria | ||||
| Protein farnesyltransferase complex | Malaria | |||||
| Serine hydroxymethyltransferase | Q8I566 | Malaria | ||||
| Serine/threonine-protein phosphatase | Q8ILV1 | Malaria | ||||
| Subtilisin-like protease 1 | Q8I0V0 | Malaria | ||||
| Subtilisin-like serine protease | A5KB00 | | Malaria | |||
| Tryptase beta-2 preproprotein | P20231 | | Malaria | |||
| Ubiquinol-cytochrome-c reductase complex | Malaria | |||||
| Vif | P69723 | Malaria | ||||
| Cathepsin B-like cysteine proteinase | P25792 P32070 | Schistosomiasis | ||||
| Histone deacetylase 8 (Schistosoma mansoni) | A5H660 | | Schistosomiasis | |||
| Thioredoxin glutathione reductase (Schistosoma mansoni) | G4V8J4 | | Schistosomiasis | |||
| Tyrosinase | P14679 | | Cancer | Diabetes Schistosomiasis Tuberculosis | ||
-
Diabetes
According to the World Health Organization, diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys, and nerves. It affects approximately 422 mln people worldwide with about 1.5 mln deaths directly attributed to diabetes each year. In the framework of our project we will study the most acute problems associated with diabetes treatment in close collaboration with medical doctors from Department of Endocrinology of Osmania General Hospital and Osmania Medical College, Hyderabad, India.
Leishmaniasis
According to the World Health Organization, there are 3 main forms of leishmaniases – visceral (the most serious), cutaneous (the most common), and mucocutaneous. Leishmaniasis is caused by the protozoan Leishmania parasites which are transmitted by the bite of infected female phlebotomine sandflies. In the framework of our project we will investigate the existing targets for antileishmanial drugs, and try to identify the novel promising targets and their ligands that may improve the curation of the disease.
Cancer
According to the World Health Organization, cancers (malignant tumors, neoplasms) are one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer related deaths. Cancer is a generic term for a large group of diseases with a complex etiology. In the framework of our project we will focus on a breast cancer, particularly on a triple negative form, which is not associated with the estrogen and progesterone hormones, or with the presence of too many HER2 receptors. In addition to design of antineoplastic compounds active against triple negative breast cancer (TNBC), we will try to identify the inhibitors of heat shock protein 70, which is overexpressed in breast cancer (Jagadish N. et al., 2016. DOI: 10.1186/s13046-016-0425-9). Ideally, the desired pharmaceutical agents have to combine the multitarget inhibitory activity on TNBC and Hsp70.
-
Tuberculosis
Tuberculosis (TB), is a common and potentially deadly infectious disease caused by species and subspecies of the Myocobacterium tuberculosis complex, primarily Mycobacterium tuberculosis. According to the World Health Organization, in 2015 there were about 10.4 mln new (incident) TB cases worldwide, including 480000 new cases of multidrug-resistant TB (MDR-TB) and an additional 100000 people with rifampicin-resistant TB (RR-TB) who were also newly eligible for MDR-TB treatment. In the framework of our project we will focus on identification of molecular targets and their combinations, action on which may be the most promising for treatment of MDR-TB.
Malaria
According to the World Health Organization, malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. In 2015 malaria affects approximately 212 mln people with 429000 deaths. In the framework of our project we will investigate the existing targets for antimalarial drugs, and try to identify the novel promising targets and their ligands that may improve the prevention and curation of the disease.
Epilepsy
According to the World Health Organization, epilepsy is a chronic noncommunicable illness of the brain that affects about 50 million people of all ages worldwide. Nearly 80% of the people with epilepsy live in low- and middle-income countries, and about three fourths of those people do not get the treatment they need. In the context of our project, we will focus on refractory (pharmacoresistant) epilepsy, which affect about 30% of epileptic patients, who may suffer from irreversible disabilities and pre-mature deaths. The mechanisms of refractory epilepsy are still unclear; however, many efforts are ongoing into discovery and development of novel antiepileptic agents with better therapeutic profiles. Better understanding of the heterogeneous nature of epilepsy and the multiple complex factors, which contribute to the abnormal neural discharges, will create the basis for progress in development of etiological rather than symptomatic therapies.